This is a Validated Antibody Database (VAD) review about human p53, based on 967 published articles (read how Labome selects the articles), using p53 antibody in all methods. It is aimed to help Labome visitors find the most suited p53 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
p53 synonym: BCC7; BMFS5; LFS1; P53; TRP53

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples at 1:1000 (fig 1b). Oncogene (2019) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:2500; loading ...; fig 1b, 4c, s3c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples at 1:2500 (fig 1b, 4c, s3c). Oncogene (2019) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig s5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot knockout validation on human samples (fig s5b). Cell Metab (2018) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • immunocytochemistry knockout validation; human; loading ...; fig 2b
  • western blot knockout validation; human; 1:1000; loading ...; fig 2c
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in immunocytochemistry knockout validation on human samples (fig 2b) and in western blot knockout validation on human samples at 1:1000 (fig 2c). Nat Commun (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 2d
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot knockout validation on human samples (fig 2d). Nucleic Acids Res (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 1f
Santa Cruz Biotechnology p53 antibody (SC Biotech, DO-1) was used in western blot knockout validation on human samples (fig 1f). Oncotarget (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig s1d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot knockout validation on human samples (fig s1d). PLoS Genet (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 2D
  • immunoprecipitation; human; loading ...; fig 6D
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot knockout validation on human samples (fig 2D) and in immunoprecipitation on human samples (fig 6D). Nucleic Acids Res (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1b
  • chromatin immunoprecipitation; human; loading ...; fig 2e
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples at 1:1000 (fig 1b) and in chromatin immunoprecipitation on human samples (fig 2e). Nat Commun (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 4f
In order to report that cathepsin S inhibition sensitizes cancer cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 4f). Antioxid Redox Signal (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 8c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 8c). Oncotarget (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig s3c
  • western blot; mouse; loading ...; fig 4j
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig s3c) and in western blot on mouse samples (fig 4j). Nature (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; mouse; loading ...; fig 3e
  • ChIP-Seq; human; loading ...; fig 4a
  • immunoprecipitation; human; loading ...; fig 5a
  • immunocytochemistry; human; loading ...; fig s5h, s5i
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on mouse samples (fig 3e), in ChIP-Seq on human samples (fig 4a), in immunoprecipitation on human samples (fig 5a), in immunocytochemistry on human samples (fig s5h, s5i) and in western blot on human samples (fig 3c). Nat Cell Biol (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 1
  • chromatin immunoprecipitation; human; fig 1
  • western blot knockout validation; mouse; fig 4
  • chromatin immunoprecipitation; mouse; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot knockout validation on human samples (fig 1), in chromatin immunoprecipitation on human samples (fig 1), in western blot knockout validation on mouse samples (fig 4) and in chromatin immunoprecipitation on mouse samples (fig 4). elife (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (PAb 240)
  • western blot knockout validation; human; fig 5c
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-99) was used in western blot knockout validation on human samples (fig 5c). Oncogene (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (B-P3)
  • western blot knockout validation; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-65334) was used in western blot knockout validation on human samples (fig 3). Sci Rep (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 3). PLoS Genet (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 5f
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot knockout validation on human samples (fig 5f). Sci Rep (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 4
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot knockout validation on human samples (fig 4). PLoS ONE (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 2
  • immunoprecipitation; human; fig 3
  • immunocytochemistry; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 2), in immunoprecipitation on human samples (fig 3) and in immunocytochemistry on human samples (fig 4). Oncotarget (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot knockout validation on human samples (fig 2a). Science (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig s7c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig s7c). Nat Commun (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 6). Oncotarget (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot knockout validation on human samples (fig 5). Sci Rep (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot knockout validation on human samples (fig 2). Nature (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 1). Cancer Res (2015) ncbi
Invitrogen
mouse monoclonal (DO-1)
  • western blot knockout validation; mouse; fig 7
  • western blot knockout validation; human; fig 7
In order to examine the role of mitochondrial p32 in ARF-induced apoptosis, Invitrogen p53 antibody (Lab Vision, DO1) was used in western blot knockout validation on mouse samples (fig 7) and in western blot knockout validation on human samples (fig 7). Cancer Cell (2008) ncbi
Invitrogen
mouse monoclonal (PAb240)
  • western blot knockout validation; human; fig 5
In order to ascertain the status of TP53 in Hec50co, Invitrogen p53 antibody (Zymed, 13-4100) was used in western blot knockout validation on human samples (fig 5). Mol Cell Biochem (2007) ncbi
Abcam
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5b
Abcam p53 antibody (Abcam, ab1101) was used in western blot knockout validation on human samples at 1:1000 (fig 5b). Nat Commun (2020) ncbi
Abcam
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig s1
Abcam p53 antibody (Abcam, ab1101) was used in western blot knockout validation on human samples (fig s1). Nucleic Acids Res (2016) ncbi
Abcam
domestic rabbit monoclonal (Y5)
  • immunocytochemistry knockout validation; human; 1:100; loading ...; fig 2e
  • western blot knockout validation; human; loading ...; fig S1c
Abcam p53 antibody (Abcam, ab32049) was used in immunocytochemistry knockout validation on human samples at 1:100 (fig 2e) and in western blot knockout validation on human samples (fig S1c). Oncotarget (2015) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; loading ...; fig s1a
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot knockout validation on mouse samples (fig s1a). Cell Rep (2020) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5h
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot knockout validation on human samples at 1:1000 (fig 5h). Nat Commun (2019) ncbi
Cell Signaling Technology
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 3a, s2g
Cell Signaling Technology p53 antibody (Cell Signaling, 18032) was used in western blot knockout validation on human samples (fig 3a, s2g). Science (2019) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; loading ...; fig 4a
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot knockout validation on mouse samples (fig 4a). Cell Rep (2017) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 6d
  • western blot knockout validation; human; loading ...; fig 1d
  • RNA immunoprecipitation; human; loading ...; fig 3b
  • ChIP-Seq; human; loading ...; fig 1a
  • immunoprecipitation; human; loading ...; fig 3d
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on mouse samples (fig 6d), in western blot knockout validation on human samples (fig 1d), in RNA immunoprecipitation on human samples (fig 3b), in ChIP-Seq on human samples (fig 1a) and in immunoprecipitation on human samples (fig 3d). Nat Genet (2016) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • immunocytochemistry knockout validation; rat; 1:50; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry knockout validation on rat samples at 1:50 (fig s1). Sci Rep (2016) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • immunoprecipitation; human; fig 6
  • western blot; human; fig 6
  • western blot knockout validation; mouse; 1:750; fig 3
In order to elucidate the mechanisms by which CYLD suppresses tumors, Cell Signaling Technology p53 antibody (Cell Signalling, 2524) was used in immunoprecipitation on human samples (fig 6), in western blot on human samples (fig 6) and in western blot knockout validation on mouse samples at 1:750 (fig 3). Nat Commun (2016) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; 1:1000; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot knockout validation on human samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; fig 1c
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot knockout validation on mouse samples (fig 1c). Nat Commun (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (7F5)
  • western blot knockout validation; human; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot knockout validation on human samples (fig 2a). Cell Death Dis (2015) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • immunocytochemistry knockout validation; rat; 1:50; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry knockout validation on rat samples at 1:50 (fig s1). Development (2015) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; 1:2000; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot knockout validation on mouse samples at 1:2000 (fig 2a). PLoS ONE (2015) ncbi
Cell Signaling Technology
mouse monoclonal (1C12)
  • western blot knockout validation; rat; 1:500; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 2524) was used in western blot knockout validation on rat samples at 1:500 (fig 1). Dis Model Mech (2013) ncbi
Leica Biosystems
domestic rabbit polyclonal (CM5)
  • western blot knockout validation; mouse; loading ...; fig 1c
Leica Biosystems p53 antibody (Leica Novocastra, CM5) was used in western blot knockout validation on mouse samples (fig 1c). Cancer Cell (2017) ncbi
Leica Biosystems
monoclonal
  • western blot knockout validation; mouse; loading ...; fig 1e
Leica Biosystems p53 antibody (Novocastra, NL-p53-505) was used in western blot knockout validation on mouse samples (fig 1e). Oncotarget (2017) ncbi
Leica Biosystems
domestic rabbit polyclonal (CM5)
  • western blot knockout validation; mouse; loading ...; fig 2e
Leica Biosystems p53 antibody (Leica Microsystems, CM5) was used in western blot knockout validation on mouse samples (fig 2e). Oncotarget (2016) ncbi
BD Biosciences
mouse monoclonal (Pab 1801)
  • western blot knockout validation; human; loading ...; fig 5e
BD Biosciences p53 antibody (PharMingen, 554170) was used in western blot knockout validation on human samples (fig 5e). Redox Biol (2017) ncbi
BD Biosciences
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 5c
In order to screen an shRNA library to identify genes whose depletion preferentially inhibit cancer cell growth, BD Biosciences p53 antibody (BD Biosciences, 554293) was used in western blot knockout validation on human samples (fig 5c). Sci Rep (2017) ncbi
BD Biosciences
mouse monoclonal (DO-7)
  • western blot knockout validation; human; fig 1
BD Biosciences p53 antibody (BD-Pharmigen, 554294) was used in western blot knockout validation on human samples (fig 1). Cell Death Dis (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DO-7)
  • western blot; mouse; loading ...; fig 3d
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-47698) was used in western blot on mouse samples (fig 3d). Cell Death Discov (2021) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 2d). iScience (2021) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; loading ...; fig 6b
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-47698) was used in western blot on human samples at 1:1000 (fig 6b). elife (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 10
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000 (fig 10). elife (2020) ncbi
mouse monoclonal (FP3.2)
  • immunocytochemistry; mouse; 1:100; loading ...; fig s5-1d
  • western blot; mouse; 1:500; loading ...; fig 5d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-51690) was used in immunocytochemistry on mouse samples at 1:100 (fig s5-1d) and in western blot on mouse samples at 1:500 (fig 5d). elife (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; loading ...; fig s3-2c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:500 (fig s3-2c). elife (2020) ncbi
mouse monoclonal (C-11)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-55476) was used in western blot on human samples (fig 3a). Cells (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:2000; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (anta Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:2000 (fig 1b). Nat Commun (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5d
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 5d). Aging (Albany NY) (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples (fig 4). Dev Reprod (2020) ncbi
mouse monoclonal (2B2.71)
  • western blot; rat; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-71819) was used in western blot on rat samples (fig 1a). Mol Med Rep (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig 2c
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on mouse samples (fig 2c). elife (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 1s1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000 (fig 1s1a). elife (2020) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 0.4 ug/ml; fig s2a
  • western blot; human; 0.4 ug/ml; loading ...; fig 7c
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in immunocytochemistry on human samples at 0.4 ug/ml (fig s2a) and in western blot on human samples at 0.4 ug/ml (fig 7c). Commun Biol (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:2500; loading ...; fig 5d
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:2500 (fig 5d). Oncogene (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 5d). elife (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig s11c
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples at 1:1000 (fig s11c). Nat Commun (2020) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; loading ...; fig 2b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on mouse samples (fig 2b). Sci Rep (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; 1:1000; fig 5c
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on mouse samples at 1:1000 (fig 5c). elife (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4i
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 4i). Mol Cancer (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig 1c). PLoS Pathog (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; 1:200; loading ...
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on mouse samples at 1:200. Oncogenesis (2020) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:500; loading ...; fig 5b
Santa Cruz Biotechnology p53 antibody (Santa, sc-47698) was used in western blot on human samples at 1:500 (fig 5b). Cancer Cell Int (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 1c, 5c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 1c, 5c). Cell Death Dis (2020) ncbi
mouse monoclonal (Pab 1801)
  • western blot; rat; 1:200; loading ...; fig 3c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in western blot on rat samples at 1:200 (fig 3c). Int J Mol Med (2020) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples at 1:1000 (fig 1b). Oncogene (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2d
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 2d). Nature (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4h
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 4h). Cell Death Dis (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig 2a). J Exp Clin Cancer Res (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; loading ...; fig 5a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:500 (fig 5a). Anal Cell Pathol (Amst) (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 3s2d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3s2d). elife (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; 1:1000; loading ...; fig s2c
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on mouse samples at 1:1000 (fig s2c). Cell (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 3g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 3g). Sci Adv (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:10,000; loading ...; fig 3i
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:10,000 (fig 3i). EMBO Mol Med (2019) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; loading ...; fig s1a
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples (fig s1a) and in western blot on human samples (fig 3a). Aging Cell (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig s2
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000 (fig s2). Clin Epigenetics (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1e
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 1e). Int J Oncol (2019) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; mouse; loading ...; fig s5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunoprecipitation on mouse samples (fig s5b). MBio (2019) ncbi
mouse monoclonal (Pab 1801)
  • western blot; mouse; 1:200; loading ...; fig s5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in western blot on mouse samples at 1:200 (fig s5b). MBio (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 2a). Int J Oncol (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig s8a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig s8a). Cancer Cell (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:200; loading ...; fig 5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:200 (fig 5b). Front Neurosci (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology p53 antibody (Santa, Sc-126) was used in western blot on human samples (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig ev2h
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig ev2h). EMBO J (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 3d
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 3d). Cell Death Dis (2019) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; loading ...; fig e8a
  • western blot; human; loading ...; fig e1b, e1d, e1e
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples (fig e8a) and in western blot on human samples (fig e1b, e1d, e1e). Nature (2019) ncbi
mouse monoclonal (2Q375)
  • western blot; human; loading ...; fig 1f
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-71820) was used in western blot on human samples (fig 1f). Oncogene (2019) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in immunohistochemistry - paraffin section on human samples (fig 3a). EMBO J (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s3f
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig s3f). Cell (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 3g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, Do-1) was used in western blot on human samples (fig 3g). Oncogene (2019) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:100; loading ...; fig 4j
  • western blot; human; 1:100; loading ...; fig 4d
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in immunohistochemistry on human samples at 1:100 (fig 4j) and in western blot on human samples at 1:100 (fig 4d). Nat Commun (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 3k
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3k). PLoS Biol (2018) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:2500; loading ...; fig 1b, 4c, s3c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples at 1:2500 (fig 1b, 4c, s3c). Oncogene (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 5d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in western blot on human samples at 1:1000 (fig 5d). elife (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 7a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 7a). Nat Commun (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig s2j
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc, sc-126) was used in western blot on human samples at 1:1000 (fig s2j). Nat Cell Biol (2018) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig s5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot knockout validation on human samples (fig s5b). Cell Metab (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4d). Cell Death Differ (2019) ncbi
mouse monoclonal (Pab 1801)
  • western blot; mouse; 1:1000; loading ...; fig 7a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in western blot on mouse samples at 1:1000 (fig 7a). Restor Neurol Neurosci (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5c
Santa Cruz Biotechnology p53 antibody (Santa, DO-1) was used in western blot on human samples (fig 5c). Sci Rep (2018) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:500; loading ...; fig 3b
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-47698) was used in western blot on human samples at 1:500 (fig 3b). Nat Commun (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:2000; loading ...; fig s11c
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot on human samples at 1:2000 (fig s11c). Nat Commun (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:2000; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot on human samples at 1:2000 (fig 1a). Oncogene (2018) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
Santa Cruz Biotechnology p53 antibody (SantaCruz, DO7) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Oncogene (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1e
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc, sc-126) was used in western blot on human samples (fig 1e). Oncogene (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 7a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples (fig 7a). J Biol Chem (2018) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry knockout validation; human; loading ...; fig 2b
  • western blot knockout validation; human; 1:1000; loading ...; fig 2c
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in immunocytochemistry knockout validation on human samples (fig 2b) and in western blot knockout validation on human samples at 1:1000 (fig 2c). Nat Commun (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; loading ...; fig 3e
  • western blot; human; 1:1000; loading ...; fig 3a
In order to identify XBP1-u as a regulator of the MDM2/p53 function, Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in immunoprecipitation on human samples (fig 3e) and in western blot on human samples at 1:1000 (fig 3a). Sci Adv (2017) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 2e
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-47698) was used in western blot on human samples (fig 2e). Oncotarget (2017) ncbi
mouse monoclonal (DO-1)
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used . Nat Med (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 2d
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot knockout validation on human samples (fig 2d). Nucleic Acids Res (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples (fig 5a). Oncogene (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (santa, DO-1) was used in western blot on human samples (fig 1a). Oncogene (2017) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; loading ...; fig 4g
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, Pab240) was used in western blot on mouse samples (fig 4g). J Pathol (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s2b
In order to investigate the role of ILF2 in RNA splicing and DNA damage response in multiple myeloma, Santa Cruz Biotechnology p53 antibody (Santa-Cruz, sc-126) was used in western blot on human samples (fig s2b). Cancer Cell (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 3e
In order to research the effects of proline and glutamine on collagen and HIF-1 expression in skin fibroblasts, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 3e). Mol Cell Biochem (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig 2f
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on mouse samples (fig 2f). Oncogene (2017) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; loading ...; fig 3b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-47698) was used in western blot on human samples at 1:1000 (fig 3b). Apoptosis (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 1f
Santa Cruz Biotechnology p53 antibody (SC Biotech, DO-1) was used in western blot knockout validation on human samples (fig 1f). Oncotarget (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 4a
In order to measure the expressions of XCR1 mRNA breast cancer cell lines, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 4a). Breast Cancer (Dove Med Press) (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 7a
In order to show that flap endonuclease 1 is critical for the rapid proliferation of lung cancer cells, Santa Cruz Biotechnology p53 antibody (SantaCruz, SC-126) was used in western blot on human samples (fig 7a). Mol Oncol (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig s1d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot knockout validation on human samples (fig s1d). PLoS Genet (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig s1b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot on human samples (fig 1b). Biochim Biophys Acta Gene Regul Mech (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig 4a
In order to investigate the me3chanisms of the effects of WDR13 on intestinal homeostasis in mice, Santa Cruz Biotechnology p53 antibody (Santa cruz, sc-126) was used in western blot on mouse samples (fig 4a). BMC Cancer (2017) ncbi
mouse monoclonal (A-1)
  • western blot; human; 1:1000; loading ...; fig 6A
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-393031) was used in western blot on human samples at 1:1000 (fig 6A). Int J Mol Med (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2a). PLoS ONE (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig 6c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on mouse samples (fig 6c). Cell Death Dis (2017) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:200; fig s3
In order to determine that HSPA9 knockdown is associated with increased TP53 expression and activity, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in immunocytochemistry on human samples at 1:200 (fig s3). PLoS ONE (2017) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:500; fig 6a
  • western blot; human; fig 5a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples at 1:500 (fig 6a) and in western blot on human samples (fig 5a). Oncotarget (2017) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:400; loading ...; fig 3a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-47698) was used in western blot on human samples at 1:400 (fig 3a). Oncol Lett (2016) ncbi
mouse monoclonal (BP 53.12)
  • western blot; human; loading ...; fig 5c
In order to assess the effect of the ROS burst on DNA integrity, cell death and differentiation potential of monocytes, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-81168) was used in western blot on human samples (fig 5c). PLoS ONE (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 8a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 8a). J Cell Physiol (2017) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; loading ...; fig 2d
  • western blot; human; loading ...; fig 1g
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126x) was used in chromatin immunoprecipitation on human samples (fig 2d) and in western blot on human samples (fig 1g). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot on human samples at 1:1000 (fig 1a). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 2D
  • immunoprecipitation; human; loading ...; fig 6D
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot knockout validation on human samples (fig 2D) and in immunoprecipitation on human samples (fig 6D). Nucleic Acids Res (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5f
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 5f). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4h-s
  • immunocytochemistry; human; fig 4a-f
  • western blot; human; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in immunohistochemistry - paraffin section on human samples (fig 4h-s), in immunocytochemistry on human samples (fig 4a-f) and in western blot on human samples (fig 2a). J Pathol (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2d). Cell Cycle (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1b
  • chromatin immunoprecipitation; human; loading ...; fig 2e
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples at 1:1000 (fig 1b) and in chromatin immunoprecipitation on human samples (fig 2e). Nat Commun (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:250; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples at 1:250 (fig 1a). Arch Biochem Biophys (2017) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5a
  • western blot; human; loading ...; fig 1a
In order to study the effect of PIK3CA in breast cancer., Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunohistochemistry - paraffin section on human samples (fig 5a) and in western blot on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 6e
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc126) was used in western blot on human samples (fig 6e). Expert Opin Ther Targets (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 4f
In order to report that cathepsin S inhibition sensitizes cancer cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 4f). Antioxid Redox Signal (2017) ncbi
mouse monoclonal (BP 53.12)
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, Bp53-12) was used in western blot on human samples (fig 5b). Cell Death Dis (2016) ncbi
mouse monoclonal (BP53-12)
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, Bp53-12) was used in western blot on human samples (fig 5b). Cell Death Dis (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 8c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 8c). Oncotarget (2016) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:3000; loading ...; fig 1d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in western blot on human samples at 1:3000 (fig 1d). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc- 126) was used in western blot on human samples (fig 1). Neuroendocrinology (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:1000; loading ...
In order to study cranial neural crest epithelial-to-mesenchymal transitions, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on mouse samples at 1:1000. J Cell Biol (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; loading ...; fig 2d
  • western blot; human; loading ...; fig 1b
In order to show a MDM2/p53-mediated rapamycin resistance in human renal cancer cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples (fig 2d) and in western blot on human samples (fig 1b). Cell Physiol Biochem (2016) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; loading ...; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in chromatin immunoprecipitation on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; loading ...; fig 1d
  • immunohistochemistry; human; 1:2000; loading ...; fig 4e
  • western blot; human; 1:3000; loading ...; fig s8
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunoprecipitation on human samples (fig 1d), in immunohistochemistry on human samples at 1:2000 (fig 4e) and in western blot on human samples at 1:3000 (fig s8). Nat Cell Biol (2016) ncbi
mouse monoclonal (PAb 240)
  • immunoprecipitation; human; loading ...; fig 7d
  • immunocytochemistry; human; 1:2000; loading ...; fig 6g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in immunoprecipitation on human samples (fig 7d) and in immunocytochemistry on human samples at 1:2000 (fig 6g). Nat Cell Biol (2016) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; loading ...; fig 2b
  • western blot; human; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in chromatin immunoprecipitation on human samples (fig 2b) and in western blot on human samples at 1:1000 (fig 2a). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; loading ...; fig 2a
In order to elucidate the contribution of MDM2 expression to retinoblastoma tumorigenesis, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in immunoprecipitation on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology p53 antibody (SantaCruz, Sc-126) was used in western blot on human samples (fig 3b). Biol Open (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 2c). Cancer Sci (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:100; loading ...; fig 2b
In order to study the effect of extracellular HIV-1 Tat protein on human uterine cervical carcinoma cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:100 (fig 2b). Oncol Lett (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig 1e
In order to explore how exercise alter p53 localization, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on mouse samples (fig 1e). J Biol Chem (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; loading ...; fig 4a
In order to elucidate the upstream mechanisms of apoptosis triggered by an anti-microtubule drug, ABT-751, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc - 126) was used in western blot on human samples at 1:500 (fig 4a). Toxicol Appl Pharmacol (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5f
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 5f). Cancer Res (2016) ncbi
mouse monoclonal (2B2.68)
  • western blot; human; 1:500; loading ...; fig 4a
In order to use polo-like kinase 1 inhibitors for a rationally designed chemotherapy protocols to treat patients with metastasized retinoblastoma, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc., sc71817) was used in western blot on human samples at 1:500 (fig 4a). Clin Exp Ophthalmol (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig 5). Cancer Sci (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig s3c
  • western blot; mouse; loading ...; fig 4j
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig s3c) and in western blot on mouse samples (fig 4j). Nature (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 3
In order to report that PPM1D modulates nucleolar formation by regulating NPM phosphorylation, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; 1:1000; loading ...; fig 1a
In order to discover that ubiquitin-specific protease 7 is a regulator of N-Myc function in neuroblastoma, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on mouse samples at 1:1000 (fig 1a). Nat Med (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 1b). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4). Mol Med Rep (2016) ncbi
mouse monoclonal (BP 53.122)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-73566) was used in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 7
In order to elucidate the mechanisms by which CYLD suppresses tumors, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 7). Nat Commun (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s10
Santa Cruz Biotechnology p53 antibody (SantaCruz, DO-1) was used in western blot on human samples (fig s10). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 1a). Nat Commun (2016) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; loading ...; fig 3b
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in chromatin immunoprecipitation on human samples (fig 3b) and in western blot on human samples (fig 2a). Sci Rep (2016) ncbi
mouse monoclonal (BP 53.12)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-81168) was used in western blot on human samples (fig 2). Mar Drugs (2016) ncbi
mouse monoclonal (Pab 1801)
  • immunoprecipitation; human; loading ...; fig 2g
  • western blot; human; loading ...; fig 4a
In order to study how SMG7 regulates p53 stability, Santa Cruz Biotechnology p53 antibody (Santa Cruz, 1801) was used in immunoprecipitation on human samples (fig 2g) and in western blot on human samples (fig 4a). Cell Discov (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4a
In order to study how SMG7 regulates p53 stability, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4a). Cell Discov (2016) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 5). Peerj (2016) ncbi
mouse monoclonal (DO-1)
  • ChIP-Seq; mouse; loading ...; fig 1a
In order to investigate the link between NEAT1 paraspeckles, p53 biology, and tumorigenesis, Santa Cruz Biotechnology p53 antibody (SCBT, DO-1) was used in ChIP-Seq on mouse samples (fig 1a). Nat Med (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; mouse; loading ...; fig 3e
  • ChIP-Seq; human; loading ...; fig 4a
  • immunoprecipitation; human; loading ...; fig 5a
  • immunocytochemistry; human; loading ...; fig s5h, s5i
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on mouse samples (fig 3e), in ChIP-Seq on human samples (fig 4a), in immunoprecipitation on human samples (fig 5a), in immunocytochemistry on human samples (fig s5h, s5i) and in western blot on human samples (fig 3c). Nat Cell Biol (2016) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human
  • immunocytochemistry; human
  • western blot; human; loading ...; fig 1d
In order to elucidate how p21 is suppressed in embryonic stem cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in chromatin immunoprecipitation on human samples , in immunocytochemistry on human samples and in western blot on human samples (fig 1d). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; fig s5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:500 (fig s5). Nat Commun (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig 7
  • western blot; human; 1:200; fig 10a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples (fig 7) and in western blot on human samples at 1:200 (fig 10a). Cancer Cell Int (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 1
  • chromatin immunoprecipitation; human; fig 1
  • western blot knockout validation; mouse; fig 4
  • chromatin immunoprecipitation; mouse; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot knockout validation on human samples (fig 1), in chromatin immunoprecipitation on human samples (fig 1), in western blot knockout validation on mouse samples (fig 4) and in chromatin immunoprecipitation on mouse samples (fig 4). elife (2016) ncbi
mouse monoclonal (2Q366)
  • western blot; mouse; loading ...; fig 1e
In order to investigate the role of growth hormone in colon cancer, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-71818) was used in western blot on mouse samples (fig 1e). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (PAb 240)
  • western blot knockout validation; human; fig 5c
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-99) was used in western blot knockout validation on human samples (fig 5c). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
In order to study how Parkin is responsible for polyubiquitination of apurinic/apyrimidinic endonuclease 1, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1). Mol Carcinog (2017) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; 1:100; fig 5
  • western blot; human; 1:1000; fig 1
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in immunoprecipitation on human samples at 1:100 (fig 5) and in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s4a
In order to assess the contribution of MEK5/ERK5 signaling in the sensitivity of colon cancer cells to 5-fluorouracil, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig s4a). Oncotarget (2016) ncbi
mouse monoclonal (Pab 1801)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; fig 3
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 1). J Biol Chem (2016) ncbi
mouse monoclonal (B-P3)
  • western blot knockout validation; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-65334) was used in western blot knockout validation on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in chromatin immunoprecipitation on human samples . Sci Rep (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 5e
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-47698) was used in western blot on human samples (fig 5e). Eur J Cell Biol (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1/sc-126) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4). Biomed Res Int (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 4). Cell Death Dis (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; loading ...; fig 3
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in western blot on human samples at 1:500 (fig 3). J Biol Chem (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 6a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 6a). Mol Cell Biochem (2016) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:500; fig 4a
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in immunohistochemistry on human samples at 1:500 (fig 4a) and in western blot on human samples (fig 1b). Oncogene (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 7g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 7g). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s8
Santa Cruz Biotechnology p53 antibody (SantaCruz, DO1) was used in western blot on human samples (fig s8). Science (2016) ncbi
mouse monoclonal (DO-1)
  • flow cytometry; human; fig 6f
  • western blot; human; 1:500; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in flow cytometry on human samples (fig 6f) and in western blot on human samples at 1:500 (fig 1a). Mol Cancer Res (2016) ncbi
mouse monoclonal (DO-1)
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used . elife (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, Sc-47698) was used in western blot on human samples (fig 5a). Nutr Cancer (2016) ncbi
mouse monoclonal (3H2820)
  • western blot; mouse; 1:100; fig 8
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-71821) was used in western blot on mouse samples at 1:100 (fig 8). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 3). PLoS Genet (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig s2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig s2). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 6
In order to determine poor prognosis markers in glioblastoma involving altered retinoic acid signaling and an association with cytoplasmic CRABP2, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 6). Glia (2016) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in western blot on human samples (fig 2). Cell Cycle (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig ev1f
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO?\1) was used in western blot on mouse samples (fig ev1f) and in western blot on human samples (fig 3a). EMBO Rep (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-47698) was used in western blot on human samples (fig 1b). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1a). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; 1:1000; loading ...; fig 3b
Santa Cruz Biotechnology p53 antibody (SantaCruz, SC-126) was used in western blot on mouse samples at 1:1000 (fig 3b). Cytokine (2016) ncbi
mouse monoclonal (C-11)
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-55476) was used in western blot on human samples (fig 3). IUBMB Life (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:200; loading ...; fig st3
  • western blot; human; 1:1000; loading ...; fig st3
In order to study the DNA damage response in senescent epithelial cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in immunocytochemistry on human samples at 1:200 (fig st3) and in western blot on human samples at 1:1000 (fig st3). Nat Commun (2016) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; loading ...; fig 9a
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in chromatin immunoprecipitation on human samples (fig 9a). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4d). J Biol Chem (2016) ncbi
mouse monoclonal (BP 53.12)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology p53 antibody (SCBT, Bp53-12) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (DO-1)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology p53 antibody (SCBT, DO-1) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (BP53-12)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology p53 antibody (SCBT, Bp53-12) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 7a
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-47698) was used in western blot on human samples (fig 7a). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 6g
  • immunocytochemistry; human; fig 2c
  • western blot; human
In order to study p53 aggregation and p53 tumor suppression in ovarian carcinomas, Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-126) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6g), in immunocytochemistry on human samples (fig 2c) and in western blot on human samples . Cancer Cell (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2a
In order to study the role of polo-like kinase 1 in essential functions of alloreactive T cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 2a). Immunol Res (2016) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; fig 1a
In order to study the effect of UBE4B on phosphorylated p53 at serines 15 and 392, Santa Cruz Biotechnology p53 antibody (Santa Cruz, Pab1801) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1a
In order to study the effect of UBE4B on phosphorylated p53 at serines 15 and 392, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:200; tbl 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in immunohistochemistry on human samples at 1:200 (tbl 4). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (PAb 122)
  • immunohistochemistry; mouse; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, Sc-56182) was used in immunohistochemistry on mouse samples (fig 6). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4
  • western blot; human; 1:500; fig 4
In order to analyze high-grade serous epithelial ovarian cancer cell lines that show sporadic and hereditary disease and the molecular diversity, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4) and in western blot on human samples at 1:500 (fig 4). Genes Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; loading ...; fig 8a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in immunohistochemistry on human samples (fig 8a). BMC Cancer (2015) ncbi
mouse monoclonal (BP53-12)
  • western blot; human; 1:1500; fig s6c
In order to determine how reuglations of m TORC1 signalling occurs by SUMOylation of AMPK alpha 1 through PIAS4, Santa Cruz Biotechnology p53 antibody (santa cruz, sc-263) was used in western blot on human samples at 1:1500 (fig s6c). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:5000; fig 3
In order to investigate MDM4 exon 6 skipping by antisense oligionucleotides and its affect on inhibiting tumor growth, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:5000 (fig 3). J Clin Invest (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 5
In order to examine the relationship between PML IV and ARF, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; fig 4b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:500 (fig 4b). Cell Death Dis (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4). BMC Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 4d
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:1000 (fig 4d). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig s4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig s4). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 5
In order to report a Cd-mediated impairment of BER pathway at sub-lethal doses, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 5). DNA Repair (Amst) (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:200; fig 1
In order to study ovarian carcinoma and the expression of stem cell markers in preinvasive tubal lesions, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnologies, sc-126) was used in immunohistochemistry on human samples at 1:200 (fig 1). Biomed Res Int (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 5
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in western blot on human samples (fig 5). Oncogenesis (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
In order to analyze a model for ductal pancreatic cancer and drug screening, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). Nat Med (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 5f
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot knockout validation on human samples (fig 5f). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 7a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 7a). Oncotarget (2017) ncbi
mouse monoclonal
  • western blot; human; 1:5000; fig s8
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-377567) was used in western blot on human samples at 1:5000 (fig s8). BMC Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3). Mol Cancer Ther (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 4
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot knockout validation on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 3). J Virol (2016) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:500; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc 98) was used in western blot on human samples at 1:500 (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; fig 3
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 1). Cell Death Dis (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 2
  • immunoprecipitation; human; fig 3
  • immunocytochemistry; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 2), in immunoprecipitation on human samples (fig 3) and in immunocytochemistry on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig s6
In order to study the relationship between arginine methylation and ubiquitylation in carcinogenesis and KLF4-mediated stability, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 11
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 11). J Biol Chem (2015) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig s3
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunocytochemistry on human samples (fig s3). Aging Cell (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 5). Nucleic Acids Res (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 1a). Mol Brain (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 6
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3). Genetics (2015) ncbi
mouse monoclonal (C-11)
  • western blot; rat; fig s8
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-55476) was used in western blot on rat samples (fig s8). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig st2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig st2). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on mouse samples (fig 5). Cancer Sci (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to identify negative regulators of NF-kappaB signaling, Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples . FEBS Lett (2015) ncbi
mouse monoclonal (Pab 1801)
  • western blot; mouse; fig 3
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-98) was used in western blot on mouse samples (fig 3) and in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:200; fig s11
In order to study how regenerative progenitors can be turned into terminally differentiated skeletal muscle cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on mouse samples at 1:200 (fig s11). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2). J Transl Med (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot knockout validation on human samples (fig 2a). Science (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig s7c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig s7c). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
In order to characterize prevention of apoptosis by degrading BBC3/PUMA due to chaperone-mediated autophagy, Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in western blot on human samples (fig 1). Autophagy (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . J Proteomics (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in western blot on human samples (fig 2b). Oncogene (2016) ncbi
mouse monoclonal (DO-1)
In order to develop a NF-kappaB functional assay in yeast and study NF-kappaB functions, interactions, and chemical modulators, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used . PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 6
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in western blot on human samples at 1:1000 (fig 3). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4g). Mol Cancer Ther (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2). Mol Biol Cell (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1). J Biomed Sci (2015) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunocytochemistry on human samples and in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig s1.
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig s1.). Nature (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa-Cruz, sc-126) was used in western blot on human samples at 1:1000. PLoS Pathog (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:500 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig s2
In order to study alpha-synuclein tetramers, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000 (fig s2). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human
In order to identify molecular targets that suppress tumorigenesis in triple negative breast cancers, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc., sc-126) was used in immunohistochemistry on human samples . J Clin Invest (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3a
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples (fig 3a). Cell Death Differ (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2A
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 2A). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:50; loading ...; fig 7d
  • western blot; human; 1:1000; loading ...; fig 3a
In order to study the contribution of p53-induced inflammation to heart failure, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples at 1:50 (fig 7d) and in western blot on human samples at 1:1000 (fig 3a). J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to identify TRIM28/KAP1 as a novel ARF-binding protein and SUMO E3 ligase for NPM1/B23, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO1) was used in western blot on human samples . Mol Cell Biol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50
Santa Cruz Biotechnology p53 antibody (MBL Company, clone sc-47698) was used in immunohistochemistry - paraffin section on human samples at 1:50. Histopathology (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000 (fig 1). Cell Cycle (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
In order to test if pomegranate juice protects trophoblasts from hypoxia-induced apoptosis by modulating NDRG1 expression, Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples at 1:1000. Placenta (2015) ncbi
mouse monoclonal (Pab 1801)
  • immunocytochemistry; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in immunocytochemistry on human samples . Cancer Cell Microenviron (2015) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:500
  • western blot; human; 1:1000
In order to describe the localization of BARD1 and study its interaction with p53, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotec, sc-126) was used in immunocytochemistry on human samples at 1:500 and in western blot on human samples at 1:1000. Cell Signal (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s7f
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig s7f). Biochem J (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:500 (fig 5). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Biomed Res Int (2015) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:250
In order to test if NBPF1 is a tumor suppressor, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in immunocytochemistry on human samples at 1:250. BMC Cancer (2015) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:500; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-98) was used in western blot on human samples at 1:500 (fig 3). Cell Death Dis (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
In order to analyze the contribution of genetic alterations and cell type of origin in breast cancer phenotypes, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotech, sc- 126) was used in western blot on human samples . Ecancermedicalscience (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:10000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:10000. J Virol (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot knockout validation on human samples (fig 5). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot knockout validation on human samples (fig 2). Nature (2015) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-99) was used in western blot on human samples at 1:500. PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC126) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). World J Surg Oncol (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4g). Oncotarget (2015) ncbi
mouse monoclonal (A-1)
  • western blot; mouse; loading ...; fig 3h
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-393031) was used in western blot on mouse samples (fig 3h). Free Radic Biol Med (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; fig 1
  • western blot; human; 1:500; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunohistochemistry - paraffin section on human samples (fig 1) and in western blot on human samples at 1:500 (fig 5). Mol Med Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 6c
Santa Cruz Biotechnology p53 antibody (santa cruz, sc-126) was used in western blot on human samples at 1:1000 (fig 6c). Oncol Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to test if base excision repair-deficient cells are a source of pre-cancerous cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Nucleic Acids Res (2015) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot knockout validation on human samples (fig 1). Cancer Res (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:100; loading ...; fig 5g
In order to use a systems biology approach to identify and study factors that contribute to Alzheimer's disease, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:100 (fig 5g). PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
In order to study the coordination of SSB repair and cell cycle progression where ATM prevents DSB formation, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4
In order to investigate how RNA polymerase I transcription inhibition induces nucleolar disruption and autophagy, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 5). Aging Cell (2015) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples . Nucleus (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:200
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:200. Cell Signal (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig s1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig s1). Aging Cell (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500
In order to determine if curcumin can diminish/prevent the development of cardiovascular pathologies, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:500. Toxicol Lett (2015) ncbi
mouse monoclonal (Pab 1801)
  • chromatin immunoprecipitation; human; fig 3b
  • western blot; human; fig 1f
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in chromatin immunoprecipitation on human samples (fig 3b) and in western blot on human samples (fig 1f). Cancer Res (2015) ncbi
mouse monoclonal (C-11)
  • western blot; human; 1:200; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-55476) was used in western blot on human samples at 1:200 (fig 4). Oncol Lett (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Cell Cycle (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3). Mol Cell Biol (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; mouse; fig 9c
  • western blot; human; 1:2000; fig 4c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunohistochemistry - paraffin section on mouse samples (fig 9c) and in western blot on human samples at 1:2000 (fig 4c). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:1000. Cell Cycle (2015) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-374087) was used in western blot on mouse samples at 1:500. Int J Mol Med (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa-Cruz, sc-126 X) was used in western blot on human samples (fig 1). Cancer Discov (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:200; fig 8
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:200 (fig 8). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 6). Mol Cell Biol (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc, DO-1) was used in western blot on human samples . Arch Biochem Biophys (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; 1:2000; loading ...; fig 4a
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-99) was used in western blot on rat samples at 1:2000 (fig 4a). PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. Free Radic Biol Med (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Br J Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . FEBS Lett (2014) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig s1
In order to determine the role of DBC1 sumoylation in p53-mediated apoptosis, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, clone DO-1) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2014) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:100
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunohistochemistry on human samples at 1:100. Br J Cancer (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa, sc-47698) was used in western blot on human samples (fig 1). Nucleic Acids Res (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to investigate the role of Rap1GAP in the cell cycle regulation, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3). Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 4a
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 4a). Hum Mol Genet (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
In order to report that NF-kappaB2 and RelB have multiple effects on the expression of key regulators of the cell cycle, reactive oxygen species generation, and protein stability, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 1). PLoS Genet (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa-Cruz Biotechnology, SC126) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; fig 5b
  • western blot; human; fig 1a
  • western blot; mouse; fig 1f
Santa Cruz Biotechnology p53 antibody (Santa, SC-126) was used in chromatin immunoprecipitation on human samples (fig 5b), in western blot on human samples (fig 1a) and in western blot on mouse samples (fig 1f). Oncotarget (2014) ncbi
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-45917) was used . Oncotarget (2014) ncbi
mouse monoclonal (2B2.68)
  • western blot; human; fig 3d
Santa Cruz Biotechnology p53 antibody (SantaCruz, sc-71817) was used in western blot on human samples (fig 3d). Mol Cancer (2014) ncbi
mouse monoclonal (C-11)
  • western blot; human
In order to determine the effect of zerumbone on p53 signaling and assess if zerumbone has anti-cancer effects on non-small cell lung cancer, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-55476) was used in western blot on human samples . Biochimie (2014) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunocytochemistry on human samples (fig 4). Immunol Lett (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to investigate the sensitization of cancer cells by c-Abl inhibition, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:5000
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunohistochemistry on human samples at 1:5000. PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 0.2 ug/ml
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples at 0.2 ug/ml. PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to study the effect of Hinokitiol on DNA damage and autophagy in gefitinib-resistant lung adenocarcinoma cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (PAb 240)
  • western blot; human
  • western blot; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, Pab240) was used in western blot on human samples and in western blot on mouse samples . Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:2000; fig 5h
In order to show that the zinc finger E-box binding homeobox 1 regulates radiosensitivity and the DNA damage response in breast cancer cells, Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples at 1:2000 (fig 5h). Nat Cell Biol (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000. J Biol Chem (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to develop high throughput methods to assess proof-of-concept in vitro-only risk assessments, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Toxicol Sci (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples . elife (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in western blot on human samples (fig 2). Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-98) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in immunoprecipitation on human samples and in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples . Arch Pharm Res (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in western blot on human samples (fig 1b). PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples (fig 6). J Pathol (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on mouse samples and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. Front Endocrinol (Lausanne) (2014) ncbi
mouse monoclonal (BP53-12)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa, sc-263) was used in western blot on human samples . elife (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse
In order to demonstrate a novel role for Poldip2 in regulating the cell cycle, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; fig s1
Santa Cruz Biotechnology p53 antibody (santa Cruz, sc-126) was used in western blot on human samples at 1:500 (fig s1). Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples . Aging Cell (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to study the involvement of RASSF1A inactivation in carcinogenesis, Santa Cruz Biotechnology p53 antibody (Santa Cruz., sc-126) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (BP53-12)
  • immunoprecipitation; human; fig 7
  • western blot; human
In order to study the role in prostate cancer poliferation of a complex containing COP9 subunits 4 and 5 along with sGC-alpha1 and p53, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-263) was used in immunoprecipitation on human samples (fig 7) and in western blot on human samples . Mol Endocrinol (2014) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human
In order to elucidate TP53-mediated oncogenic transformation of epithelial cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in chromatin immunoprecipitation on human samples . Sci Rep (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotech, DO-1) was used in western blot on human samples (fig 2). Nature (2014) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunoprecipitation on human samples and in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 5b). J Cell Sci (2014) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; 1:300
  • western blot; human
In order to study the effect of a UBE2N inhibitor on neuroblastoma and its mechanism, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples at 1:300 and in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (PAb 240)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on human samples . ScientificWorldJournal (2014) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:500
In order to determine the cellular function of Lyar, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-17846) was used in western blot on human samples at 1:500. Genes Cells (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . Cell Death Differ (2014) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in immunocytochemistry on human samples and in western blot on human samples . Mol Oncol (2014) ncbi
mouse monoclonal (DO-1)
  • EMSA; mouse
  • EMSA; rat
In order to study the upregulation of pancreatic beta cell ARAP1 by a functional regulatory DNA variant at a type 2 diabetes locus, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126X) was used in EMSA on mouse samples and in EMSA on rat samples . Am J Hum Genet (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:2000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:2000. Nucleic Acids Res (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples at 1:1000. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. FEBS J (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human
  • immunocytochemistry; human
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples and in western blot on human samples . Cell Cycle (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples . Br J Cancer (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . Cell Cycle (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples at 1:1000 (fig 2). Exp Cell Res (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in western blot on human samples . Nucleic Acids Res (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Mol Cancer (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on mouse samples . J Neurosci (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . J Biol Chem (2013) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in immunocytochemistry on human samples (fig 5). J Cell Biol (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 3
In order to investigate the function of ING4 in normal, non-transformed primary fibroblasts, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 3). Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . Blood (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples (fig 5). Biochem J (2013) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples (fig 2). EMBO J (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples . Mol Oncol (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in western blot on human samples at 1:1000. Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples . Nucleic Acids Res (2013) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . Nucleic Acids Res (2013) ncbi
mouse monoclonal (BP53-12)
  • western blot; human; fig 4c
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-263) was used in western blot on human samples (fig 4c). Cell Cycle (2012) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples . J Ethnopharmacol (2011) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. Nucleic Acids Res (2011) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in western blot on human samples . Mol Cell (2009) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biot, DO-1) was used in western blot on human samples . Cell Res (2008) ncbi
mouse monoclonal (DO-1)
  • western blot; human
In order to investigate the potential role of the proteasome in checkpoint activation and ATM/ATR signaling in response to UV light-induced DNA damage, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples . J Biol Chem (2008) ncbi
mouse monoclonal (PAb 240)
  • western blot; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-99) was used in western blot on human samples . Oncogene (2007) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:500; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa, sc-99) was used in western blot on mouse samples at 1:500 (fig 1a). Nucleic Acids Res (2006) ncbi
Invitrogen
mouse monoclonal (X77)
  • western blot; Xenopus laevis; 1:1000; loading ...; fig 1e
Invitrogen p53 antibody (Thermo Fisher, MA1-12549) was used in western blot on Xenopus laevis samples at 1:1000 (fig 1e). elife (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4a
Invitrogen p53 antibody (Labvision, MS-187P) was used in western blot on human samples (fig 4a). Cell Rep (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1c
Invitrogen p53 antibody (Thermo Fisher, DO-1) was used in western blot on human samples (fig 1c). Oncotarget (2018) ncbi
domestic rabbit recombinant (14H61L24)
  • western blot; human; loading ...; fig 1c
Invitrogen p53 antibody (Thermo Fisher, 14H61L24) was used in western blot on human samples (fig 1c). Oncotarget (2018) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 1a
Invitrogen p53 antibody (Invitrogen, DO1) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1a). Science (2018) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; rat; 1:100; loading ...; fig 1b
In order to compare the efficiency of fascaplysin with other drugs used to treat glial tumors, Invitrogen p53 antibody (Thermo Fisher Scientific, AHO0152) was used in immunocytochemistry on rat samples at 1:100 (fig 1b). Oncol Lett (2017) ncbi
domestic rabbit recombinant (14H61L24)
  • western blot; human; loading ...; fig 3e
In order to show that ROS-induced DNA damage reduces metabolic activity, inhibits proliferation, and induces cell cycle arrest followed by activation of p16-, p21-, and p27- mediated DNA damage response pathways, premature senescence, and apoptosis induction, Invitrogen p53 antibody (Thermo Scientific, 700439) was used in western blot on human samples (fig 3e). Exp Cell Res (2017) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; 1:500; loading ...; fig 2n
In order to suggest that CASP9 germline mutations may promote the development of brain tumors, Invitrogen p53 antibody (NeoMarkers, BP53-12) was used in immunohistochemistry on human samples at 1:500 (fig 2n). Brain Pathol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:50; loading ...; fig 5a
In order to determine the effect of 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one on the induction of apoptosis and cell cycle arrest in human bladder carcinoma cells, Invitrogen p53 antibody (Thermo Fisher Scientific, PA5-27822) was used in western blot on human samples at 1:50 (fig 5a). Mol Med Rep (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; tbl 2
In order to review the relevance of BRAF V600E mutation to colorectal cancer, Invitrogen p53 antibody (Thermo Fisher Scientific, D07) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). J Korean Med Sci (2017) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
In order to analyze high-risk HPV incidence, prognostic biomarkers, and outcome in HIV-positive and -negative patients with head and neck squamous cell cancer, Invitrogen p53 antibody (Thermo Scientific, DO-1) was used in immunohistochemistry - paraffin section on human samples (fig 2). Mol Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7c
  • western blot; mouse; loading ...; fig 7b
In order to study histone deacetylase 9 in diffuse large B-cell lymphoma, Invitrogen p53 antibody (Thermo Scientific, PA5-17287) was used in immunohistochemistry - paraffin section on mouse samples (fig 7c) and in western blot on mouse samples (fig 7b). Dis Model Mech (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; rat; 1:100; loading ...
In order to study the use of hematopoietic stem cells to treat glioblastoma, Invitrogen p53 antibody (Thermo, AHO0152) was used in immunocytochemistry on rat samples at 1:100. Mol Med Rep (2016) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry; human; loading ...; fig 1b
In order to correlate 1p/19q codeletion, IDH1 mutation and p53 protein overexpression with prognosis in Turkish anaplastic oligodendroglioma patients treated with adjuvant radiotherapy and temozolomide chemotherapy, Invitrogen p53 antibody (Thermo Fisher, DO-7+BP53-12) was used in immunohistochemistry on human samples (fig 1b). Turk Neurosurg (2017) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; 1:2000; loading ...; fig 4c
In order to propose that leukemia inhibitory factor signaling confers a dormancy phenotype in breast cancer cells that have disseminated to bone, Invitrogen p53 antibody (Invitrogen, 13-4000) was used in western blot on human samples at 1:2000 (fig 4c). Nat Cell Biol (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; rat; 1:100; fig 1
In order to clarify the interaction between microglial cells and cancer stem cells, Invitrogen p53 antibody (Novex, Thermo Fisher Scientific, AHO0152) was used in immunocytochemistry on rat samples at 1:100 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to find prognostic clusters for breast cancer, Invitrogen p53 antibody (NeoMarkers, DO7) was used in immunohistochemistry - paraffin section on human samples (fig 1). BMC Cancer (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; loading ...; fig 3c
In order to describe the mechanism behind the association between single nucleotide polymorphism rs55705857 and glioma development., Invitrogen p53 antibody (Thermo Fisher, A00021-IFU) was used in immunohistochemistry on human samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (PAb 122)
  • immunocytochemistry; rat; 1:1000; fig 11
  • western blot; rat; fig s6
In order to elucidate an increase of apoptosis and disruption of cytoskeleton organization of rat neural crest stem cells via upregulating CXCR4 expression and RhoA-ROCK1-p38 MAPK-p53 signaling due to simulated microgravity, Invitrogen p53 antibody (Invitrogen, PAb 122) was used in immunocytochemistry on rat samples at 1:1000 (fig 11) and in western blot on rat samples (fig s6). Stem Cells Dev (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:600; fig 1
In order to study 3 cases of uterine adenomyosis/adenomyotic cysts of the cervical stump leading to serous carcinoma, Invitrogen p53 antibody (Thermo, DO-7) was used in immunohistochemistry on human samples at 1:600 (fig 1). Diagn Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1b
In order to evaluate the diagnostic value of stathmin expression in samples of vulvar intraepithelial neoplastic lesions, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1b). J Clin Pathol (2016) ncbi
domestic rabbit monoclonal (SP5)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 1
In order to examine the association between pretreatment molecular and clinical factors and axillary lymph node metastases in early breast cancer, Invitrogen p53 antibody (Neomarkers, SP5) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Medicine (Baltimore) (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:1000; tbl 2
In order to perform morphological, p53 immunohistochemical, and TP53 gene mutational analyses of pelvic carcinosarcomas, Invitrogen p53 antibody (Thermo Fisher, DO-7) was used in immunohistochemistry on human samples at 1:1000 (tbl 2). Virchows Arch (2016) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1i
In order to measure adenosine A1 and A2a receptor expression and determine their association with glioma development and epilepsy, Invitrogen p53 antibody (Thermo Scientific, DO-7+BP53-12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1i). Neurochem Res (2016) ncbi
mouse monoclonal (BP53-12)
  • western blot; human; fig 2
In order to study attenuation of AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC by the human papillomavirus 16 E7 oncoprotein, Invitrogen p53 antibody (Thermo Scientific, MA1-19055) was used in western blot on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 4
In order to study APC/C(Cdh1) function, Invitrogen p53 antibody (Thermo Scientific, MS-186) was used in western blot on human samples at 1:1000 (fig 4). Nucleic Acids Res (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2a
In order to ask if p53 status of patients with hepatocellular carcinoma affects the efficacy of herpes simplex virus-1 thymidine kinase/ganciclovir therapy, Invitrogen p53 antibody (NeoMarkers, DO-1) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (PAb240)
  • western blot; human; 1:1000; fig 4
In order to assess antiproliferative inhibitors of protein-protein interactions by pooled screening, Invitrogen p53 antibody (Invitrogen, 13-4100) was used in western blot on human samples at 1:1000 (fig 4). Nat Chem Biol (2016) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; fig 3
In order to report the crystal structure of the E6/E6AP/p53 complex, Invitrogen p53 antibody (Life Technologies, 13-4000) was used in western blot on human samples (fig 3). Nature (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 1b
In order to develop a method to examine protein oligomerization in cells using a single electrophoresis gel, Invitrogen p53 antibody (Thermo Fisher, DO-7) was used in western blot on human samples (fig 1b). Anal Bioanal Chem (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s2a
In order to identify and study roles for MAP3K8 in high-grade serous ovarian carcinomas, Invitrogen p53 antibody (Thermoscientific, MS-187-PO) was used in western blot on human samples (fig s2a). Nat Commun (2015) ncbi
domestic rabbit monoclonal (Y5)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to characterize hepatocellular carcinoma tissues and missense mutations in exons 18-24 of EGFR, Invitrogen p53 antibody (Lab Vision, Y5) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Biomed Res Int (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:200; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, Invitrogen p53 antibody (Thermo Scientific, p53 Ab-6 (Clone DO-1)) was used in immunohistochemistry on human samples at 1:200 (fig 3). Gastroenterology (2015) ncbi
mouse monoclonal (Pab1801)
  • western blot; human
In order to show that the INO80 complex negatively regulates the p21Waf1/Cip1 expression in a p53-mediated mechanism, Invitrogen p53 antibody (ZYMED, 13-4000) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry - paraffin section; human; 1:70; fig 4
In order to study adenosine deaminase and adenosine kinase expression in human glioma and to determine its correlation with glioma associated epilepsy, Invitrogen p53 antibody (Thermo Fisher Scientific, DO-7+BP53-12) was used in immunohistochemistry - paraffin section on human samples at 1:70 (fig 4). Mol Med Rep (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 8
In order to assess links between telomere-dysfunction and centrosome defects in early breast carcinogenesis, Invitrogen p53 antibody (Thermo Scientific, MS-186) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; 1:4000; tbl 1
In order to determine if p53 overexpression can be used to distinguish different breast cancer subtypes, Invitrogen p53 antibody (Invitrogen, MD21704USA) was used in immunohistochemistry on human samples at 1:4000 (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen p53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Pathol Res Pract (2015) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry - paraffin section; human; fig 1
In order to demonstrate that RUNX2 and p53 independently predict early tumor recurrence in bladder carcinoma patients, Invitrogen p53 antibody (Thermo Scientific, DO-7+BP53-12) was used in immunohistochemistry - paraffin section on human samples (fig 1). Appl Immunohistochem Mol Morphol (2016) ncbi
domestic rabbit monoclonal (SP5)
  • immunohistochemistry; human; 1:200
Invitrogen p53 antibody (Thermo, SP5) was used in immunohistochemistry on human samples at 1:200. Urol Oncol (2015) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to analyze breast cancer subtypes and retrospective analysis of metastatic behaviour, Invitrogen p53 antibody (Thermo Scientific, DO-7 +BP53-12) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human
  • western blot; human
In order to study the homo- and heterodimerization of an E3 ligase MDM2, Invitrogen p53 antibody (Labvision, DO-1) was used in immunoprecipitation on human samples and in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:400
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on human samples at 1:400. Gynecol Oncol (2015) ncbi
mouse monoclonal (X77)
  • western blot; Xenopus laevis; 1:800
In order to determine the role of NOL11 in vertebrate ribosome biogenesis and craniofacial development, Invitrogen p53 antibody (Thermo Scientific, MA1-12549) was used in western blot on Xenopus laevis samples at 1:800. PLoS Genet (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 1
In order to report that p53 and DeltaNp63alpha are transcriptional partners for SMAD proteins, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in western blot on human samples (fig 1). Mol Cancer Res (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:400
In order to describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases, Invitrogen p53 antibody (Thermo Fisher Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:400. Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen p53 antibody (LabVisio, DO-7) was used in immunohistochemistry - paraffin section on human samples . APMIS (2015) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3a
In order to compare the features of patients with proliferative verrucous leukoplakia and those with conventional squamous cell carcinoma, Invitrogen p53 antibody (Neomarkers, DO-7+Bp53-12) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3a). Oral Surg Oral Med Oral Pathol Oral Radiol (2015) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry; human; 1:100
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen p53 antibody (Lab Vision, DO-7+BP53-12) was used in immunohistochemistry on human samples at 1:100. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen p53 antibody (Thermo Scientific, MS187) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen p53 antibody (LabVision, DO-7) was used in immunohistochemistry on human samples at 1:50. Arch Dermatol Res (2015) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:1000; fig 5
In order to characterize inhibition of neuronal tumor cell proliferation by mitochondrial ferritin, Invitrogen p53 antibody (Thermo Fisher Scientific, MS-105-P0) was used in western blot on human samples at 1:1000 (fig 5). Cell Mol Life Sci (2015) ncbi
domestic rabbit monoclonal (SP5)
  • immunohistochemistry; human; 1:50; tbl 1
In order to study 3-Tesla MRI diffusion coefficient measurements correlated with biomarkers of bladder cancer proliferative activity, Invitrogen p53 antibody (Neomarkers, RM-9105-S) was used in immunohistochemistry on human samples at 1:50 (tbl 1). PLoS ONE (2014) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; fig 1
In order to study the effect of ceramide treatment on p53, Invitrogen p53 antibody (Invitrogen, 13-4000) was used in western blot on human samples (fig 1). Biochim Biophys Acta (2014) ncbi
domestic rabbit recombinant (14H61L24)
  • immunohistochemistry - paraffin section; human; 1:400
In order to investigate Bcl2 expression in colorectal adenocarcinoma, Invitrogen p53 antibody (Invitrogen, 700439) was used in immunohistochemistry - paraffin section on human samples at 1:400. J Am Coll Surg (2014) ncbi
domestic rabbit recombinant (14H61L24)
  • western blot; human
In order to develop high throughput methods to assess proof-of-concept in vitro-only risk assessments, Invitrogen p53 antibody (Invitrogen, 700439) was used in western blot on human samples . Toxicol Sci (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:250
Invitrogen p53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:250. Am J Clin Pathol (2014) ncbi
domestic rabbit monoclonal (SP5)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to study the correlation of Ki-67 and cell cycle proteins in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation, Invitrogen p53 antibody (Neomarkers, RM 9105-S) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Biomed Res Int (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; rat; 1:100; fig 1, 2, 3
In order to study the effect of artificial food colors and additives on laryngeal histomorphology and immunohistochemical expression in maternally exposed rats, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on rat samples at 1:100 (fig 1, 2, 3). J Environ Pathol Toxicol Oncol (2014) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; rat; 1:100; fig 1, 2, 3
In order to study the effect of artificial food colors and additives on laryngeal histomorphology and immunohistochemical expression in maternally exposed rats, Invitrogen p53 antibody (Thermo Scientific, BP53-12) was used in immunohistochemistry on rat samples at 1:100 (fig 1, 2, 3). J Environ Pathol Toxicol Oncol (2014) ncbi
mouse monoclonal (PAb240)
  • western blot; mouse; fig 2
In order to study the oncogenic and developmental properties of TBX3, Invitrogen p53 antibody (Invitrogen, 134100) was used in western blot on mouse samples (fig 2). elife (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
In order to describe a new polymeric-phospholipidic hybrid delivery system which enhanced the accumulation and activity of Dox in all tested cancer cell lines, Invitrogen p53 antibody (NeoMarkers, Do-1) was used in western blot on human samples at 1:1000. J Biomed Nanotechnol (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Invitrogen p53 antibody (Invitrogen, CA#AHO0152) was used in western blot on human samples . Arch Biochem Biophys (2014) ncbi
mouse monoclonal (PAb240)
  • immunohistochemistry; mouse
Invitrogen p53 antibody (Invitrogen, PAb 240) was used in immunohistochemistry on mouse samples . Tumour Biol (2014) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:800
In order to characterize a melanoma cell line with a novel deletion/substitution from CC to T in the shared exon 2 of p14ARF/p16, Invitrogen p53 antibody (Thermo, PAb1801) was used in western blot on human samples at 1:800. PLoS ONE (2014) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; 1:800
In order to characterize a melanoma cell line with a novel deletion/substitution from CC to T in the shared exon 2 of p14ARF/p16, Invitrogen p53 antibody (Thermo, PAb1801) was used in western blot on human samples at 1:800. PLoS ONE (2014) ncbi
mouse monoclonal (Pab 1801)
  • immunocytochemistry; human; 1:100
  • western blot; human; 1:500
Invitrogen p53 antibody (Biosource, PAb 1801) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (Pab1801)
  • immunocytochemistry; human; 1:100
  • western blot; human; 1:500
Invitrogen p53 antibody (Biosource, PAb 1801) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to assess the association between methylation of the FHIT gene and its expression in breast cancer, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Oncol Rep (2013) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:500; tbl 1
In order to measure the expression of VEGF, HIF-1alpha, and CD34 in breast tumors and correlate the findings with clinical and pathological variables, Invitrogen p53 antibody (Zymed, clone BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 1). Acta Histochem (2014) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to study triple negative breast cancer in Chinese women, Invitrogen p53 antibody (Zymed, clone BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Int J Clin Exp Pathol (2013) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx, Invitrogen p53 antibody (Lab Vision, DO-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Laryngoscope (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
In order to report and characterize two cases of accessory breast cancer occurring concurrently with primary invasive breast cancer, Invitrogen p53 antibody (Zymed, DO-7) was used in immunohistochemistry on human samples . Cancer Biol Med (2012) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human
In order to determine the relationship of AEG-1 and p53 with the prognostic parameters of renal cell carcinoma, Invitrogen p53 antibody (Zymed, clone BP53-12) was used in immunohistochemistry - paraffin section on human samples . Pol J Pathol (2013) ncbi
mouse monoclonal (DO-7)
  • immunocytochemistry; human; 1:200; fig 1
  • western blot; human; 1:1000; fig 2
In order to analyze the activity of p53 after stimulation with p53-dependent and -independent DNA damaging agents during human herpesvirus-infection, Invitrogen p53 antibody (Life Technologies, DO-7) was used in immunocytochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human
In order to discuss the role of breast cancer-derived IgG in cancer development, Invitrogen p53 antibody (Zymed Laboratories, AHO0152) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; 1:200
  • western blot; human; 1:250; fig 2
In order to determine the localization and expression of RARalpha, RARbeta, and RARgamma in bull and dog sperm, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry on human samples at 1:200 and in western blot on human samples at 1:250 (fig 2). Theriogenology (2013) ncbi
mouse monoclonal (BP53-12)
  • immunocytochemistry; human; fig 4
In order to study the role of p53 and p21 in apoptosis using congenital cholesteatoma samples, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunocytochemistry on human samples (fig 4). Otol Neurotol (2013) ncbi
mouse monoclonal (PAb240)
  • western blot; mouse; fig 3
In order to determine the occurrence of social deficits and mitochondrial outcomes in conditional Phosphatase and tensin homolog haplo-insufficient mice, Invitrogen p53 antibody (Invitrogen, 134100) was used in western blot on mouse samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:2000; fig 3
In order to study the cellular changes induced by resveratrol using Hodgkin lymphoma-derived L-428 cells, Invitrogen p53 antibody (Zymed, PAB1801) was used in western blot on human samples at 1:2000 (fig 3). Int J Cancer (2013) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; 1:2000; fig 3
In order to study the cellular changes induced by resveratrol using Hodgkin lymphoma-derived L-428 cells, Invitrogen p53 antibody (Zymed, PAB1801) was used in western blot on human samples at 1:2000 (fig 3). Int J Cancer (2013) ncbi
mouse monoclonal (DO-7, BP53-12)
  • western blot; mouse; 1:500
In order to study the role of TGF-beta inhibitors in abolishing the resistance of glioblastoma to ionozing radiation therapy, Invitrogen p53 antibody (Neomarkers, MS-738-P) was used in western blot on mouse samples at 1:500. Cancer Res (2012) ncbi
mouse monoclonal (DO-7, BP53-12)
  • immunohistochemistry - paraffin section; human; 1:2000; tbl 1
In order to correlate various clinicopathological and immunohistological variables to pancreatic ductal adenocarcinoma survival, Invitrogen p53 antibody (Thermo Scientific, MS-738-7) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (tbl 1). Cell Oncol (Dordr) (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; tbl 3
In order to study the expression of Ki-67, tumor protein P53, P21, and P27 in 8 paired WHO grade II astrocytoma samples, Invitrogen p53 antibody (Zymed, Do-7) was used in immunohistochemistry - paraffin section on human samples (tbl 3). Chin J Cancer (2012) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to assess the role of age on expression of p53-target genes, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Mech Ageing Dev (2012) ncbi
mouse monoclonal (PAb240)
  • immunohistochemistry; mouse; 1:250; fig s1
In order to investigate the origin of UV-induced squamous cell carcinomas, Invitrogen p53 antibody (Thermo Fisher Scientific, Pab240) was used in immunohistochemistry on mouse samples at 1:250 (fig s1). Carcinogenesis (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:30
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen p53 antibody (Lab Vision, MS-186) was used in immunohistochemistry - paraffin section on human samples at 1:30. Int J Oncol (2012) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 1
In order to develop a method to quantify p53 degradation activity of E6 in vivo and assess HPV variants, Invitrogen p53 antibody (Invitrogen, AHO0152) was used in western blot on human samples (fig 1). J Virol (2012) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human
In order to examine human papillomavirus type 16 status and the expression levels of a defined set of biomarkers for head and neck squamous cell carcinoma to identify predictors of treatment, Invitrogen p53 antibody (Zymed, clone BP53-12) was used in immunohistochemistry on human samples . Cancer (2012) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; fig 3
In order to report a case of pituicytoma with unusual histological features mimicking ependymoma, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunohistochemistry - paraffin section on human samples (fig 3). Pathol Int (2011) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the roles of p53 and hMSH2 proteins in oral squamous cell carcinoma and oral dysplastic lesions, Invitrogen p53 antibody (Zymed, Do7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oral Oncol (2012) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; fig 1
In order to study clusterin in Hodgkin's lymphoma-derived cell lines, Invitrogen p53 antibody (Zymed, PAB1801) was used in western blot on human samples (fig 1). Int J Oncol (2011) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; fig 1
In order to study clusterin in Hodgkin's lymphoma-derived cell lines, Invitrogen p53 antibody (Zymed, PAB1801) was used in western blot on human samples (fig 1). Int J Oncol (2011) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 5
In order to identify preoperative predictive factors associated with intraductal papillary mucinous neoplasms of the pancreas, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 5). World J Gastroenterol (2010) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 8
In order to assess antibodies to use for the diagnosis of metastatic adenocarcinomas, Invitrogen p53 antibody (ZYMED, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8). Diagn Cytopathol (2011) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; 1:50; fig 5
In order to establish a reference device for validating immunohistochemical biomarkers, Invitrogen p53 antibody (Zymed-Invitrogen, BP53.12) was used in immunohistochemistry on human samples at 1:50 (fig 5). J Histochem Cytochem (2010) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2, 3, 4
In order to report a new clinical case of prostatic adenomas with abnormal p63 expression, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2, 3, 4). Int J Surg Pathol (2011) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; fig 4
In order to determine the methylation status in the promoter region of the p14ARF gene in brain tissues isolated from glioma patients, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry on human samples (fig 4). Med Oncol (2011) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to report and characterize an unusual intraductal growing bile duct tumor, which shares features with an intraductal tubulopapillary neoplasm, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Pathol Int (2010) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 4
In order to assess the prognostic impact of p53 alteration in human uterine endometrial adenocarcinoma, Invitrogen p53 antibody (Zymed, Bp53-12) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 4). Gynecol Oncol (2010) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 3
In order to assess the effect of mismatch repair status on the treatment outcomes in recurrent or metastatic colon cancer, Invitrogen p53 antibody (Zymed, Bp53-12) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 3). Med Oncol (2010) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; fig 4
In order to identify genes important in hepatocellular carcinogenesis, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples (fig 4). Toxicology (2009) ncbi
mouse monoclonal (PAb240)
  • immunohistochemistry; rat
In order to report that pretreatment of Wistar rats with the aqueous extract of Asparagus racemosus prevents diethylnitrosamine-induced damage, Invitrogen p53 antibody (Biosource, Pab240) was used in immunohistochemistry on rat samples . Phytother Res (2008) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; mouse; fig 7
  • western blot knockout validation; human; fig 7
In order to examine the role of mitochondrial p32 in ARF-induced apoptosis, Invitrogen p53 antibody (Lab Vision, DO1) was used in western blot knockout validation on mouse samples (fig 7) and in western blot knockout validation on human samples (fig 7). Cancer Cell (2008) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; tbl 3
In order to assess expression of Her2, epidermal growth factor receptor, and cyclin D1 in primary breast carcinomas, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples (tbl 3). Pathol Int (2008) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; fig 2
In order to correlate p53 expression in the development of squamous cell carcinoma lesions, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Am Acad Dermatol (2007) ncbi
mouse monoclonal (PAb240)
  • immunohistochemistry - paraffin section; dogs
In order to explore the origin of spindle cell tumors in the anterior uveal tract of dogs and assess the influence of ultraviolet radiation on the development of this tumor, Invitrogen p53 antibody (Zymed, 13-4100) was used in immunohistochemistry - paraffin section on dogs samples . Vet Pathol (2007) ncbi
mouse monoclonal (PAb240)
  • western blot; mouse
In order to investigate Abl nuclear import in DNA damage-induced apoptosis, Invitrogen p53 antibody (Zymed/Invitrogen, PAB240) was used in western blot on mouse samples . Cell Death Differ (2007) ncbi
mouse monoclonal (PAb240)
  • western blot knockout validation; human; fig 5
In order to ascertain the status of TP53 in Hec50co, Invitrogen p53 antibody (Zymed, 13-4100) was used in western blot knockout validation on human samples (fig 5). Mol Cell Biochem (2007) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; 1:50
In order to characterize cases of postradiation carcinomas, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry on human samples at 1:50. Int J Gynecol Pathol (2006) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:150; fig 1
In order to propose that the estrogen receptor regulates the p14ARF-MDM2-p53 pathway in ovarian serous neoplasms, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1). Int J Gynecol Cancer (2006) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; 1:2000; fig 5
  • western blot; African green monkey; 1:2000; fig 3
In order to identify and study a novel p53/an autosomal homolog of the fragile X mental retardation chimeric gene generated by an interstitial deletion, Invitrogen p53 antibody (Zymed, PAb1801) was used in western blot on human samples at 1:2000 (fig 5) and in western blot on African green monkey samples at 1:2000 (fig 3). Tohoku J Exp Med (2006) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; 1:2000; fig 5
  • western blot; African green monkey; 1:2000; fig 3
In order to identify and study a novel p53/an autosomal homolog of the fragile X mental retardation chimeric gene generated by an interstitial deletion, Invitrogen p53 antibody (Zymed, PAb1801) was used in western blot on human samples at 1:2000 (fig 5) and in western blot on African green monkey samples at 1:2000 (fig 3). Tohoku J Exp Med (2006) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:50
In order to correlate expression patterns of COX-2 and p53 in several skin tumors, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Dermatol (2006) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to examine apoptosis and cell proliferation in synovial sarcoma, Invitrogen p53 antibody (Zymed, D07) was used in immunohistochemistry - paraffin section on human samples . Eur J Cancer Prev (2006) ncbi
mouse monoclonal (BP53-12)
  • western blot; human; fig 9
In order to assess the effect of 4-hydroxynonenal on telomerase activity and hTERT expression in human leukemic cell lines, Invitrogen p53 antibody (Zymed, BP53.12) was used in western blot on human samples (fig 9). Free Radic Biol Med (2006) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to discuss recurrent intracranial hemangiopericytoma with multiple metastases, Invitrogen p53 antibody (Zymed Laboratories, do-7) was used in immunohistochemistry on human samples at 1:50. Chin Med J (Engl) (2006) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the extent and prognostic significance of MDR-related protein expression in ovarian serous carcinomas and correlate their expression with apoptosis-related proteins, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:100. Gynecol Oncol (2006) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; tbl 4
In order to evaluate the association of serum anti-p53 antibodies and overexpression of tumor p53 protein with survival and prognostic factors in patients with urinary bladder tumors, Invitrogen p53 antibody (Zymed, BP53 12) was used in immunohistochemistry - paraffin section on human samples (tbl 4). Int J Urol (2004) ncbi
mouse monoclonal (BP53-12)
  • western blot; human; fig 5
In order to study the effect of 4-hydroxynonenal treatment on p53 and other related proteins in human neuroblastoma cells, Invitrogen p53 antibody (Zymed, BP53.12) was used in western blot on human samples (fig 5). Free Radic Biol Med (2005) ncbi
mouse monoclonal (PAb240)
  • western blot; human
In order to develop a new method for proteomic studies of SUMO-modified proteins, Invitrogen p53 antibody (Zymed, PAB240) was used in western blot on human samples . Mol Cell Proteomics (2005) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:60; fig 1
In order to discuss features of children with nasopharyngeal carcinoma, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:60 (fig 1). Pediatr Blood Cancer (2005) ncbi
mouse monoclonal (Pab 1801)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to use Kcnq1 mutant mice to study factor that promote gastric cancer, Invitrogen p53 antibody (Zymed, PAB1801) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Hum Mol Genet (2004) ncbi
mouse monoclonal (Pab1801)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to use Kcnq1 mutant mice to study factor that promote gastric cancer, Invitrogen p53 antibody (Zymed, PAB1801) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Hum Mol Genet (2004) ncbi
mouse monoclonal (PAb240)
  • immunohistochemistry - paraffin section; rat; 1:25; fig 9
In order to show that 1-oxo-5beta, 6beta-epoxy-witha-2-enolide prevents the incidence of skin carcinoma induced by UV B radiation in rats, Invitrogen p53 antibody (Biosource, Pab240) was used in immunohistochemistry - paraffin section on rat samples at 1:25 (fig 9). Phytomedicine (2004) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to study the expression of p63, p53, survivin, and hTERT in skin tumors, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). J Cutan Pathol (2004) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:250
In order to present a case of ganglioglioma, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:250. Pathol Int (2003) ncbi
mouse monoclonal (BP53-12)
  • immunocytochemistry; human; fig 9
  • immunocytochemistry; rhesus macaque; fig 9
In order to examine the role of PSF-TFE3 fusion protein in mediating cell transformation, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunocytochemistry on human samples (fig 9) and in immunocytochemistry on rhesus macaque samples (fig 9). Oncogene (2003) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:50; fig 5
In order to report a case of ovarian borderline endometrioid tumor showing the morules associated with optically clear nuclei, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5). APMIS (2002) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human
In order to compare ways to detect human hepatocellular carcinoma, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry - paraffin section on human samples . J Korean Med Sci (2002) ncbi
mouse monoclonal (BP53-12)
  • immunocytochemistry; human
In order to investigate p16-related senescence using keratinocytes, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunocytochemistry on human samples . Mol Cell Biol (2002) ncbi
mouse monoclonal (Pab1801)
  • immunohistochemistry - paraffin section; human
In order to determine the immunoexpression of deleted in colon cancer, p53, E-cadherin, and beta-catenin in the duodenal mucosa of children with coeliac disease, Invitrogen p53 antibody (Zymed, 1801) was used in immunohistochemistry - paraffin section on human samples . J Clin Pathol (2001) ncbi
mouse monoclonal (Pab 1801)
  • immunohistochemistry - paraffin section; human
In order to determine the immunoexpression of deleted in colon cancer, p53, E-cadherin, and beta-catenin in the duodenal mucosa of children with coeliac disease, Invitrogen p53 antibody (Zymed, 1801) was used in immunohistochemistry - paraffin section on human samples . J Clin Pathol (2001) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human
In order to characterize surgically resected non-small cell lung cancers, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples . J Korean Med Sci (2001) ncbi
mouse monoclonal (Pab1801)
  • western blot; human
In order to investigate the relationship between androgen receptor and p53, Invitrogen p53 antibody (Zymed, 13-4000) was used in western blot on human samples . J Biol Chem (2001) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human
In order to study the expression of MDM2 by the stromal and giant cells present in giant cell tumors of bone, Invitrogen p53 antibody (ZYMED, PAB1801) was used in western blot on human samples . Int J Oncol (2001) ncbi
mouse monoclonal (Pab1801)
  • western blot; human
In order to study the expression of MDM2 by the stromal and giant cells present in giant cell tumors of bone, Invitrogen p53 antibody (ZYMED, PAB1801) was used in western blot on human samples . Int J Oncol (2001) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:50
In order to investigate the role of p53 in clear cell chondrosarcoma, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Oncol (2001) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; fig 1B
In order to evaluate p53 expression and proliferative activity in primary and recurrent pterygia from the same eyes, Invitrogen p53 antibody (Zymed, bp53.12) was used in immunohistochemistry - paraffin section on human samples (fig 1B). Ophthalmology (2001) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to test if Ki-67, proliferating cell nuclear antigen, silver-staining nucleolar organizer regions and p53 could differentiate spontaneous abortions from subtypes of gestational trophoblastic diseases, Invitrogen p53 antibody (Zymed Laboratories, clone DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Am J Obstet Gynecol (2001) ncbi
mouse monoclonal (PAb240)
  • western blot; mouse; 1:1000; fig 1
In order to test if p53 and MMR mediate X-ray cytotoxicity via the same pathway, Invitrogen p53 antibody (Zymed Laboratories, 13-4100) was used in western blot on mouse samples at 1:1000 (fig 1). Cancer Res (2000) ncbi
mouse monoclonal (BP53-12)
  • immunocytochemistry; human
In order to elucidate the relationships among telomerase activity, cell cycle control, senescence, and differentiation using keratinocytes and mesothelial cells, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunocytochemistry on human samples . Mol Cell Biol (2000) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1 ug/ml; fig 1
In order to determine the expression of brain-type glycogen phosphorylase and p53 in colorectal carcinoma, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1 ug/ml (fig 1). Am J Gastroenterol (2000) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human
In order to study the expression of tumor markers associated with chemotherapy resistance, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples . Clin Cancer Res (1999) ncbi
mouse monoclonal (BP53-12)
  • immunocytochemistry; human; tbl 4
In order to examine if specific tumor or biologic factors were predictive of chemotherapy response, organ preservation, or survival in patients with advanced laryngeal cancer, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunocytochemistry on human samples (tbl 4). Otolaryngol Head Neck Surg (1999) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1, 2
In order to study p53 and Ki-67 in Kaposi's sarcoma samples, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1, 2). Am J Dermatopathol (1999) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry; human; 1:10; fig 5
In order to characterize vein bypass atherectomy specimens, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry on human samples at 1:10 (fig 5). Atherosclerosis (1998) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human
In order to determine the expression of p53, Rb, and bcl-2 during the cell cycle in stimulated peripheral blood lymphocytes and microwave heated reactive lymphoid tissue sections, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry - paraffin section on human samples . J Clin Pathol (1995) ncbi
mouse monoclonal (BP53-12)
  • immunohistochemistry - paraffin section; human
In order to discuss why p53 mutations may not be detected in cancer, Invitrogen p53 antibody (Zymed, Bp53.12) was used in immunohistochemistry - paraffin section on human samples . Cancer (1995) ncbi
Abcam
mouse monoclonal (PAb 240)
  • immunoprecipitation; mouse; 1:100; loading ...
Abcam p53 antibody (Abcam, ab26) was used in immunoprecipitation on mouse samples at 1:100. elife (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4c
Abcam p53 antibody (Abcam, ab131442) was used in immunohistochemistry on mouse samples at 1:100 (fig 4c). Sci Rep (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4c
Abcam p53 antibody (Abcam, ab131442) was used in immunohistochemistry on mouse samples at 1:100 (fig 4c). Malays J Med Sci (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4c
Abcam p53 antibody (Abcam, ab131442) was used in immunohistochemistry on mouse samples at 1:100 (fig 4c). BMC Cancer (2020) ncbi
mouse monoclonal (Pab 1801)
  • western blot; human; loading ...; fig 3g
Abcam p53 antibody (Abcam, ab28) was used in western blot on human samples (fig 3g). elife (2020) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5b
Abcam p53 antibody (Abcam, ab1101) was used in western blot knockout validation on human samples at 1:1000 (fig 5b). Nat Commun (2020) ncbi
domestic rabbit monoclonal (Y5)
  • western blot; human; 1:1000; loading ...; fig 2b, 4d
Abcam p53 antibody (Abcam, ab32049) was used in western blot on human samples at 1:1000 (fig 2b, 4d). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 9a, 9b
Abcam p53 antibody (Abcam, ab131442) was used in western blot on human samples at 1:1000 (fig 9a, 9b). Cancer Manag Res (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; 1:200; loading ...; fig 5j
  • western blot; rat; 1:200; loading ...; fig 5e
Abcam p53 antibody (Abcam, ab131442) was used in immunocytochemistry on rat samples at 1:200 (fig 5j) and in western blot on rat samples at 1:200 (fig 5e). Mol Med Rep (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:100; loading ...; fig 5a
  • western blot; mouse; 1:500; loading ...; fig 3f
Abcam p53 antibody (Abcam, ab1431) was used in immunocytochemistry on mouse samples at 1:100 (fig 5a) and in western blot on mouse samples at 1:500 (fig 3f). Aging (Albany NY) (2020) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:200; loading ...; fig 3f, 7b
Abcam p53 antibody (Abcam, ab26) was used in western blot on mouse samples at 1:200 (fig 3f, 7b). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Abcam p53 antibody (Abcam, ab131442) was used in western blot on human samples (fig 3d). J Cancer (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 5e
Abcam p53 antibody (Abcam, ab131442) was used in western blot on mouse samples at 1:1000 (fig 5e). Aging (Albany NY) (2019) ncbi
mouse monoclonal (DO-1)
  • ChIP-Seq; human; loading ...; fig 2a, s6c
Abcam p53 antibody (Abcam, 1101) was used in ChIP-Seq on human samples (fig 2a, s6c). Science (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig s3
Abcam p53 antibody (Abcam, ab26) was used in western blot on human samples (fig s3). Int J Biol Sci (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:1000; loading ...; fig 4b
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1e
Abcam p53 antibody (Abcam, ab131442) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig 4b) and in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1e). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (EPR17343)
  • mass cytometry; human; loading ...; fig 3a
Abcam p53 antibody (Abcam, ab179477) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2d
Abcam p53 antibody (Abcam, 1101) was used in western blot on human samples (fig 2d). PLoS Biol (2019) ncbi
(10E5)
  • immunocytochemistry; mouse; loading ...; fig 6a
Abcam p53 antibody (Abcam, ab78316) was used in immunocytochemistry on mouse samples (fig 6a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (PAb 240)
  • immunoprecipitation; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 1a, 1b
Abcam p53 antibody (Abcam, ab26) was used in immunoprecipitation on human samples (fig 4a) and in western blot on human samples (fig 1a, 1b). Redox Biol (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; 1:1000; loading ...; fig s3b
Abcam p53 antibody (Abcam, ab26) was used in western blot on human samples at 1:1000 (fig s3b). J Clin Invest (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 1b
Abcam p53 antibody (Abcam, ab131442) was used in western blot on rat samples (fig 1b). Braz J Med Biol Res (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; 1:1000; loading ...; fig 1c
Abcam p53 antibody (Abcam, ab26) was used in western blot on rat samples at 1:1000 (fig 1c). BMC Biotechnol (2019) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 7a
Abcam p53 antibody (Abcam, DO-1) was used in western blot on human samples (fig 7a). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; loading ...; fig 4b
Abcam p53 antibody (Abcam, ab26) was used in western blot on rat samples (fig 4b). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 5a
Abcam p53 antibody (Abcam, ab26) was used in western blot on human samples (fig 5a). J Mol Neurosci (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; loading ...; fig 6a
  • western blot; human; loading ...; fig 6a
Abcam p53 antibody (Abcam, ab26) was used in western blot on rat samples (fig 6a) and in western blot on human samples (fig 6a). Cancer Lett (2018) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 6c
Abcam p53 antibody (Abcam, ab1431) was used in western blot on rat samples at 1:1000 (fig 6c). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; 1:1000; loading ...; fig 6c
Abcam p53 antibody (Abcam, ab26) was used in western blot on rat samples at 1:1000 (fig 6c). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:500; loading ...; fig 2d
Abcam p53 antibody (Abcam, Ab26) was used in western blot on mouse samples at 1:500 (fig 2d). Kidney Blood Press Res (2018) ncbi
mouse monoclonal (Pab 1801)
  • western blot; mouse; fig 4h
Abcam p53 antibody (Abcam, ab28) was used in western blot on mouse samples (fig 4h). Cell (2018) ncbi
domestic rabbit monoclonal
  • western blot; mouse; fig 5d
Abcam p53 antibody (Abcam, ab62376) was used in western blot on mouse samples (fig 5d). Neurobiol Dis (2018) ncbi
domestic rabbit monoclonal
  • western blot; human; 1:1000; loading ...; fig s5e
Abcam p53 antibody (Abcam, ab62376) was used in western blot on human samples at 1:1000 (fig s5e). Nat Cell Biol (2017) ncbi
(10E5)
  • immunohistochemistry; human; 1:100; loading ...; fig 6c
  • western blot; human; 1:1000; loading ...; fig 6e
Abcam p53 antibody (Abcam, ab78316) was used in immunohistochemistry on human samples at 1:100 (fig 6c) and in western blot on human samples at 1:1000 (fig 6e). Nat Cell Biol (2017) ncbi
domestic rabbit monoclonal (EPR358(2))
  • western blot; human; 1:1000; loading ...; fig s5e
Abcam p53 antibody (Abcam, ab75754) was used in western blot on human samples at 1:1000 (fig s5e). Nat Cell Biol (2017) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig s6
Abcam p53 antibody (Abcam, Ab240) was used in western blot on human samples (fig s6). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 4b
Abcam p53 antibody (Abcam, ab1431) was used in western blot on human samples at 1:500 (fig 4b). Mol Med Rep (2017) ncbi
  • western blot; human; loading ...; fig 1b
Abcam p53 antibody (Abcam, ab31333) was used in western blot on human samples (fig 1b). Nucleic Acids Res (2017) ncbi
domestic rabbit monoclonal (EPR17343)
  • western blot; human; loading ...; fig s2a
Abcam p53 antibody (Abcam, ab179477) was used in western blot on human samples (fig s2a). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:5000; loading ...; fig 3a
Abcam p53 antibody (Abcam, ab1431) was used in western blot on mouse samples at 1:5000 (fig 3a). PLoS ONE (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 7a
Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples (fig 7a). Int J Mol Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig s6
In order to elucidate tumor-derived factors and genetic changes in endothelial cells that contribute to excess centrosomes in tumor endothelial cells, Abcam p53 antibody (Abcam, ab131442) was used in western blot on human samples at 1:500 (fig s6). PLoS ONE (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig s6
In order to elucidate tumor-derived factors and genetic changes in endothelial cells that contribute to excess centrosomes in tumor endothelial cells, Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples at 1:1000 (fig s6). PLoS ONE (2016) ncbi
mouse monoclonal (Pab122)
  • western blot; rat; 1:500; loading ...; fig 3a
Abcam p53 antibody (Abcam, ab90363) was used in western blot on rat samples at 1:500 (fig 3a). Sci Rep (2016) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human; loading ...; fig 4c
  • western blot; human; loading ...; fig 4c
Abcam p53 antibody (Abcam, ab1101) was used in immunoprecipitation on human samples (fig 4c) and in western blot on human samples (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; fig s1
Abcam p53 antibody (Abcam, ab1101) was used in western blot knockout validation on human samples (fig s1). Nucleic Acids Res (2016) ncbi
mouse monoclonal (PAb 240)
  • immunocytochemistry; human; loading ...; fig s9
Abcam p53 antibody (Abcam, 240) was used in immunocytochemistry on human samples (fig s9). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (Pab122)
  • immunocytochemistry; human; fig s11
In order to identify an atheroprotective role for circular RNAs, Abcam p53 antibody (Abcam, ab90363) was used in immunocytochemistry on human samples (fig s11). Nat Commun (2016) ncbi
domestic rabbit monoclonal (EPR17343)
  • western blot; rat; 1:2000; loading ...; fig 5
Abcam p53 antibody (Abcam, ab179477) was used in western blot on rat samples at 1:2000 (fig 5). Exp Ther Med (2016) ncbi
(10E5)
  • western blot; human; loading ...; fig s3b
In order to elucidate how p21 is suppressed in embryonic stem cells, Abcam p53 antibody (Abcam, 10E5) was used in western blot on human samples (fig s3b). Sci Rep (2016) ncbi
  • western blot; human; 1:200; fig 4
Abcam p53 antibody (Abcam, ab31333) was used in western blot on human samples at 1:200 (fig 4). Biol Open (2016) ncbi
mouse monoclonal (DO-1)
  • immunocytochemistry; human; fig 2a
Abcam p53 antibody (Abcam, ab1101) was used in immunocytochemistry on human samples (fig 2a). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:100; fig 8
Abcam p53 antibody (Abcam, ab61241) was used in western blot on mouse samples at 1:100 (fig 8). Oncotarget (2016) ncbi
mouse monoclonal (Pab 1801)
  • western blot; mouse; loading ...; fig 4a
Abcam p53 antibody (Abcam, ab28) was used in western blot on mouse samples (fig 4a). Sci Rep (2016) ncbi
(10E5)
  • western blot; mouse; 1:1000; loading ...; fig 3f
Abcam p53 antibody (Abcam, ab78316) was used in western blot on mouse samples at 1:1000 (fig 3f). Exp Hematol (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:200; loading ...; fig st3
  • western blot; human; 1:1000; loading ...; fig st3
In order to study the DNA damage response in senescent epithelial cells, Abcam p53 antibody (Abcam, ab1431) was used in immunocytochemistry on human samples at 1:200 (fig st3) and in western blot on human samples at 1:1000 (fig st3). Nat Commun (2016) ncbi
mouse monoclonal (Pab 1801)
  • chromatin immunoprecipitation; mouse; fig 4
Abcam p53 antibody (Abcam, ab28) was used in chromatin immunoprecipitation on mouse samples (fig 4). Int J Mol Sci (2016) ncbi
mouse monoclonal (9D3DE3)
  • flow cytometry; human; fig 5
Abcam p53 antibody (Abcam, Ab156030) was used in flow cytometry on human samples (fig 5). Sci Rep (2015) ncbi
domestic rabbit monoclonal
  • western blot; human; fig 4
Abcam p53 antibody (Abcam, AB62376) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
Abcam p53 antibody (Abcam, ab1431) was used in western blot on human samples (fig 5). Nucleic Acids Res (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 2
Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples (fig 2). PLoS ONE (2015) ncbi
domestic rabbit monoclonal
  • western blot; rat; fig s8
Abcam p53 antibody (Abcam, ab76242) was used in western blot on rat samples (fig s8). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples . Neurobiol Aging (2015) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 2a
Abcam p53 antibody (Abcam, ab26) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (Y5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1a
Abcam p53 antibody (Abcam, ab32049) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1a). Int J Oral Sci (2015) ncbi
domestic rabbit monoclonal (Y5)
  • immunocytochemistry knockout validation; human; 1:100; loading ...; fig 2e
  • western blot knockout validation; human; loading ...; fig S1c
Abcam p53 antibody (Abcam, ab32049) was used in immunocytochemistry knockout validation on human samples at 1:100 (fig 2e) and in western blot knockout validation on human samples (fig S1c). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EPR358(2))
  • immunocytochemistry; human
  • western blot; human; 1:1000
Abcam p53 antibody (Abcam, ab75754) was used in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:500; loading ...; fig 1
Abcam p53 antibody (Abcam, ab1101) was used in immunohistochemistry on human samples at 1:500 (fig 1). Oncol Lett (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human
Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples . BMC Biotechnol (2014) ncbi
MilliporeSigma
mouse monoclonal (Pab1801)
  • ELISA; human; 1:5000; fig 1c
MilliporeSigma p53 antibody (Sigma-Aldrich, P6749) was used in ELISA on human samples at 1:5000 (fig 1c). Arch Pharm Res (2018) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 5a
In order to explore the use of bacterial carriers in a rat model of glioblastoma, MilliporeSigma p53 antibody (Sigma, P8999) was used in immunohistochemistry - paraffin section on rat samples (fig 5a). Mol Ther Oncolytics (2017) ncbi
mouse monoclonal (Pab1801)
  • western blot; human; 1:1000; loading ...; fig 8a
MilliporeSigma p53 antibody (Sigma-Aldrich, P6749) was used in western blot on human samples at 1:1000 (fig 8a). Oncotarget (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; mouse; loading ...; fig 6d
  • RNA immunoprecipitation; human; loading ...; fig 3b
  • ChIP-Seq; human; loading ...; fig 1a
  • immunoprecipitation; human; loading ...; fig 3d
  • western blot; human; loading ...; fig 1d
MilliporeSigma p53 antibody (Sigma, DO-1) was used in western blot on mouse samples (fig 6d), in RNA immunoprecipitation on human samples (fig 3b), in ChIP-Seq on human samples (fig 1a), in immunoprecipitation on human samples (fig 3d) and in western blot on human samples (fig 1d). Nat Genet (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s10a
In order to use naked mole-rat-induced pluripotent stem cells to study mechanisms of cancer resistance, MilliporeSigma p53 antibody (Sigma Aldrich, AV02055) was used in western blot on mouse samples at 1:1000 (fig s10a). Nat Commun (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; mouse; loading ...; fig 5a
MilliporeSigma p53 antibody (Sigma, P8999) was used in western blot on mouse samples (fig 5a). Cell Signal (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 6
MilliporeSigma p53 antibody (Sigma, P8999) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; fig 2
MilliporeSigma p53 antibody (Sigma, P6874) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human
In order to determine if an imbalance exists in activities, mRNA, and protein expression of the antioxidant enzymes SOD1, SOD2, glutathione-peroxidase, and catalase in T21F cells, MilliporeSigma p53 antibody (Sigma-Aldrich, P8999) was used in western blot on human samples . Oxid Med Cell Longev (2015) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; fig 2
  • western blot; human; fig 1
MilliporeSigma p53 antibody (Sigma, P6874) was used in chromatin immunoprecipitation on human samples (fig 2) and in western blot on human samples (fig 1). PLoS Genet (2015) ncbi
Novus Biologicals
mouse monoclonal (PAb 240)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 4a
Novus Biologicals p53 antibody (Novus Biologicals, NB200-103SS) was used in immunohistochemistry on mouse samples at 1:500 (fig 4a). elife (2020) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; loading ...; fig af6e
Novus Biologicals p53 antibody (Novus, NB200-103) was used in western blot on mouse samples (fig af6e). Mol Syst Biol (2017) ncbi
R&D Systems
mouse monoclonal (184721)
  • western blot; mouse; 1:200; loading ...; fig 5i
R&D Systems p53 antibody (R&D, MAB1355) was used in western blot on mouse samples at 1:200 (fig 5i). Nat Commun (2020) ncbi
Enzo Life Sciences
mouse monoclonal (PAb421)
  • chromatin immunoprecipitation; mouse; fig 4
Enzo Life Sciences p53 antibody (Enzo Life Sciences, pab421) was used in chromatin immunoprecipitation on mouse samples (fig 4). Mol Neurodegener (2016) ncbi
LifeSpan Biosciences
mouse monoclonal (PAb 122)
  • western blot; rat; fig 1
  • immunocytochemistry; mouse
LifeSpan Biosciences p53 antibody (LSBio, LS-C63152) was used in western blot on rat samples (fig 1) and in immunocytochemistry on mouse samples . PLoS ONE (2015) ncbi
BioLegend
mouse monoclonal (DO-7)
  • flow cytometry; human; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, BioLegend p53 antibody (Biolegend, 645806) was used in flow cytometry on human samples (fig 3). Gastroenterology (2015) ncbi
Active Motif
mouse monoclonal (DO1)
  • chromatin immunoprecipitation; human
Active Motif p53 antibody (active motif, 39553) was used in chromatin immunoprecipitation on human samples . Oncogene (2015) ncbi
Bio-Rad
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; loading ...; fig 4a
Bio-Rad p53 antibody (AbD Serotec, MCA1703) was used in western blot on human samples at 1:1000 (fig 4a). Mol Oncol (2015) ncbi
OriGene
mouse monoclonal (DO7)
  • immunohistochemistry - paraffin section; human; fig 1
OriGene p53 antibody (Beijing Zhongshan Goldenbridge Biotechnology, DO7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncol Lett (2014) ncbi
Abnova
mouse monoclonal (HR231)
  • western blot; bovine; 1:1000; loading ...; tbl 1
In order to examine the relationships among a list of 23 protein biomarkers with CIE-L*a*b* meat color traits and ultimate pH on muscles of Maine-Anjou cows, Abnova p53 antibody (Abnova, MAB1969) was used in western blot on bovine samples at 1:1000 (tbl 1). J Agric Food Chem (2017) ncbi
Cell Signaling Technology
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:200; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 18032) was used in immunohistochemistry on human samples at 1:200 (fig 2a). J Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2j
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000 (fig 2j). Nucleic Acids Res (2021) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig 1a, 1b, 1c
Cell Signaling Technology p53 antibody (Cell signaling, 2524) was used in western blot on mouse samples at 1:1000 (fig 1a, 1b, 1c). elife (2020) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples (fig 3b). PLoS ONE (2020) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:500; loading ...; fig 7a
Cell Signaling Technology p53 antibody (CST, 2527) was used in western blot on human samples at 1:500 (fig 7a). Cell Mol Life Sci (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:600; loading ...; fig s2-1b
  • western blot; mouse; 1:1000; loading ...; fig 5c
Cell Signaling Technology p53 antibody (Cell Signaling Technologies, 2570) was used in immunohistochemistry on mouse samples at 1:600 (fig s2-1b) and in western blot on mouse samples at 1:1000 (fig 5c). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 2h
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9282) was used in western blot on mouse samples at 1:2000 (fig 2h). PLoS Genet (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 2h
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples at 1:2000 (fig 2h). PLoS Genet (2020) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig s7
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples at 1:1000 (fig s7). Science (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s7
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples at 1:1000 (fig s7). Science (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1f, s3
Cell Signaling Technology p53 antibody (CST, 9284) was used in western blot on human samples at 1:1000 (fig 1f, s3). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 3a). Cells (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology p53 antibody (CST, 2528) was used in western blot on human samples at 1:1000 (fig 7a). Onco Targets Ther (2020) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:500; loading ...; fig 7a
Cell Signaling Technology p53 antibody (CST, 2527) was used in western blot on human samples at 1:500 (fig 7a). Onco Targets Ther (2020) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples . Nat Commun (2020) ncbi
mouse monoclonal (1C12)
  • immunohistochemistry; mouse; 1:2000; loading ...; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in immunohistochemistry on mouse samples at 1:2000 (fig 3a). JCI Insight (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology p53 antibody (CST, 9282) was used in western blot on human samples (fig 3d). Mol Cell Biol (2020) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:200; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 18032) was used in immunohistochemistry on human samples at 1:200 (fig 2a). Int J Mol Sci (2020) ncbi
mouse monoclonal (16G8)
  • western blot; dogs; 1:500; fig 4c
Cell Signaling Technology p53 antibody (CST, 9286) was used in western blot on dogs samples at 1:500 (fig 4c). Cells (2020) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 6s1b
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples (fig 6s1b). elife (2020) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...
Cell Signaling Technology p53 antibody (Cell Signaling, 2524S) was used in western blot on mouse samples . elife (2020) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; loading ...; fig 1b, 3b
Cell Signaling Technology p53 antibody (CST, 2527) was used in western blot on human samples at 1:1000 (fig 1b, 3b). Exp Ther Med (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig 6d). Am J Cancer Res (2020) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:2000; loading ...; fig 5f
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples at 1:2000 (fig 5f). elife (2020) ncbi
domestic rabbit monoclonal (7F5)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s18
  • immunocytochemistry; human; 1:200; loading ...; fig s8, s9, s10
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology p53 antibody (Cell signaling, 2527) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s18), in immunocytochemistry on human samples at 1:200 (fig s8, s9, s10) and in western blot on human samples at 1:1000 (fig 3d). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s5c
Cell Signaling Technology p53 antibody (Cell Signaling, 9284S) was used in western blot on human samples at 1:1000 (fig s5c). Cell Death Dis (2020) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 4e
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples (fig 4e). Aging (Albany NY) (2020) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig 3a, 3b, 3c, s6c
Cell Signaling Technology p53 antibody (Cell Signalling, 1C12) was used in western blot on mouse samples at 1:1000 (fig 3a, 3b, 3c, s6c). Nat Commun (2020) ncbi
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; loading ...; fig s1a
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot knockout validation on mouse samples (fig s1a). Cell Rep (2020) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s10d
Cell Signaling Technology p53 antibody (CST, 48818) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s10d). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 2525) was used in western blot on human samples (fig 2a). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology p53 antibody (CST, 9282) was used in western blot on human samples (fig 1a). Cancer Sci (2020) ncbi
mouse monoclonal (1C12)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5h
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot knockout validation on human samples at 1:1000 (fig 5h). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6m
Cell Signaling Technology p53 antibody (Cell Signaling, 2521) was used in western blot on human samples at 1:1000 (fig 6m). Nat Commun (2019) ncbi
mouse monoclonal (16G8)
  • flow cytometry; human; loading ...; fig 4a
Cell Signaling Technology p53 antibody (Cell Signaling, 16G8) was used in flow cytometry on human samples (fig 4a). Aging Cell (2020) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:500; loading ...; fig 6b
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:500 (fig 6b). FEBS Open Bio (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology p53 antibody (Cell Signalling Technology, 9284S) was used in western blot on human samples (fig 6a). Cancer Lett (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology p53 antibody (Cell Signaling, 9287) was used in western blot on human samples (fig 4c). Biochem Pharmacol (2019) ncbi
mouse monoclonal (16G8)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples (fig 4c). Biochem Pharmacol (2019) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig s2a
Cell Signaling Technology p53 antibody (Cell signaling, 2524) was used in western blot on mouse samples (fig s2a). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 11
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9282S) was used in western blot on human samples (fig 11). Biomolecules (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 1a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples at 1:1000 (fig 1a). Biochem J (2019) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 3a, s2g
Cell Signaling Technology p53 antibody (Cell Signaling, 18032) was used in western blot knockout validation on human samples (fig 3a, s2g). Science (2019) ncbi
mouse monoclonal (1C12)
  • immunoprecipitation; human; 1:200; loading ...; fig s4
  • western blot; human; 1:1000; loading ...; fig 3e, 5d
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunoprecipitation on human samples at 1:200 (fig s4) and in western blot on human samples at 1:1000 (fig 3e, 5d). Oncogene (2019) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology p53 antibody (cell signaling technologies, 48818) was used in western blot on human samples (fig 5a). Front Genet (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s2c
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples at 1:1000 (fig s2c). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples at 1:1000 (fig 1a). Cancer Discov (2019) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples (fig 2c). Biomed Res Int (2019) ncbi
mouse monoclonal (1C12)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s3b
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s3b). Science (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig s4d
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:500 (fig s4d). Sci Adv (2019) ncbi
mouse monoclonal (1C12)
  • western blot; rat; loading ...; fig 2f
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on rat samples (fig 2f). Sci Adv (2019) ncbi
mouse monoclonal (1C12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4b
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b). Cell Rep (2019) ncbi
mouse monoclonal (16G8)
  • western blot; human; loading ...
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples . elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples . elife (2019) ncbi
mouse monoclonal (16G8)
  • western blot; human; loading ...; fig s1a
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples (fig s1a). Cell (2019) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; loading ...; fig 3b
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in immunocytochemistry on human samples at 1:100 (fig 3b). Nature (2019) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; loading ...; fig s2c
Cell Signaling Technology p53 antibody (Cell Signaling, 2524S) was used in western blot on human samples at 1:1000 (fig s2c). Nat Commun (2019) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 2j
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig 2j). Aging Cell (2019) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology p53 antibody (CST, 2524) was used in western blot on mouse samples at 1:1000 (fig 4b). Theranostics (2019) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; loading ...; fig 5b
Cell Signaling Technology p53 antibody (Cell Signaling, 48818) was used in western blot on human samples at 1:1000 (fig 5b). JCI Insight (2019) ncbi
mouse monoclonal (1C12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s8a
  • western blot; mouse; loading ...; fig s8b
  • western blot; human; fig s8c, s8d
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunohistochemistry - paraffin section on mouse samples (fig s8a), in western blot on mouse samples (fig s8b) and in western blot on human samples (fig s8c, s8d). Hepatology (2018) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples at 1:1000 (fig 6b). Cancer Sci (2019) ncbi
mouse monoclonal (1C12)
  • western blot; rat; 1:1000; loading ...; fig 6c
  • western blot; mouse; 1:1000; loading ...; fig 7a
Cell Signaling Technology p53 antibody (CST, 2524) was used in western blot on rat samples at 1:1000 (fig 6c) and in western blot on mouse samples at 1:1000 (fig 7a). Redox Biol (2019) ncbi
domestic rabbit polyclonal
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used . Cell Stem Cell (2018) ncbi
domestic rabbit polyclonal
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used . Cell Stem Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7a
  • immunocytochemistry; pigs ; 1:1000; loading ...; fig 7f
Cell Signaling Technology p53 antibody (Cell Signalling Technology, 9282) was used in western blot on mouse samples at 1:1000 (fig 7a) and in immunocytochemistry on pigs samples at 1:1000 (fig 7f). Redox Biol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology p53 antibody (Cell Signaling, 9282s) was used in western blot on human samples at 1:1000 (fig 5a). J Biol Chem (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology p53 antibody (cst, 9284) was used in western blot on human samples (fig 4b). PLoS ONE (2018) ncbi
domestic rabbit monoclonal (7F5)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1b
  • western blot; human; loading ...; fig s1c
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in immunohistochemistry - paraffin section on human samples (fig s1b) and in western blot on human samples (fig s1c). Science (2018) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:2000; loading ...; fig 1g
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples at 1:2000 (fig 1g). Cell Death Dis (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s5e
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples at 1:1000 (fig s5e). J Clin Invest (2018) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 2h
Cell Signaling Technology p53 antibody (Cell Signaling technology, 2524) was used in western blot on mouse samples (fig 2h). Mol Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s3a
Cell Signaling Technology p53 antibody (Cell signaling, 2570) was used in western blot on mouse samples (fig s3a). Science (2018) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig s3a
Cell Signaling Technology p53 antibody (Cell signaling, 2524) was used in western blot on mouse samples (fig s3a). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 6a
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on rat samples (fig 6a) and in western blot on human samples (fig 6a). Cancer Lett (2018) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on human samples (fig 6d). PLoS ONE (2018) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 2d
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples (fig 2d). Cell (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig 5a
Cell Signaling Technology p53 antibody (CST, 2524) was used in western blot on mouse samples at 1:1000 (fig 5a). Cell Death Differ (2018) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 3d
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on mouse samples (fig 3d). Cell Death Dis (2018) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; loading ...; fig s8a
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples at 1:1000 (fig s8a). Nat Commun (2018) ncbi
mouse monoclonal (1C12)
  • flow cytometry; mouse; loading ...; fig e6a
Cell Signaling Technology p53 antibody (Cell Signalling, 1C12) was used in flow cytometry on mouse samples (fig e6a). Nature (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology p53 antibody (Cell Signaling, 2525) was used in western blot on human samples (fig 7a). J Biol Chem (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 1c). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples (fig 5a). J Clin Invest (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig 5a). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; human; 1:200; loading ...; fig 3a, 3b
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9282) was used in immunoprecipitation on human samples at 1:200 (fig 3a, 3b). Nat Med (2017) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; fig 4b
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 7F5) was used in western blot on human samples at 1:1000 (fig 4b). Immun Inflamm Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6e
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2521) was used in western blot on human samples at 1:1000 (fig 6e). Sci Rep (2017) ncbi
domestic rabbit monoclonal (7F5)
  • immunocytochemistry; human; 1:1000; loading ...; fig 7f
  • western blot; human; 1:1000; loading ...; fig 6e
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2527s) was used in immunocytochemistry on human samples at 1:1000 (fig 7f) and in western blot on human samples at 1:1000 (fig 6e). Sci Rep (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig s4c
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig s4c). J Clin Invest (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 3n
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig 3n). Mol Neurobiol (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; fig 4b
  • western blot; human; 1:1000; fig 4a
In order to measure the expressions of XCR1 mRNA breast cancer cell lines, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4b) and in western blot on human samples at 1:1000 (fig 4a). Breast Cancer (Dove Med Press) (2017) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; mouse; loading ...; fig 2c
Cell Signaling Technology p53 antibody (Cell Signaling, 7F5) was used in western blot on mouse samples (fig 2c). Nat Med (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 3i
Cell Signaling Technology p53 antibody (cell signalling, 1C12) was used in western blot on mouse samples (fig 3i). Cell Death Dis (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 1d
Cell Signaling Technology p53 antibody (cell signalling, 2524) was used in western blot on mouse samples (fig 1d). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1c
In order to identify the protein ATM as a target for senescence alleviation through chemical screen, Cell Signaling Technology p53 antibody (Cell signaling, 9284) was used in western blot on human samples at 1:1000 (fig 1c). Nat Chem Biol (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology p53 antibody (CST, 9282) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; fig 2g
In order to analyze the contributions of developmental Hedgehog signaling effectors HDAC1 and HDAC2 in SHH Medulloblastoma, Cell Signaling Technology p53 antibody (Cell signaling, 2524) was used in western blot on mouse samples at 1:1000 (fig 2g). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig EV1C-E
In order to clarify the roles of SIRT1 in adipose tissues, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9282) was used in western blot on mouse samples (fig EV1C-E). EMBO Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4a
In order to investigate the role of adiponectin in a mouse model of colitis, Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig 4a). J Biol Chem (2017) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 3b
In order to identify compounds that inhibit the proteasome 19S subunit Rpn11, Cell Signaling Technology p53 antibody (Cell Signaling, 2524S) was used in western blot on human samples (fig 3b). Nat Chem Biol (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig s6b
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig s6b). Nature (2017) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:2000; fig 1h
In order to demonstrate that IGF2 secreted by inhibitor of differentiation-overexpressing oesophageal cancer cells instigates VEGFR1-positive bone marrow cells in the tumor macroenvironment, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples at 1:2000 (fig 1h). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology p53 antibody (CST, 9284) was used in western blot on human samples (fig 6a). Cell Death Dis (2017) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology p53 antibody (CST, 2524) was used in western blot on human samples (fig 6a). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology p53 antibody (Cell Signalling Technolog, 9284) was used in western blot on human samples (fig 3d). Nucleic Acids Res (2017) ncbi
mouse monoclonal (1C12)
  • flow cytometry; human; fig s2a
In order to determine that HSPA9 knockdown is associated with increased TP53 expression and activity, Cell Signaling Technology p53 antibody (cell signaling, 2533S) was used in flow cytometry on human samples (fig s2a). PLoS ONE (2017) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; loading ...; fig 1c
Cell Signaling Technology p53 antibody (Cell signaling, 1C12) was used in western blot on human samples at 1:1000 (fig 1c). Oncol Lett (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1200; loading ...; fig 2e
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1200 (fig 2e). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 1a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2570) was used in western blot on mouse samples at 1:2000 (fig 1a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5c
In order to assess the effect of the ROS burst on DNA integrity, cell death and differentiation potential of monocytes, Cell Signaling Technology p53 antibody (Cell Signaling, 2521) was used in western blot on human samples (fig 5c). PLoS ONE (2017) ncbi
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; loading ...; fig 4a
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot knockout validation on mouse samples (fig 4a). Cell Rep (2017) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 5c
Cell Signaling Technology p53 antibody (Cell signaling, 2524S) was used in western blot on mouse samples (fig 5c). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 2d). Cell Cycle (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9282) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 5
In order to elucidate a mutually regulatory relationship between signal transducer and activator of transcription 5 and nucleophosmin, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples (fig 5). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
In order to elucidate a mutually regulatory relationship between signal transducer and activator of transcription 5 and nucleophosmin, Cell Signaling Technology p53 antibody (Cell Signaling, 2529) was used in western blot on human samples (fig 5). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
In order to elucidate a mutually regulatory relationship between signal transducer and activator of transcription 5 and nucleophosmin, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 5). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000 (fig 1a). Arch Biochem Biophys (2017) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1500; fig 7i
  • western blot; mouse; 1:1500; loading ...; fig 3i
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1500 (fig 7i) and in western blot on mouse samples at 1:1500 (fig 3i). EMBO Mol Med (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 6b
  • western blot; human; loading ...; fig 6c
In order to evaluate the therapeutic use of polo-like kinase 1 inhibition to treat melanoma, Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6b) and in western blot on human samples (fig 6c). Cancer Lett (2017) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; fig 1d
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples at 1:1000 (fig 1d). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
In order to explore the role of the S100A7 in oral squamous cell carcinoma, Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig 7a). Cancer Gene Ther (2016) ncbi
mouse monoclonal (16G8)
  • western blot; dogs; loading ...; tbl 1
In order to report the changes associated with gonadotropin-releasing hormone agonist treatment, Cell Signaling Technology p53 antibody (Cell Signaling, 9286S) was used in western blot on dogs samples (tbl 1). Mol Reprod Dev (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig 2). BMC Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 4a
In order to test if RGS6 is a tumor suppressor using the BBN-induced bladder carcinogenesis model, Cell Signaling Technology p53 antibody (Cell signaling, 9284S) was used in western blot on mouse samples at 1:2000 (fig 4a). Oncotarget (2016) ncbi
mouse monoclonal (16G8)
  • western blot; human; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9286) was used in western blot on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9287) was used in western blot on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9281) was used in western blot on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig s6a
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples (fig s6a). Cell Death Dis (2016) ncbi
mouse monoclonal (16G8)
  • western blot; human; 1:1000; loading ...; fig 4a
In order to elucidate the upstream mechanisms of apoptosis triggered by an anti-microtubule drug, ABT-751, Cell Signaling Technology p53 antibody (cell signalling, 9286) was used in western blot on human samples at 1:1000 (fig 4a). Toxicol Appl Pharmacol (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 6d
  • western blot knockout validation; human; loading ...; fig 1d
  • RNA immunoprecipitation; human; loading ...; fig 3b
  • ChIP-Seq; human; loading ...; fig 1a
  • immunoprecipitation; human; loading ...; fig 3d
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on mouse samples (fig 6d), in western blot knockout validation on human samples (fig 1d), in RNA immunoprecipitation on human samples (fig 3b), in ChIP-Seq on human samples (fig 1a) and in immunoprecipitation on human samples (fig 3d). Nat Genet (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology p53 antibody (Cell Signaling, 9281) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples at 1:1000 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 6i
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples (fig 6i). Oncotarget (2016) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry knockout validation; rat; 1:50; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry knockout validation on rat samples at 1:50 (fig s1). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling Technologies, 9284) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; loading ...
In order to study the role of RB1 in cancer cell proliferation., Cell Signaling Technology p53 antibody (CST, 1C12) was used in western blot on human samples at 1:1000. J Clin Invest (2016) ncbi
mouse monoclonal (1C12)
  • immunoprecipitation; human; fig 6
  • western blot; human; fig 6
  • western blot knockout validation; mouse; 1:750; fig 3
In order to elucidate the mechanisms by which CYLD suppresses tumors, Cell Signaling Technology p53 antibody (Cell Signalling, 2524) was used in immunoprecipitation on human samples (fig 6), in western blot on human samples (fig 6) and in western blot knockout validation on mouse samples at 1:750 (fig 3). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s7a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig s7a). Autophagy (2016) ncbi
mouse monoclonal (16G8)
  • western blot; human; 1:500; fig 5
In order to investigate the impact of serine-arginine rich splicing factor 2 mutations to myelodysplastic syndrome, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples at 1:500 (fig 5). BMC Mol Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; roundworm ; fig s3b
Cell Signaling Technology p53 antibody (Cell signaling, 9284) was used in western blot on roundworm samples (fig s3b). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284S) was used in western blot on human samples (fig 1a). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 1d). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology p53 antibody (Cell Signaling, 9287) was used in western blot on human samples (fig 1d). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig 2). J Virol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9284) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology p53 antibody (Signaling Technology, 9284) was used in western blot on human samples (fig 5). J Cell Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology p53 antibody (Signaling Technology, 9282) was used in western blot on human samples (fig 5). J Cell Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5f
In order to study how SMG7 regulates p53 stability, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 5f). Cell Discov (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9282) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s4a
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on mouse samples (fig s4a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; human; fig 5
Cell Signaling Technology p53 antibody (Cell signaling, 2525S) was used in immunoprecipitation on human samples (fig 5). Am J Cancer Res (2016) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; fig 6
Cell Signaling Technology p53 antibody (Cell Signaling, 7F5) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (16G8)
  • proximity ligation assay; human; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9286S) was used in proximity ligation assay on human samples (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; loading ...; fig 5b
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples (fig 5b). J Proteomics (2017) ncbi
mouse monoclonal (1C12)
  • western blot; rat; 1:1000; loading ...; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling Antibodies, 2015) was used in western blot on rat samples at 1:1000 (fig 3a). Toxicol Appl Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 7
In order to characterize 3D-cultured prostate cancer cells' drug response and expression of drug-action associated proteins and the influence of matrices, Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples at 1:1000 (fig 7). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (7F5)
  • immunocytochemistry; human; 1:1600; loading ...; fig 4b
In order to discover that LACE1 mediates mitochondrial translocation of p53 and its transcription-independent apoptosis, Cell Signaling Technology p53 antibody (Cell Signaling, 2527S) was used in immunocytochemistry on human samples at 1:1600 (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 2524) was used in western blot on human samples at 1:1000 (fig 5). Int J Mol Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 9284) was used in western blot on human samples at 1:1000 (fig 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; loading ...; fig 1b
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples (fig 1b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling, cs2524) was used in western blot on mouse samples at 1:1000 (fig 3a). Toxicol Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; 1:1000; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot knockout validation on human samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 2526) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 9284) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
  • western blot; human; 1:1000; fig 3a
Cell Signaling Technology p53 antibody (ell Signaling Technology, 9282) was used in immunocytochemistry on human samples at 1:500 (fig 4) and in western blot on human samples at 1:1000 (fig 3a). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 9287) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 2521) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 2676) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 2529) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (ell Signaling Technology, 9289) was used in immunocytochemistry on human samples at 1:500 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s1
Cell Signaling Technology p53 antibody (Cell Signal, 9284) was used in western blot on mouse samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 3c
  • western blot; human; loading ...; fig s4
Cell Signaling Technology p53 antibody (cell signalling, 2524) was used in western blot on mouse samples (fig 3c) and in western blot on human samples (fig s4). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology p53 antibody (Cell signaling, 9282) was used in western blot on human samples (fig 1). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; fig s5
  • western blot; human; 1:500; fig 4
Cell Signaling Technology p53 antibody (Cell signaling, 9282) was used in immunohistochemistry on human samples at 1:100 (fig s5) and in western blot on human samples at 1:500 (fig 4). Autophagy (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling, 2525) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
Cell Signaling Technology p53 antibody (Cell signaling, 9284L) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 6
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:2000; fig 1
In order to investigate the PTHrP-cAMP-CREB1 axis in osteosarcoma, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples at 1:2000 (fig 1). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples (fig 1). Cell Death Dis (2016) ncbi
mouse monoclonal (1C12)
  • western blot; rat; fig 3
In order to study the correlation between glutamate-induced neurotoxicity and expression of cell cycle proteins in cortical neurons, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on rat samples (fig 3). Biofactors (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2521) was used in western blot on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 1
In order to utilize a model of metastatic HPV+ oropharyngeal squamous cell carcinoma to displays heterogeneity in tumor metastasis, Cell Signaling Technology p53 antibody (Cell signaling, 1C12) was used in western blot on mouse samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (7F5)
  • immunohistochemistry; human; 1:500; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling, 7F5) was used in immunohistochemistry on human samples at 1:500 (fig 3a). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 8a
Cell Signaling Technology p53 antibody (Cell Signaling, 2570) was used in western blot on human samples (fig 8a). Oncotarget (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; loading ...; fig 8
Cell Signaling Technology p53 antibody (Cell signalling, 1C12) was used in western blot on human samples at 1:1000 (fig 8). PLoS ONE (2016) ncbi
mouse monoclonal (16G8)
  • immunohistochemistry - paraffin section; human; 1:100; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). BMC Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 1). Breast Cancer Res Treat (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 2e
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples (fig 2e). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling Technolog, 2570) was used in western blot on mouse samples (fig s1). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling Technolog, 9284) was used in western blot on mouse samples (fig s1). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology p53 antibody (cell signalling, 9284) was used in western blot on human samples (fig 1b). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology p53 antibody (cell signalling, 9287) was used in western blot on human samples (fig 1b). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; fig 2
Cell Signaling Technology p53 antibody (Cell Signaling, 7F5) was used in western blot on human samples (fig 2). Cell Death Differ (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling technology, 2524) was used in western blot on mouse samples (fig 1). Aging Cell (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1i
Cell Signaling Technology p53 antibody (cell signalling, 9282) was used in western blot on human samples (fig 1i). EMBO Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on rat samples (fig 3). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5j
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 5j). Genes Dev (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s1c
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples (fig s1c). Nat Commun (2016) ncbi
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; fig 1c
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot knockout validation on mouse samples (fig 1c). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000 (fig 2a). Mol Cancer Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4d
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000 (fig 4d). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2570) was used in western blot on mouse samples at 1:500 (fig 5). J Neurosci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4d
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 4d). J Biol Chem (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524s) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling, 2528) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 5d
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on mouse samples (fig 5d). PLoS Genet (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology p53 antibody (Cell signaling, 9284) was used in western blot on mouse samples at 1:1000 (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig s7a
In order to study protein lysine methyltransferase SMYD2 via SILAC-based proteomics, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples (fig s7a). Mol Cell Proteomics (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology p53 antibody (Cell signaling, 9284S) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; loading ...; fig 1a
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples at 1:1000 (fig 1a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig s4
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples at 1:1000 (fig s4). DNA Repair (Amst) (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2d
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2570) was used in western blot on mouse samples at 1:1000 (fig 2d). Aging Cell (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:200; fig 1d
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples at 1:200 (fig 1d). Aging Cell (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling, 9284L) was used in western blot on mouse samples at 1:1000 (fig 5). J Med Chem (2016) ncbi
mouse monoclonal (1C12)
  • immunohistochemistry; mouse; 1:300; fig 4
  • western blot; mouse; 1:400; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in immunohistochemistry on mouse samples at 1:300 (fig 4) and in western blot on mouse samples at 1:400 (fig 5). Exp Ther Med (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s5
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig s5). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5A
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on human samples (fig 5A). Oncotarget (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 6e
Cell Signaling Technology p53 antibody (cellsignalling, 2524) was used in western blot on mouse samples (fig 6e). Oncotarget (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human; fig 2
Cell Signaling Technology p53 antibody (Cell Signaling, 9286P) was used in western blot on human samples (fig 2). Aging (Albany NY) (2015) ncbi
mouse monoclonal (1C12)
  • chromatin immunoprecipitation; human; fig 3
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in chromatin immunoprecipitation on human samples (fig 3), in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig s3
In order to study the role of autophagy during pancreatitis, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig s3). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit monoclonal (7F5)
  • western blot knockout validation; human; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot knockout validation on human samples (fig 2a). Cell Death Dis (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human; 1:1000; loading ...; fig 4c, d
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples at 1:1000 (fig 4c, d). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000 (fig 1). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
Cell Signaling Technology p53 antibody (CST, 2528) was used in western blot on human samples (fig 5). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
Cell Signaling Technology p53 antibody (CST, 9281) was used in western blot on human samples (fig 5). Nucleic Acids Res (2016) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry knockout validation; rat; 1:50; fig s1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry knockout validation on rat samples at 1:50 (fig s1). Development (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig 5b
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples at 1:1000 (fig 5b). BMC Cancer (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 3e
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples (fig 3e). Nature (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 3
Cell Signaling Technology p53 antibody (Cell signaling, 2524) was used in western blot on human samples (fig 3). J Cell Biol (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig 5a
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1000 (fig 5a). Mol Cancer (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1000 (fig 3). Nat Chem (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1k
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9282) was used in western blot on human samples (fig 1k). Oncogene (2016) ncbi
mouse monoclonal (16G8)
  • western blot; human; 1:1000; fig 7a
Cell Signaling Technology p53 antibody (Cell Signaling TECHNOLOGY, 9286) was used in western blot on human samples at 1:1000 (fig 7a). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; fig 2
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on mouse samples at 1:1000 (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:500
Cell Signaling Technology p53 antibody (Cell Signaling, 2524-clon 1C12) was used in western blot on mouse samples at 1:500. Mol Cell Biol (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; fig 4b
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples at 1:1000 (fig 4b). Nat Commun (2015) ncbi
mouse monoclonal (1C12)
  • western blot; rhesus macaque; fig 2
  • western blot; pigs ; fig 2
In order to study nuclear African swine fever virus replication, Cell Signaling Technology p53 antibody (Cell Signalling Technology, 2524) was used in western blot on rhesus macaque samples (fig 2) and in western blot on pigs samples (fig 2). Virus Res (2015) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry; human; 1:2000; fig st1
In order to assess the responses of human embryonic stem cells to metal toxins, Cell Signaling Technology p53 antibody (Cell Signalling, 2524) was used in immunocytochemistry on human samples at 1:2000 (fig st1). Sci Rep (2015) ncbi
domestic rabbit monoclonal (7F5)
  • immunohistochemistry; human; 1:200; fig s18
Cell Signaling Technology p53 antibody (Cell signaling, 2527) was used in immunohistochemistry on human samples at 1:200 (fig s18). Nat Commun (2015) ncbi
mouse monoclonal (16G8)
  • western blot; mouse; fig 6a
In order to determine the functional role of HDAC1 and HDAC2 in an acute model of optic nerve injury, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on mouse samples (fig 6a). ASN Neuro (2015) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; fig 8b
Cell Signaling Technology p53 antibody (Cell signaling technology, 2524) was used in western blot on mouse samples at 1:1000 (fig 8b). Dis Model Mech (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology p53 antibody (Cell signalling, 1C12) was used in western blot on mouse samples (fig 4b). Cell Death Dis (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples (fig 3a). Cell Death Differ (2016) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 3a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples (fig 3a). Cell Death Differ (2016) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig s3
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples (fig s3). J Cell Biol (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:1000; fig 1b
In order to study the contribution of p53-induced inflammation to heart failure, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples at 1:1000 (fig 1b). J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry; human; 1:100; loading ...; fig 4c
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry on human samples at 1:100 (fig 4c). Oncotarget (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples (fig 4a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; loading ...; fig s5
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples at 1:1000 (fig s5). Sci Rep (2015) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:2000; loading ...; fig 5a
Cell Signaling Technology p53 antibody (Cell Signaling, 2527) was used in western blot on human samples at 1:2000 (fig 5a). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to investigate the effect of PC4 on genome stability and DNA repair, Cell Signaling Technology p53 antibody (Cell signalling, 9284) was used in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry; human; 1:1000
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in immunocytochemistry on human samples at 1:1000 and in western blot on human samples . Mol Cancer Ther (2015) ncbi
mouse monoclonal (16G8)
  • western blot; rat
  • immunocytochemistry; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on rat samples and in immunocytochemistry on human samples . Toxicol Lett (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 1c,1e
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on human samples (fig 1c,1e). Biochem J (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig s5
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig s5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (1C12)
  • western blot knockout validation; mouse; 1:2000; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot knockout validation on mouse samples at 1:2000 (fig 2a). PLoS ONE (2015) ncbi
mouse monoclonal (16G8)
  • western blot; mouse; loading ...; fig 3h
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on mouse samples (fig 3h). Free Radic Biol Med (2015) ncbi
domestic rabbit monoclonal (7F5)
  • immunocytochemistry; mouse; fig 5
  • western blot; mouse; fig 5
Cell Signaling Technology p53 antibody (Cell signaling, 2527) was used in immunocytochemistry on mouse samples (fig 5) and in western blot on mouse samples (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 8
Cell Signaling Technology p53 antibody (Cell signaling, 1C12) was used in western blot on human samples (fig 8). Oncogene (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig s4g
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on human samples (fig s4g). Nature (2015) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry; human; fig s3
Cell Signaling Technology p53 antibody (CST, 2524) was used in immunocytochemistry on human samples (fig s3). Cancer Res (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:2000; fig 1
Cell Signaling Technology p53 antibody (R&D, 2524) was used in western blot on human samples at 1:2000 (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples . Int J Oncol (2015) ncbi
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling, #9919) was used in western blot on human samples . Mutat Res (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples (fig 2b). J Mol Cell Biol (2015) ncbi
mouse monoclonal (1C12)
  • immunoprecipitation; human; loading ...; fig 2b
  • immunoprecipitation; mouse; loading ...; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in immunoprecipitation on human samples (fig 2b) and in immunoprecipitation on mouse samples (fig 2a). Mol Cell Biol (2015) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry; mouse
  • western blot; mouse
Cell Signaling Technology p53 antibody (Cell signaling, 1C12) was used in immunocytochemistry on mouse samples and in western blot on mouse samples . Cell Death Dis (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 1c
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on mouse samples (fig 1c). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (7F5)
  • immunohistochemistry; human; 1:200; fig 1
  • western blot; human; 1:1000; fig 2
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2527) was used in immunohistochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:1000 (fig 2). Cancer Lett (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse
In order to study the relationship between Rb and p53 in normal and tumor cells, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on mouse samples . Stem Cells (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; 1:2500; loading ...; fig 3a
Cell Signaling Technology p53 antibody (Cell signaling, 2524) was used in western blot on mouse samples at 1:2500 (fig 3a). Brain Res (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human
In order to identify the role of IFI27 in the cell proliferation of human epidermal keratinocytes, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples . Cell Prolif (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology p53 antibody (Cell signaling, 9286) was used in western blot on human samples (fig 4a). PLoS Genet (2015) ncbi
  • western blot; mouse
In order to elucidate the factors that mediate radiation-induced endothelial dysfunction, Cell Signaling Technology p53 antibody (Cst, 9919) was used in western blot on mouse samples . J Proteome Res (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human; 1:1000; loading ...; fig 4B
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples at 1:1000 (fig 4B). Mol Med Rep (2015) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 6
Cell Signaling Technology p53 antibody (Cell Signaling, #2524) was used in western blot on human samples (fig 6). Cell Death Differ (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples . Cancer Res (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; tbl 1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1000 (tbl 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (16G8)
  • western blot; human; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples (fig 3). Oncogene (2015) ncbi
mouse monoclonal (1C12)
  • western blot; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples . Biochim Biophys Acta (2015) ncbi
domestic rabbit monoclonal (7F5)
  • immunocytochemistry; human
In order to identify and characterize several p53-activating small molecules, Cell Signaling Technology p53 antibody (Cell Signaling Technologies, 7F5) was used in immunocytochemistry on human samples . Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; 1:1000; loading ...; fig 5i
Cell Signaling Technology p53 antibody (Cell Signaling, CST-2527) was used in western blot on human samples at 1:1000 (fig 5i). Cell Death Dis (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human
Cell Signaling Technology p53 antibody (cell signaling technology, 2524) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (1C12)
  • western blot; rat; 1:1000
Cell Signaling Technology p53 antibody (Cell Signalling, 1C12) was used in western blot on rat samples at 1:1000. Neurosci Lett (2014) ncbi
mouse monoclonal (16G8)
  • western blot; human; fig 1
In order to study the effect of ceramide treatment on p53, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286S) was used in western blot on human samples (fig 1). Biochim Biophys Acta (2014) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; fig 5
In order to analyze the Ewing Sarcoma family of tumors for genomics to reveal STAG2 mutations, Cell Signaling Technology p53 antibody (Cell Signaling, 7F5) was used in western blot on human samples (fig 5). PLoS Genet (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse
In order to study p65-dependent NF-kapaB signaling in keratinocytes and its contribution to skin carcinogenesis, Cell Signaling Technology p53 antibody (Cell signalling, 2524) was used in western blot on mouse samples . EMBO Mol Med (2014) ncbi
mouse monoclonal (16G8)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig 1). J Am Soc Nephrol (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2015) was used in western blot on human samples at 1:1000. Oncol Rep (2014) ncbi
domestic rabbit monoclonal (7F5)
  • western blot; human; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2527) was used in western blot on human samples (fig 3). PLoS ONE (2014) ncbi
mouse monoclonal (1C12)
  • immunocytochemistry; bovine; 1:100
In order to elucidate the acquired motility and invasiveness of T. annulata-infected cells, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry on bovine samples at 1:100. PLoS Pathog (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig 3c
In order to study the role of a p53-miRNA-34 positive-feedback loop in tumor suppression in lung cancer, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1000 (fig 3c). Genes Dev (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 6a
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig 6a). PLoS ONE (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 4
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 2524) was used in western blot on mouse samples (fig 4). Autophagy (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse
In order to study the mechanism for 2-hydroxyethyl methacrylate-induced apoptosis, Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on mouse samples . Biomaterials (2014) ncbi
mouse monoclonal (16G8)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 16G8) was used in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 2524s) was used in western blot on mouse samples . Eur J Pharmacol (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000; fig 6a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on human samples at 1:1000 (fig 6a). Endocrinology (2014) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 3
Cell Signaling Technology p53 antibody (Cell Signalling, 1C12) was used in western blot on mouse samples (fig 3). Oncogene (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human; 1:1000
In order to study the relationship between tumor protein D52 and ATM protein, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on human samples at 1:1000. Cell Cycle (2013) ncbi
mouse monoclonal (16G8)
  • western blot; human; 1:1000
In order to study the relationship between tumor protein D52 and ATM protein, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 16G8) was used in western blot on human samples at 1:1000. Cell Cycle (2013) ncbi
mouse monoclonal (1C12)
  • western blot; mouse; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on mouse samples (fig 3). Oncogene (2014) ncbi
mouse monoclonal (1C12)
  • western blot; human; fig 5
  • immunohistochemistry - frozen section; mouse
  • western blot; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 2524s) was used in western blot on human samples (fig 5), in immunohistochemistry - frozen section on mouse samples and in western blot on mouse samples . J Am Heart Assoc (2013) ncbi
mouse monoclonal (16G8)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (16G8)
  • western blot; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples . Radiat Res (2013) ncbi
mouse monoclonal (16G8)
  • western blot; mouse; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on mouse samples at 1:1000. Cell Rep (2012) ncbi
mouse monoclonal (1C12)
  • western blot knockout validation; rat; 1:500; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling Tech, 2524) was used in western blot knockout validation on rat samples at 1:500 (fig 1). Dis Model Mech (2013) ncbi
mouse monoclonal (1C12)
  • immunohistochemistry - frozen section; mouse
  • western blot; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in immunohistochemistry - frozen section on mouse samples and in western blot on mouse samples . J Biol Chem (2012) ncbi
mouse monoclonal (16G8)
  • immunohistochemistry; mouse
In order to examine the neuronal cell death in the spinal cords of mSOD1 and wtSOD1 mice, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in immunohistochemistry on mouse samples . J Comp Neurol (2007) ncbi
Dako
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:6000; fig s3e
Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:6000 (fig s3e). Nat Commun (2020) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 3f
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3f). Cancer Sci (2020) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig s4
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig s4). Clin Epigenetics (2019) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 3
Dako p53 antibody (Dako, M7001) was used in western blot on human samples (fig 3). Int J Oncol (2018) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 1c
Dako p53 antibody (Dako, M7001) was used in western blot on human samples (fig 1c). Nucleic Acids Res (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; fig 4d
In order to describe the molecular typing of hobnail variant of papillary thyroid carcinoma, Dako p53 antibody (Dako, DO7) was used in immunohistochemistry on human samples (fig 4d). Endocr Relat Cancer (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50; tbl 1
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry on human samples at 1:50 (tbl 1). Cancer (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 1
In order to use mass spectroscopy to classify anaplastic glioma by integration of clinical data, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Biochim Biophys Acta Proteins Proteom (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to determine the prognostic impact of parameters in peritoneal carcinomatosis from colorectal cancer, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Am J Surg (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
Dako p53 antibody (DAKO, DO7) was used in immunohistochemistry on human samples . Hum Pathol (2017) ncbi
mouse monoclonal (DO-7)
  • other; human; 1:100; loading ...; fig 5e
Dako p53 antibody (Dako, M700129) was used in other on human samples at 1:100 (fig 5e). Oncotarget (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1i
In order to present an unusual case of mantle cell lymphoma, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1i). Virchows Arch (2016) ncbi
domestic rabbit monoclonal (318-6-11)
  • western blot; human; 1:500; loading ...; fig 2b
In order to find that USP2 stabilizes Mdm2 which antagonizes p53 activity, Dako p53 antibody (DAKO, M3629) was used in western blot on human samples at 1:500 (fig 2b). Oncotarget (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:200; fig s3d
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on human samples at 1:200 (fig s3d). Nat Cell Biol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 3
In order to investigate evidence for two distinct pathogenetic pathways by studing the squamous cell carcinoma of the oral cavity and cytokeratin and protein expression patterns, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Oncol Lett (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 2
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Ann Diagn Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 1
In order to study the role of cell polarity determinant human Discs-large in endometrial cancer, Dako p53 antibody (DAKO, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Br J Cancer (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:30; loading ...; tbl 2
In order to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma, Dako p53 antibody (DakoCytomation, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:30 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:800; tbl 4
In order to test if atypical fibroxanthoma is the non-infiltrating precursor lesion of pleomorphic dermal sarcoma, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:800 (tbl 4). Oncotarget (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 3
In order to investigate the role of CHD5 in renal cell carcinoma, Dako p53 antibody (Dako, M7001) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 4
Dako p53 antibody (Dako, DO7) was used in immunohistochemistry - paraffin section on human samples (tbl 4). Chin J Cancer (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:100
In order to determine the mechanisms of bevacizumab resistance, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry on human samples at 1:100. Brain Tumor Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to characterize aggressive tumors in African breast cancer and the strong expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) and its association with Axl expression, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:1000. PLoS ONE (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:300; tbl 1
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry on human samples at 1:300 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:1000
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Ann Clin Lab Res (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig s5
Dako p53 antibody (DakoCytomation, DO-7) was used in western blot on human samples (fig s5). Nucleic Acids Res (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; fig s3
In order to determine how sensitivity is restored in resistant ovarian cancer cells by targeting the Ras-MAPK pathway by miR-634, Dako p53 antibody (DAKO, M7001) was used in immunohistochemistry on human samples (fig s3). Mol Cancer (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 2a
Dako p53 antibody (DAKO, DO-7) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Dako p53 antibody (Dako, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:200. J Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to analyze how aggressiveness and invasiveness of human breast carcinoma is correlated with hexokinase and phosphofructokinase kinase and intracellular distribution, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples . Oncotarget (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human
Dako p53 antibody (Dako, M7001) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50; fig 4
  • western blot; human; fig 2
Dako p53 antibody (DakoCytomation, M7001) was used in immunohistochemistry on human samples at 1:50 (fig 4) and in western blot on human samples (fig 2). J Pathol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:100
In order to investigate markers expressed by stromal cells in breast cancer patients, Dako p53 antibody (DakoCytomation, M7001) was used in immunohistochemistry on human samples at 1:100. Mol Clin Oncol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:3000
In order to develop and characterize patient-derived primary xenografts to a model of muscle invasive bladder cancer, Dako p53 antibody (DAKO, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:3000. Oncotarget (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:80
Dako p53 antibody (Dako, clone DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:80. BMC Cancer (2015) ncbi
mouse monoclonal (DO-7)
  • immunoprecipitation; human; fig 5
  • western blot; human; fig 1
Dako p53 antibody (Dako, DO7) was used in immunoprecipitation on human samples (fig 5) and in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (DO-7)
  • immunocytochemistry; human; fig 2.
  • western blot; human; fig 2.
Dako p53 antibody (DAKO, M7001) was used in immunocytochemistry on human samples (fig 2.) and in western blot on human samples (fig 2.). PLoS ONE (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:1500
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:1500. Ann Surg Oncol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; rat; 1:150
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on rat samples at 1:150. Acta Cir Bras (2015) ncbi
mouse monoclonal (DO-7)
  • immunocytochemistry; human; fig s1
In order to explore how Tpr regulated chromosomal segregation, Dako p53 antibody (Dako, DO-7) was used in immunocytochemistry on human samples (fig s1). Cell Cycle (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human
Dako p53 antibody (DAKO, DO-7) was used in western blot on human samples . Mutat Res (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; mouse; fig 6
Dako p53 antibody (Dako, M7001) was used in western blot on mouse samples (fig 6). Free Radic Biol Med (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human
Dako p53 antibody (Dako, DO-7) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50
In order to study the relationship between autophagy and anti-tumor immune responses using immunohistochemistry, Dako p53 antibody (Dako, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Cancer Sci (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:300
Dako p53 antibody (DAKOCytomation, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:300. Anticancer Res (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:700
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:700. Endocr Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • immunocytochemistry; human; 1:50
Dako p53 antibody (Dako, DO7) was used in immunocytochemistry on human samples at 1:50. Cell Stress Chaperones (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
Dako p53 antibody (Dako, DO7) was used in immunohistochemistry on human samples at 1:50. Cancer Med (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
In order to describe the histological features canalicular adenoma, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry on human samples . Head Neck Pathol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 3
In order to analyze LRIG3 expression through immunohistochemical studies in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer and the association with tumor markers, hormones, high-risk HPV infection, smoking, and patient outcome, Dako p53 antibody (DakoCytomation, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 3). Eur J Histochem (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; mouse
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on mouse samples . Head Neck (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to correlate 18-F-fluoro-deoxyglucose uptake and aggressive tumor biology in predicting outcome in esophageal cancer, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Ann Surg Oncol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100
Dako p53 antibody (DAKO, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:100. Biomed Res Int (2014) ncbi
domestic rabbit monoclonal (318-6-11)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
Dako p53 antibody (DAKO, 3629) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Cell Tissue Res (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:100
Dako p53 antibody (Dako, clone DO-7) was used in immunohistochemistry on human samples at 1:100. Oncol Lett (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:40000
In order to screen a panel of 33 proteins to establish a set of biomarkers that predict the agressiveness of prostate cancer, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:40000. BMC Cancer (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50
In order to determine the immunohistochemical, ultrastructural and genetic features of a patient with tanycytic ependymoma and that has a heterozygous truncating mutation in the NF2 gene, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Neuropathology (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
Dako p53 antibody (Dako Denmark, M-7001) was used in immunohistochemistry on human samples . ScientificWorldJournal (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:100
Dako p53 antibody (Dako, M 7001) was used in immunohistochemistry on human samples at 1:100. Anticancer Res (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:300
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:300. Cancer Res (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:1500
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on human samples at 1:1500. Hum Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry on human samples at 1:50. Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
In order to study salivary duct carcinoma with rhabdoid features, Dako p53 antibody (DakoCytomation, DO-7) was used in immunohistochemistry on human samples . Head Neck (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
In order to compare the diagnostic efficacies of cell block method and conventional smear method for bile cytology, Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on human samples . Dig Endosc (2013) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:500
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:500. World Neurosurg (2014) ncbi
mouse monoclonal (DO-7)
  • western blot; human
Dako p53 antibody (Dako, M 7001) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:300
Dako p53 antibody (DAKOCytomation, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:300. Oncology (2013) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to report an example of an atypical prolactin-producing pituitary adenoma that shows clear morphologic and immunohistochemical evidence of neurocytic transformation, Dako p53 antibody (Dako, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Appl Immunohistochem Mol Morphol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to investigate the contribution of the PI3K/Akt pathway to trastuzumab resistance, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Br J Cancer (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Virchows Arch (2008) ncbi
Vector Laboratories
  • western blot; mouse; loading ...; fig 2h
Vector Laboratories p53 antibody (Vector Laboratories, VP-P956) was used in western blot on mouse samples (fig 2h). Mol Cell (2018) ncbi
polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; fig 5a
Vector Laboratories p53 antibody (Vector Labs, CM5) was used in immunohistochemistry - paraffin section on mouse samples (fig 5a). J Exp Med (2018) ncbi
  • immunohistochemistry; human; 1:2500; loading ...; fig 4e
Vector Laboratories p53 antibody (Vector Laboratories, VP-P956) was used in immunohistochemistry on human samples at 1:2500 (fig 4e). Nat Cell Biol (2016) ncbi
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 1d
  • flow cytometry; mouse; 1:50; loading ...; fig 1e
In order to study the contribution of p53-induced inflammation to heart failure, Vector Laboratories p53 antibody (Vector Laboratories, VP-P956) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1d) and in flow cytometry on mouse samples at 1:50 (fig 1e). J Mol Cell Cardiol (2015) ncbi
  • western blot; human
Vector Laboratories p53 antibody (Vector Laboratories, VP-P956) was used in western blot on human samples . Cell Death Differ (2015) ncbi
Agilent Technologies
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:2000; loading ...; fig 2
Agilent Technologies p53 antibody (Agilent, DO7) was used in immunohistochemistry on human samples at 1:2000 (fig 2). Cancer Sci (2020) ncbi
BioVision
  • immunocytochemistry; human; 1:100; fig 4
BioVision p53 antibody (BioVision, 3036R-100) was used in immunocytochemistry on human samples at 1:100 (fig 4). PLoS ONE (2015) ncbi
  • western blot; mouse; fig 6
BioVision p53 antibody (Biovision, 3036) was used in western blot on mouse samples (fig 6). PLoS Genet (2015) ncbi
Leica Biosystems
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 4b
Leica Biosystems p53 antibody (Leica Biosystems, NCL-p53-cmSP) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4b). Sci Rep (2020) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry; mouse; 1:500; fig 4a
  • western blot; mouse; 1:500; loading ...; fig 1a
Leica Biosystems p53 antibody (Leica Biosystem, NCLL-p53-CM5p) was used in immunohistochemistry on mouse samples at 1:500 (fig 4a) and in western blot on mouse samples at 1:500 (fig 1a). Nature (2019) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5a
  • western blot; mouse; loading ...; fig 4b
Leica Biosystems p53 antibody (Novocastra Laboratories, NCL-p53-CM5p) was used in immunohistochemistry - paraffin section on mouse samples (fig 5a) and in western blot on mouse samples (fig 4b). Stem Cell Reports (2019) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry; mouse; loading ...; fig 4c
Leica Biosystems p53 antibody (Leica Biosystems, CM5) was used in immunohistochemistry on mouse samples (fig 4c). Cell Death Dis (2019) ncbi
domestic rabbit polyclonal (CM5)
  • western blot knockout validation; mouse; loading ...; fig 1c
Leica Biosystems p53 antibody (Leica Novocastra, CM5) was used in western blot knockout validation on mouse samples (fig 1c). Cancer Cell (2017) ncbi
monoclonal
  • western blot knockout validation; mouse; loading ...; fig 1e
Leica Biosystems p53 antibody (Novocastra, NL-p53-505) was used in western blot knockout validation on mouse samples (fig 1e). Oncotarget (2017) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 6c
Leica Biosystems p53 antibody (Novocastra, NCL-p53-CM5p) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6c). Dis Model Mech (2017) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; loading ...; fig 5a
Leica Biosystems p53 antibody (Leica Biosystems, CM5) was used in western blot on mouse samples (fig 5a). Genes Dev (2017) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; loading ...; fig 1a
In order to determine the effect of constitutive activation of mammalian target of rapamycin complex 1 on premature senescence activation in fibroblasts, Leica Biosystems p53 antibody (Novocastra Laboratories, NCL-p53-CM5p) was used in western blot on mouse samples (fig 1a). EMBO J (2017) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s4d
In order to elucidate novel functions of the senescence-associated secretory in promoting a proregenerative response through the induction of cell plasticity and stemness, Leica Biosystems p53 antibody (Leica Microsystems, CM5) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s4d). Genes Dev (2017) ncbi
mouse monoclonal
  • western blot; human; fig 2a
In order to identify pathways that contribute to resistance to the antiandrogen drug enzalutamide, Leica Biosystems p53 antibody (Leica, NCL-p53-DO1) was used in western blot on human samples (fig 2a). Science (2017) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; 1:1000; loading ...; fig 2b
In order to investigate the effects of a CDK4/6 inhibitor on the senescence-associated secretory phenotype, Leica Biosystems p53 antibody (Leica Biosystems, CM5) was used in western blot on mouse samples at 1:1000 (fig 2b). Mol Cancer Res (2017) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; human; loading ...; fig 1c
Leica Biosystems p53 antibody (Novocastra, CM5) was used in western blot on human samples (fig 1c). Cell Signal (2017) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
In order to explore the interplay between p53 loss and Wnt/beta-catenin signaling in stem cell function and tumorigenesis, Leica Biosystems p53 antibody (Novocastra, NCL-p53-CM5p) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Oncogene (2017) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; human; 1:1000; fig 5a
Leica Biosystems p53 antibody (Leica, CM5) was used in western blot on human samples at 1:1000 (fig 5a). Nat Immunol (2016) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 8. a","b
  • immunocytochemistry; mouse; 1:200; fig s1b
Leica Biosystems p53 antibody (Novacastra, NCL-p53-CM5p) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 8. a","b) and in immunocytochemistry on mouse samples at 1:200 (fig s1b). Nat Commun (2016) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig s6d
Leica Biosystems p53 antibody (Leica, NCL-p53-CM5p) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig s6d). Nature (2016) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; fig 1
Leica Biosystems p53 antibody (Novacastra, CM5) was used in western blot on mouse samples (fig 1). Cancer Res (2016) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4e
In order to find a role for RelA in regulating oncogene-induced senescence, Leica Biosystems p53 antibody (Leica Biosystems, NCL-p53-CM5p) was used in immunohistochemistry - paraffin section on mouse samples (fig 4e). J Clin Invest (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; fig 5
Leica Biosystems p53 antibody (Leica Novocastra, NCL-L-p53-DO7) was used in immunohistochemistry - paraffin section on human samples (fig 5). Am J Transl Res (2016) ncbi
domestic rabbit polyclonal (CM5)
  • immunocytochemistry; mouse; loading ...; fig s5a
In order to elucidate how p21 is suppressed in embryonic stem cells, Leica Biosystems p53 antibody (novocastra, CM5) was used in immunocytochemistry on mouse samples (fig s5a). Sci Rep (2016) ncbi
monoclonal
  • immunohistochemistry; human; 0.875 ug/ml; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, Leica Biosystems p53 antibody (Novocastra, NCL-L-p53-DO7) was used in immunohistochemistry on human samples at 0.875 ug/ml (tbl 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal (CM5)
  • immunohistochemistry - frozen section; mouse; fig 2
In order to describe a role for Nbn in skin homeostasis, Leica Biosystems p53 antibody (Novocastra, NCL-p53-CM5p) was used in immunohistochemistry - frozen section on mouse samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; 1:1000; loading ...; fig s5b
Leica Biosystems p53 antibody (Novocastra, CM5) was used in western blot on mouse samples at 1:1000 (fig s5b). Nat Commun (2016) ncbi
domestic rabbit polyclonal (CM5)
  • western blot knockout validation; mouse; loading ...; fig 2e
Leica Biosystems p53 antibody (Leica Microsystems, CM5) was used in western blot knockout validation on mouse samples (fig 2e). Oncotarget (2016) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; fig 1
Leica Biosystems p53 antibody (Novocastra, NCL-p53-CM5p) was used in western blot on mouse samples (fig 1). Cell Death Differ (2016) ncbi
monoclonal
  • western blot; human; 1:500; loading ...; fig 2a
Leica Biosystems p53 antibody (Leica Microsystems, NCL-L-p53-DO7) was used in western blot on human samples at 1:500 (fig 2a). Mol Cancer Ther (2016) ncbi
monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to report a unique case of familial adenomatous polyposis, Leica Biosystems p53 antibody (Novocastra, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Pathol Res Pract (2016) ncbi
monoclonal (DO-7)
  • immunohistochemistry; human; fig 1a
Leica Biosystems p53 antibody (Leica Biosystems, DO-7) was used in immunohistochemistry on human samples (fig 1a). Cell Death Dis (2015) ncbi
domestic rabbit polyclonal (CM5)
  • western blot; mouse; 1:5000; fig s10
Leica Biosystems p53 antibody (Leica Biosystems, NCL-p53-CM5p) was used in western blot on mouse samples at 1:5000 (fig s10). Arch Toxicol (2016) ncbi
monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to describe an unusual case of a recurrent dural neoplasm, Leica Biosystems p53 antibody (Novocastra, DO-7) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
monoclonal
  • western blot; human; 1:1000; fig s1
Leica Biosystems p53 antibody (Leica Biosystems, NCL-L-p53-DO7) was used in western blot on human samples at 1:1000 (fig s1). Oncotarget (2015) ncbi
monoclonal
  • western blot; mouse; 1:500; fig 2e
Leica Biosystems p53 antibody (Novocastra, NCL-p53-505) was used in western blot on mouse samples at 1:500 (fig 2e). Nat Biotechnol (2015) ncbi
monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 4
In order to analyze the significance biologically and clinically of PARP1 protein expression in breast cancer, Leica Biosystems p53 antibody (Novocstra, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 4). Breast Cancer Res Treat (2015) ncbi
monoclonal (DO-7)
  • immunohistochemistry; human
Leica Biosystems p53 antibody (Novocastra Laboratories Ltd, DO7) was used in immunohistochemistry on human samples . Pathol Int (2014) ncbi
monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to study triple negative primary breast cancer biological characteristics and clinical outcome in older women in comparison to their younger counterparts, Leica Biosystems p53 antibody (Novocastra, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2014) ncbi
domestic rabbit polyclonal (CM5)
Leica Biosystems p53 antibody (Leica, NCL-P53-CM5P) was used . Nat Commun (2014) ncbi
monoclonal (DO-7)
  • immunohistochemistry; human; 1:100
Leica Biosystems p53 antibody (Novocastra, DO-7) was used in immunohistochemistry on human samples at 1:100. Pathol Res Pract (2014) ncbi
monoclonal
  • western blot; mouse; 1:1000; fig 2b
Leica Biosystems p53 antibody (Leica, NCL-p53?C505) was used in western blot on mouse samples at 1:1000 (fig 2b). J Biol Chem (2014) ncbi
monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
Leica Biosystems p53 antibody (Leica, DO-7) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
BD Biosciences
mouse monoclonal (80/p53)
  • western blot; dogs; 1:500; fig 4c
BD Biosciences p53 antibody (BD, 610183) was used in western blot on dogs samples at 1:500 (fig 4c). Cells (2020) ncbi
mouse monoclonal (80/p53)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig s21b
BD Biosciences p53 antibody (BD, 610183) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig s21b). Nat Commun (2020) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000; loading ...; fig 3
BD Biosciences p53 antibody (BD Pharmingen, 554293) was used in western blot on human samples at 1:1000 (fig 3). Sci Rep (2019) ncbi
mouse monoclonal (Pab 1801)
  • western blot knockout validation; human; loading ...; fig 5e
BD Biosciences p53 antibody (PharMingen, 554170) was used in western blot knockout validation on human samples (fig 5e). Redox Biol (2017) ncbi
mouse monoclonal (DO-1)
  • western blot knockout validation; human; loading ...; fig 5c
In order to screen an shRNA library to identify genes whose depletion preferentially inhibit cancer cell growth, BD Biosciences p53 antibody (BD Biosciences, 554293) was used in western blot knockout validation on human samples (fig 5c). Sci Rep (2017) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:10,000; loading ...; fig 2a, 2e
BD Biosciences p53 antibody (BD, 554293) was used in western blot on human samples at 1:10,000 (fig 2a, 2e). Am J Pathol (2017) ncbi
mouse monoclonal (DO-7)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences p53 antibody (BD Biosciences, DO-7) was used in flow cytometry on human samples (fig 3b). Cell Death Dis (2016) ncbi
mouse monoclonal (Pab 1801)
  • immunocytochemistry; human; loading ...; fig 5d
  • western blot; human; loading ...; fig 5b
In order to show that fibroblast growth factor 12 regulates the vascular smooth muscle cell switch between synthetic and contractile states, BD Biosciences p53 antibody (BD Pharmingen, 554169) was used in immunocytochemistry on human samples (fig 5d) and in western blot on human samples (fig 5b). Arterioscler Thromb Vasc Biol (2016) ncbi
  • western blot; human; fig 8
BD Biosciences p53 antibody (BD Biosciences, 550832) was used in western blot on human samples (fig 8). Oncogenesis (2016) ncbi
mouse monoclonal (DO-7)
  • western blot knockout validation; human; fig 1
BD Biosciences p53 antibody (BD-Pharmigen, 554294) was used in western blot knockout validation on human samples (fig 1). Cell Death Dis (2016) ncbi
mouse monoclonal (G59-12)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences p53 antibody (BD, G59-12) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig s10
BD Biosciences p53 antibody (BD, 554294) was used in western blot on human samples (fig s10). Cell Mol Life Sci (2016) ncbi
mouse monoclonal (80/p53)
  • western blot; human; loading ...; fig 5c
BD Biosciences p53 antibody (BD, 610183) was used in western blot on human samples (fig 5c). Oncotarget (2015) ncbi
mouse monoclonal (80/p53)
  • western blot; human; fig 8
BD Biosciences p53 antibody (BD Biosciences, 610183) was used in western blot on human samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 3d
BD Biosciences p53 antibody (BD Biosciences, 554294) was used in western blot on human samples (fig 3d). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 8f
BD Biosciences p53 antibody (Becton Dickinson, 554293) was used in western blot on human samples (fig 8f). Mol Cell Biol (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:500; fig 1
BD Biosciences p53 antibody (BD Pharmingen, 554293) was used in western blot on human samples at 1:500 (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (DO-7)
  • flow cytometry; human
In order to discuss the role of CD47 modulation in treatment of chronic lymphocytic leukemia, BD Biosciences p53 antibody (BD Biosciences, DO-7) was used in flow cytometry on human samples . PLoS Med (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:500
In order to study the regulation of the human papillomavirus 16 oncoprotein expression, BD Biosciences p53 antibody (BD Pharmingen, DO-7) was used in western blot on human samples at 1:500. J Virol (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 2c
BD Biosciences p53 antibody (BD Biosciences, 554294) was used in western blot on human samples at 1:1000 (fig 2c). Sci Rep (2015) ncbi
mouse monoclonal (DO-1)
  • chromatin immunoprecipitation; human; fig 1
BD Biosciences p53 antibody (BD Pharmingen, DO-1) was used in chromatin immunoprecipitation on human samples (fig 1). Oncogene (2015) ncbi
mouse monoclonal (J159-641.79)
  • western blot; human
BD Biosciences p53 antibody (BD, 560282) was used in western blot on human samples . Hum Mol Genet (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 9
BD Biosciences p53 antibody (BD, 554294) was used in western blot on human samples (fig 9). Hum Mol Genet (2015) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:6000; fig s7
In order to determine how PAXX interacts with Ku to promote DNA double-strand break repair, BD Biosciences p53 antibody (BD Biosciences, 554293) was used in western blot on human samples at 1:6000 (fig s7). Science (2015) ncbi
mouse monoclonal (80/p53)
  • western blot; human
BD Biosciences p53 antibody (BD Biosciences, 610183) was used in western blot on human samples . Biol Pharm Bull (2014) ncbi
mouse monoclonal (G59-12)
  • western blot; rat; 1:1000
BD Biosciences p53 antibody (BD Pharmingen, 554157) was used in western blot on rat samples at 1:1000. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (G59-12)
  • western blot; mouse; 1:500
In order to study the role of TGF-beta inhibitors in abolishing the resistance of glioblastoma to ionozing radiation therapy, BD Biosciences p53 antibody (BD Biosciences, 554157) was used in western blot on mouse samples at 1:500. Cancer Res (2012) ncbi
mouse monoclonal (DO-1)
  • western blot; human
BD Biosciences p53 antibody (BD Pharmingen, 554293) was used in western blot on human samples . Cell Death Differ (2011) ncbi
mouse monoclonal (80/p53)
  • western blot; human
BD Biosciences p53 antibody (BD Biosciences, 610183) was used in western blot on human samples . Int J Cancer (2011) ncbi
mouse monoclonal (DO-7)
  • western blot; human
BD Biosciences p53 antibody (BD Biosciences, DO-7) was used in western blot on human samples . Cell Death Differ (2008) ncbi
MBL International
monoclonal
  • western blot; human; 1:1000
In order to describe the mechanisms by which hepatitis B virus core protein mediates resistance of hepatoma cells to apoptosis induced by anti-Fas antibody treatment, MBL International p53 antibody (MBL, K0181-3) was used in western blot on human samples at 1:1000. FASEB J (2015) ncbi
monoclonal
  • western blot; human; fig 6
MBL International p53 antibody (MBL, K0181-3) was used in western blot on human samples (fig 6). Oncogene (2015) ncbi
Articles Reviewed
  1. Lee J, Park I, Kwak M, Rhee W, Kim S, Shin J. HMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells. Cell Death Discov. 2021;7:28 pubmed publisher
  2. Chen C, Mo H, Jiang Y, Zhao X, Ma S, You K, et al. BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma. J Cancer. 2021;12:1507-1519 pubmed publisher
  3. Singh S, Abu Zaid A, Lin W, Low J, Abdolvahabi A, Jin H, et al. 17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma. iScience. 2021;24:101996 pubmed publisher
  4. Roliński M, Montaldo N, Aksu M, Fordyce Martin S, Brambilla A, Kunath N, et al. Loss of Mediator complex subunit 13 (MED13) promotes resistance to alkylation through cyclin D1 upregulation. Nucleic Acids Res. 2021;: pubmed publisher
  5. Wang H, Wan X, Pilch P, Ellisen L, Fried S, Liu L. An AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte metabolic reprogramming. elife. 2020;9: pubmed publisher
  6. Song M, YEKU O, Rafiq S, Purdon T, Dong X, Zhu L, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11:6298 pubmed publisher
  7. Blanden A, Yu X, Blayney A, Demas C, Ha J, Liu Y, et al. Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants. elife. 2020;9: pubmed publisher
  8. Khayati K, Bhatt V, Hu Z, Fahumy S, Luo X, Guo J. Autophagy compensates for Lkb1 loss to maintain adult mice homeostasis and survival. elife. 2020;9: pubmed publisher
  9. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  10. Phan T, Paliogiannis P, Nasrallah G, Giordo R, Eid A, Fois A, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2021;78:2031-2057 pubmed publisher
  11. Atkins A, Xu M, Li M, Rogers N, Pryzhkova M, Jordan P. SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis. elife. 2020;9: pubmed publisher
  12. Konger R, Ren L, Sahu R, Derr Yellin E, Kim Y. Evidence for a non-stochastic two-field hypothesis for persistent skin cancer risk. Sci Rep. 2020;10:19200 pubmed publisher
  13. Dewhurst M, Ow J, Zafer G, Van Hul N, Wollmann H, Bisteau X, et al. Loss of hepatocyte cell division leads to liver inflammation and fibrosis. PLoS Genet. 2020;16:e1009084 pubmed publisher
  14. Guo H, Chou W, Lai Y, Liang K, Tam J, Brickey W, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020;370: pubmed publisher
  15. Hao Q, Zong X, Sun Q, Lin Y, Song Y, Hashemikhabir S, et al. The S-phase-induced lncRNA SUNO1 promotes cell proliferation by controlling YAP1/Hippo signaling pathway. elife. 2020;9: pubmed publisher
  16. Nakamura Y, Kanemaru K, Shoji M, Totoki K, Nakamura K, Nakaminami H, et al. Phosphatidylinositol-specific phospholipase C enhances epidermal penetration by Staphylococcus aureus. Sci Rep. 2020;10:17845 pubmed publisher
  17. Omer A, Barrera M, Moran J, Lian X, Di Marco S, Beausejour C, et al. G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat Commun. 2020;11:4979 pubmed publisher
  18. Moses N, Zhang M, Wu J, Hu C, Xiang S, Geng X, et al. HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1. Cells. 2020;9: pubmed publisher
  19. Cheng X, Zhang Y, Song F, Song F, Gao C, Liang X, et al. URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma. Onco Targets Ther. 2020;13:8011-8025 pubmed publisher
  20. Sulistiyowati I, Yunus J, Sari D, Arfian N. Upregulation of p16, Bax and Bcl-2 mRNA Expression Associated with Epithelial Apoptosis and Myofibroblast Proliferation in Kidney Fibrosis Model in Mice. Malays J Med Sci. 2020;27:37-44 pubmed publisher
  21. Capaci V, Bascetta L, Fantuz M, Beznoussenko G, Sommaggio R, Cancila V, et al. Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome. Nat Commun. 2020;11:3945 pubmed publisher
  22. Varela Eirin M, Carpintero Fernández P, Sánchez Temprano A, Varela Vazquez A, Paíno C, Casado Diaz A, et al. Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis. Aging (Albany NY). 2020;12:15882-15905 pubmed publisher
  23. Lee S, Hong K, Seong Y, Kwak S. Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2/M Entry in U2-OS Cells. Dev Reprod. 2020;24:101-111 pubmed publisher
  24. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  25. Li H, Lu C, Zhang H, Hu Q, Zhang J, Cuevas I, et al. A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response. JCI Insight. 2020;5: pubmed publisher
  26. Zhang F, Liu R, Zhang H, Liu C, Liu C, Lu Y. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells. BMC Cancer. 2020;20:673 pubmed publisher
  27. Osei Amponsa V, Sridharan V, Tandon M, Evans C, Klarmann K, Cheng K, et al. Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity. Mol Cell Biol. 2020;: pubmed publisher
  28. Hu D, Dong R, Zhang Y, Yang Y, Chen Z, Tang Y, et al. Age‑related changes in mineralocorticoid receptors in rat hearts. Mol Med Rep. 2020;22:1859-1867 pubmed publisher
  29. Hastings J, González Rajal A, Latham S, Han J, McCloy R, O Donnell Y, et al. Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma. elife. 2020;9: pubmed publisher
  30. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  31. Wakabayashi H, Miyamura G, Nagao N, Kato S, Naito Y, Sudo A. Functional Block of Interleukin-6 Reduces a Bone Pain Marker but Not Bone Loss in Hindlimb-Unloaded Mice. Int J Mol Sci. 2020;21: pubmed publisher
  32. Sola M, Magrin C, Pedrioli G, Pinton S, Salvade A, Papin S, et al. Tau affects P53 function and cell fate during the DNA damage response. Commun Biol. 2020;3:245 pubmed publisher
  33. Shinada M, Kato D, Kamoto S, Yoshimoto S, Tsuboi M, Yoshitake R, et al. PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma. Cells. 2020;9: pubmed publisher
  34. Wu P, Hong S, Starenki D, Oshima K, Shao H, Gestwicki J, et al. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene. 2020;39:4257-4270 pubmed publisher
  35. Tsang Y, Wang Y, Kong K, Grzeskowiak C, Zagorodna O, Dogruluk T, et al. Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression. elife. 2020;9: pubmed publisher
  36. Alessio N, Squillaro T, Di Bernardo G, Galano G, De Rosa R, Melone M, et al. Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence. elife. 2020;9: pubmed publisher
  37. Lochab S, Singh Y, Sengupta S, Nandicoori V. Mycobacterium tuberculosis exploits host ATM kinase for survival advantage through SecA2 secretome. elife. 2020;9: pubmed publisher
  38. Liu J, Liu Z, Wu Q, Lu Y, Wong C, Miao L, et al. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nat Commun. 2020;11:1507 pubmed publisher
  39. Feng C, Zhang H, Zeng A, Bai M, Wang X. Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Mol Ther Nucleic Acids. 2020;20:186-195 pubmed publisher
  40. Atashpaz S, Samadi Shams S, Gonzalez J, Sebestyén E, Arghavanifard N, Gnocchi A, et al. ATR expands embryonic stem cell fate potential in response to replication stress. elife. 2020;9: pubmed publisher
  41. Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L, et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun. 2020;11:1310 pubmed publisher
  42. Lee J, Yu S, Nam T, Roh J, Jin Y, Han J, et al. The position of the target site for engineered nucleases improves the aberrant mRNA clearance in in vivo genome editing. Sci Rep. 2020;10:4173 pubmed publisher
  43. Che H, Li J, Li Y, Ma C, Liu H, Qin J, et al. p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle. elife. 2020;9: pubmed publisher
  44. Chen Y, Liu Z, Wang Y, Zhuang J, Peng Y, Mo X, et al. FKBP51 induces p53-dependent apoptosis and enhances drug sensitivity of human non-small-cell lung cancer cells. Exp Ther Med. 2020;19:2236-2242 pubmed publisher
  45. Pothuraju R, Rachagani S, Krishn S, Chaudhary S, Nimmakayala R, Siddiqui J, et al. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Mol Cancer. 2020;19:37 pubmed publisher
  46. Gain C, Malik S, Bhattacharjee S, Ghosh A, Robertson E, Das B, et al. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway. PLoS Pathog. 2020;16:e1008105 pubmed publisher
  47. Ailiken G, Kitamura K, Hoshino T, Satoh M, Tanaka N, Minamoto T, et al. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer. Oncogenesis. 2020;9:26 pubmed publisher
  48. Zhao Z, Wang Y, Yun D, Huang Q, Meng D, Li Q, et al. TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma. Am J Cancer Res. 2020;10:114-130 pubmed
  49. Sciascia N, Wu W, Zong D, Sun Y, Wong N, John S, et al. Suppressing proteasome mediated processing of Topoisomerase II DNA-protein complexes preserves genome integrity. elife. 2020;9: pubmed publisher
  50. Li K, Zhao S, Long J, Su J, Wu L, Tao J, et al. A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products. Cancer Cell Int. 2020;20:36 pubmed publisher
  51. You F, Li J, Zhang P, Zhang H, Cao X. miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin. Cancer Manag Res. 2020;12:233-246 pubmed publisher
  52. Zhang M, Wang Z, Li B, Sun F, Chen A, Gong M. Identification of microRNA‑363‑3p as an essential regulator of chondrocyte apoptosis in osteoarthritis by targeting NRF1 through the p53‑signaling pathway. Mol Med Rep. 2020;21:1077-1088 pubmed publisher
  53. Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways. Nat Commun. 2020;11:594 pubmed publisher
  54. Marin Navarro A, Pronk R, van der Geest A, Oliynyk G, Nordgren A, Arsenian Henriksson M, et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 2020;11:52 pubmed publisher
  55. Cui J, Duan J, Chu J, Guo C, Xi M, Li Y, et al. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway. Aging (Albany NY). 2020;12:1591-1609 pubmed publisher
  56. Zhang C, Xie Y, Chen H, Lv L, Yao J, Zhang M, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020;12:1272-1284 pubmed publisher
  57. Qiao H, Tan X, Lv D, Xing R, Shu F, Zhong C, et al. Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis. J Cancer. 2020;11:1027-1037 pubmed publisher
  58. Kim J, Fei L, Yin W, Coquenlorge S, Rao Bhatia A, Zhang X, et al. Single cell and genetic analyses reveal conserved populations and signaling mechanisms of gastrointestinal stromal niches. Nat Commun. 2020;11:334 pubmed publisher
  59. Cassidy L, Young A, Young C, Soilleux E, Fielder E, Weigand B, et al. Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk. Nat Commun. 2020;11:307 pubmed publisher
  60. Blagih J, Zani F, Chakravarty P, Hennequart M, Pilley S, Hobor S, et al. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses. Cell Rep. 2020;30:481-496.e6 pubmed publisher
  61. Laukoter S, Beattie R, Pauler F, Amberg N, Nakayama K, Hippenmeyer S. Imprinted Cdkn1c genomic locus cell-autonomously promotes cell survival in cerebral cortex development. Nat Commun. 2020;11:195 pubmed publisher
  62. Cai H, Han B, Hu Y, Zhao X, He Z, Chen X, et al. Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways. Int J Mol Med. 2020;45:715-730 pubmed publisher
  63. Kobayashi G, Sentani K, Babasaki T, Sekino Y, Shigematsu Y, Hayashi T, et al. Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma. Cancer Sci. 2020;111:1020-1027 pubmed publisher
  64. Verdura S, Cuyàs E, Cortada E, Brunet J, Lopez Bonet E, Martin Castillo B, et al. Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. Aging (Albany NY). 2020;12:8-34 pubmed publisher
  65. Shimada Y, Kudo Y, Maehara S, Matsubayashi J, Otaki Y, Kajiwara N, et al. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers. Cancer Sci. 2020;111:610-620 pubmed publisher
  66. Fujita Y, Matsuda S, Sasaki Y, Masugi Y, Kitago M, Yagi H, et al. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis. Cancer Sci. 2020;111:739-748 pubmed publisher
  67. Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10:5492 pubmed publisher
  68. Callender L, Carroll E, Bober E, Akbar A, Solito E, Henson S. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19:e13067 pubmed publisher
  69. Yang Y, Tang F, Wei F, Yang L, Kuang C, Zhang H, et al. Silencing of long non-coding RNA H19 downregulates CTCF to protect against atherosclerosis by upregulating PKD1 expression in ApoE knockout mice. Aging (Albany NY). 2019;11:10016-10030 pubmed publisher
  70. Lv L, Zhou M, Zhang J, Liu F, Qi L, Zhang S, et al. SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21CIPI , cyclin D1 and β-catenin. FEBS Open Bio. 2020;10:135-146 pubmed publisher
  71. Guo S, Liu R, Wen Y, Liu L, Yuan L, Li Y, et al. Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis. Cancer Lett. 2020;468:27-40 pubmed publisher
  72. Jung J, Lee H, Cao B, Liao P, Zeng S, Lu H. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53. Oncogene. 2019;: pubmed publisher
  73. Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019;: pubmed publisher
  74. Han D, Schomacher L, Schüle K, Mallick M, Musheev M, Karaulanov E, et al. NEIL1 and NEIL2 DNA glycosylases protect neural crest development against mitochondrial oxidative stress. elife. 2019;8: pubmed publisher
  75. Zhu B, Ren C, Du K, Zhu H, Ai Y, Kang F, et al. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways. Biochem Pharmacol. 2019;170:113642 pubmed publisher
  76. Chollat Namy M, Ben Safta Saadoun T, Haferssas D, Meurice G, Chouaib S, Thiery J. The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell Death Dis. 2019;10:695 pubmed publisher
  77. Morris J, Yashinskie J, Koche R, Chandwani R, Tian S, Chen C, et al. α-Ketoglutarate links p53 to cell fate during tumour suppression. Nature. 2019;573:595-599 pubmed publisher
  78. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  79. Thiem A, Hesbacher S, Kneitz H, di Primio T, Heppt M, Hermanns H, et al. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression. J Exp Clin Cancer Res. 2019;38:397 pubmed publisher
  80. Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V. Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells. Biomolecules. 2019;9: pubmed publisher
  81. Martínez J, Tarallo D, Martinez Palma L, Victoria S, Bresque M, Rodriguez Bottero S, et al. Mitofusins modulate the increase in mitochondrial length, bioenergetics and secretory phenotype in therapy-induced senescent melanoma cells. Biochem J. 2019;476:2463-2486 pubmed publisher
  82. Gao X, Chen H, Liu J, Shen S, Wang Q, Clement T, et al. The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling. Stem Cell Reports. 2019;13:559-571 pubmed publisher
  83. Boettcher S, Miller P, Sharma R, McConkey M, Leventhal M, Krivtsov A, et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science. 2019;365:599-604 pubmed publisher
  84. El Kott A, Shati A, Al Kahtani M, Alqahtani S. Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway. Anal Cell Pathol (Amst). 2019;2019:9627810 pubmed publisher
  85. Zhang X, Du K, Lou Z, Ding K, Zhang F, Zhu J, et al. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells. Int J Biol Sci. 2019;15:1460-1471 pubmed publisher
  86. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  87. Sun B, Zhao X, Ming J, Liu X, Liu D, Jiang C. Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma. Oncogene. 2019;38:6142-6157 pubmed publisher
  88. Kaur S, Nag A, Gangenahalli G, Sharma K. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Front Genet. 2019;10:554 pubmed publisher
  89. Wiel C, Le Gal K, Ibrahim M, Jahangir C, Kashif M, Yao H, et al. BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis. Cell. 2019;: pubmed publisher
  90. Zhang J, Lee Y, Dang F, Gan W, Menon A, Katon J, et al. PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage. Cancer Discov. 2019;: pubmed publisher
  91. Hari P, Millar F, Tarrats N, Birch J, Quintanilla A, Rink C, et al. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Sci Adv. 2019;5:eaaw0254 pubmed publisher
  92. Hou N, He X, Yang Y, Fu J, Zhang W, Guo Z, et al. TRPV1 Induced Apoptosis of Colorectal Cancer Cells by Activating Calcineurin-NFAT2-p53 Signaling Pathway. Biomed Res Int. 2019;2019:6712536 pubmed publisher
  93. Luo X, Jiang X, Li J, Bai Y, Li Z, Wei P, et al. Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53-progerin interaction. Cell Death Dis. 2019;10:451 pubmed publisher
  94. Benyelles M, Episkopou H, O Donohue M, Kermasson L, Frange P, Poulain F, et al. Impaired telomere integrity and rRNA biogenesis in PARN-deficient patients and knock-out models. EMBO Mol Med. 2019;: pubmed publisher
  95. Pantazi A, Quintanilla A, Hari P, Tarrats N, Parasyraki E, Dix F, et al. Inhibition of the 60S ribosome biogenesis GTPase LSG1 causes endoplasmic reticular disruption and cellular senescence. Aging Cell. 2019;18:e12981 pubmed publisher
  96. Chaves Pérez A, Yilmaz M, Perna C, de la Rosa S, Djouder N. URI is required to maintain intestinal architecture during ionizing radiation. Science. 2019;364: pubmed publisher
  97. Frischknecht L, Britschgi C, Galliker P, Christinat Y, Vichalkovski A, Gstaiger M, et al. BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly. Sci Rep. 2019;9:7779 pubmed publisher
  98. Shin Y, Kim Y, Wen X, Cho N, Lee S, Kim W, et al. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer. Clin Epigenetics. 2019;11:77 pubmed publisher
  99. Sonego M, Pellarin I, Costa A, Vinciguerra G, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv. 2019;5:eaav3235 pubmed publisher
  100. Xie X, Bi H, Lai S, Zhang Y, Li N, Cao H, et al. The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation. Sci Adv. 2019;5:eaau0495 pubmed publisher
  101. Forte I, Indovina P, Iannuzzi C, Cirillo D, Di Marzo D, Barone D, et al. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide. Int J Oncol. 2019;54:2189-2199 pubmed publisher
  102. Teo Y, Rattanavirotkul N, Olova N, Salzano A, Quintanilla A, Tarrats N, et al. Notch Signaling Mediates Secondary Senescence. Cell Rep. 2019;27:997-1007.e5 pubmed publisher
  103. Goodman D, Pretto C, Krepostman T, Carnahan K, Spindler K. Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR). MBio. 2019;10: pubmed publisher
  104. Gao R, Chakraborty A, Geater C, Pradhan S, Gordon K, Snowden J, et al. Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. elife. 2019;8: pubmed publisher
  105. Kucab J, Zou X, Morganella S, Joel M, Nanda A, Nagy E, et al. A Compendium of Mutational Signatures of Environmental Agents. Cell. 2019;177:821-836.e16 pubmed publisher
  106. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  107. Chan E, Shibue T, McFarland J, Gaeta B, Ghandi M, Dumont N, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. 2019;568:551-556 pubmed publisher
  108. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665 pubmed publisher
  109. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  110. Fu L, Hu Y, Song M, Liu Z, Zhang W, Yu F, et al. Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis. PLoS Biol. 2019;17:e3000201 pubmed publisher
  111. Choi Y, Kang M, Hong K, Kim J. Tubastatin A inhibits HDAC and Sirtuin activity rather than being a HDAC6-specific inhibitor in mouse oocytes. Aging (Albany NY). 2019;11:1759-1777 pubmed publisher
  112. Chen L, Yang R, Qiao W, Zhang W, Chen J, Mao L, et al. 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. Aging Cell. 2019;18:e12951 pubmed publisher
  113. Pillay N, Tighe A, Nelson L, Littler S, Coulson Gilmer C, Bah N, et al. DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors. Cancer Cell. 2019;35:519-533.e8 pubmed publisher
  114. Kon N, Wang D, Gu W. Loss of SET reveals both the p53-dependent and the p53-independent functions in vivo. Cell Death Dis. 2019;10:237 pubmed publisher
  115. Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol. 2019;22:101157 pubmed publisher
  116. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  117. Zhang X, Qin Q, Dai H, Cai S, Zhou C, Guan J. Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression. Braz J Med Biol Res. 2019;52:e7994 pubmed publisher
  118. Jia Q, Yang F, Huang W, Zhang Y, Bao B, Li K, et al. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy. Theranostics. 2019;9:424-435 pubmed publisher
  119. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed publisher
  120. Geng Y, Liu X, Liang J, Habiel D, Kulur V, Coelho A, et al. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI Insight. 2019;4: pubmed publisher
  121. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed publisher
  122. Zhao Y, Ding L, Wang D, Ye Z, He Y, Ma L, et al. EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis. EMBO J. 2019;38: pubmed publisher
  123. Wu Y, Li X, Yu J, Bjorkholm M, Xu D. ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells. Cell Death Dis. 2019;10:76 pubmed publisher
  124. Zhang G, Liu Y, Xu L, Sha C, Zhang H, Xu W. Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model. BMC Biotechnol. 2019;19:10 pubmed publisher
  125. Nassour J, Radford R, Correia A, Fusté J, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659-663 pubmed publisher
  126. Wang D, Xu Q, Yuan Q, Jia M, Niu H, Liu X, et al. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab. Oncogene. 2019;38:3458-3474 pubmed publisher
  127. Sachs N, Papaspyropoulos A, Zomer van Ommen D, Heo I, Böttinger L, Klay D, et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 2019;38: pubmed publisher
  128. Mohni K, Wessel S, Zhao R, Wojciechowski A, Luzwick J, Layden H, et al. HMCES Maintains Genome Integrity by Shielding Abasic Sites in Single-Strand DNA. Cell. 2019;176:144-153.e13 pubmed publisher
  129. Wang Y, Du L, Liang X, Meng P, Bi L, Wang Y, et al. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice. Hepatology. 2018;: pubmed publisher
  130. Liu B, Yi J, Yang X, Liu L, Lou X, Zhang Z, et al. MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner. Oncogene. 2019;38:2501-2515 pubmed publisher
  131. Jeon Y, Kim T, Park D, Nuovo G, Rhee S, Joshi P, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nat Commun. 2018;9:5110 pubmed publisher
  132. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  133. Xu T, Ding W, Ao X, Chu X, Wan Q, Wang Y, et al. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening. Redox Biol. 2019;20:414-426 pubmed publisher
  134. Tan P, Ye Y, He L, Xie J, Jing J, Ma G, et al. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10. PLoS Biol. 2018;16:e3000051 pubmed publisher
  135. Zhang J, Tan P, Guo L, Gong J, Ma J, Li J, et al. p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance. Oncogene. 2019;38:1905-1919 pubmed publisher
  136. Hsu J, Dayaram T, Tovy A, De Braekeleer E, Jeong M, Wang F, et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell. 2018;23:700-713.e6 pubmed publisher
  137. Li H, Feng J, Zhang Y, Feng J, Wang Q, Zhao S, et al. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway. Redox Biol. 2019;20:261-274 pubmed publisher
  138. De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui A, Saha S, et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-κB signaling. J Biol Chem. 2018;293:19740-19760 pubmed publisher
  139. Yang Y, Peng X. The silencing of long non-coding RNA ANRIL suppresses invasion, and promotes apoptosis of retinoblastoma cells through the ATM-E2F1 signaling pathway. Biosci Rep. 2018;38: pubmed publisher
  140. Ivanyi Nagy R, Ahmed S, Peter S, Ramani P, Ong P, Dreesen O, et al. The RNA interactome of human telomerase RNA reveals a coding-independent role for a histone mRNA in telomere homeostasis. elife. 2018;7: pubmed publisher
  141. Li Y, Liu Y, Xu H, Jiang G, Van der Jeught K, Fang Y, et al. Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II. Nat Commun. 2018;9:4394 pubmed publisher
  142. Fu J, Yu W, Jiang D. Acidic pH promotes nucleus pulposus cell senescence through activating the p38 MAPK pathway. Biosci Rep. 2018;38: pubmed publisher
  143. Cheruiyot A, Li S, Nickless A, Roth R, Fitzpatrick J, You Z. Compound C inhibits nonsense-mediated RNA decay independently of AMPK. PLoS ONE. 2018;13:e0204978 pubmed publisher
  144. Park J, Lee J, Sheu K, Wang L, Balanis N, Nguyen K, et al. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018;362:91-95 pubmed publisher
  145. Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181-1192 pubmed publisher
  146. Walia M, Taylor S, Ho P, Martin T, Walkley C. Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53. Cell Death Dis. 2018;9:844 pubmed publisher
  147. Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya M, Wang X, et al. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. J Clin Invest. 2018;128:4924-4937 pubmed publisher
  148. Tajan M, Hock A, Blagih J, Robertson N, Labuschagne C, Kruiswijk F, et al. A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3. Cell Metab. 2018;28:721-736.e6 pubmed publisher
  149. Leslie P, Franklin D, Liu Y, Zhang Y. p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop. Cell Rep. 2018;24:1484-1495 pubmed publisher
  150. Kim S, Jin H, Seo H, Lee H, Lee Y. Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation. Cell Death Differ. 2019;26:812-825 pubmed publisher
  151. Bernal A, Moltó Abad M, Dominguez D, Tusell L. Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4a-deficient epithelial cells. Oncotarget. 2018;9:27151-27170 pubmed publisher
  152. Li R, Sahu S, Schachner M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor Neurol Neurosci. 2018;36:469-483 pubmed publisher
  153. Komori H, Goto Y, Kurayoshi K, Ozono E, Iwanaga R, Bradford A, et al. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes. Sci Rep. 2018;8:8438 pubmed publisher
  154. Ng S, Yoshida N, Christie A, Ghandi M, Dharia N, Dempster J, et al. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018;9:2024 pubmed publisher
  155. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  156. Bellelli R, Borel V, Logan C, Svendsen J, Cox D, Nye E, et al. Polε Instability Drives Replication Stress, Abnormal Development, and Tumorigenesis. Mol Cell. 2018;70:707-721.e7 pubmed publisher
  157. Ryu K, Nandu T, Kim J, Challa S, DeBerardinis R, Kraus W. Metabolic regulation of transcription through compartmentalized NAD+ biosynthesis. Science. 2018;360: pubmed publisher
  158. Parisotto M, Grelet E, El Bizri R, Dai Y, Terzic J, Eckert D, et al. PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. J Exp Med. 2018;215:1749-1763 pubmed publisher
  159. Wang J, Wang F, Zhu J, Song M, An J, Li W. Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. J Mol Neurosci. 2018;65:102-109 pubmed publisher
  160. Wang Z, Ding Y, Wang X, Lu S, Wang C, He C, et al. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT. Cancer Lett. 2018;428:21-33 pubmed publisher
  161. Jin L, Lu J, Gao J. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep. 2018;38: pubmed publisher
  162. Yang X, Ding Y, Yang M, Yu L, Hu Y, Deng Y. Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5. Kidney Blood Press Res. 2018;43:616-627 pubmed publisher
  163. Qiu C, Wang Y, Wang X, Zhang Q, Li Y, Xu Y, et al. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma. Int J Oncol. 2018;52:2041-2050 pubmed publisher
  164. Ghosh R, Roy S, Franco S. PARP1 depletion induces RIG-I-dependent signaling in human cancer cells. PLoS ONE. 2018;13:e0194611 pubmed publisher
  165. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed publisher
  166. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  167. Jin Y, Kim S, Kim H, Ju W, Kim Y, Kim H. Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer. Arch Pharm Res. 2018;41:438-449 pubmed publisher
  168. Hoshii T, Cifani P, Feng Z, Huang C, Koche R, Chen C, et al. A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response. Cell. 2018;172:1007-1021.e17 pubmed publisher
  169. Fu X, Zhang C, Meng H, Zhang K, Shi L, Cao C, et al. Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress. Cell Death Differ. 2018;25:1625-1637 pubmed publisher
  170. Li F, Liu J, Bao R, Yan G, Feng X, Xu Y, et al. Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis. Nat Commun. 2018;9:508 pubmed publisher
  171. Zhao Y, Tan M, Liu X, Xiong X, Sun Y. Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2-MRN-ATM axes. Cell Death Dis. 2018;9:145 pubmed publisher
  172. Gong L, Pan X, Lim C, de Polo A, Little J, Yuan Z. A functional interplay between Δ133p53 and ΔNp63 in promoting glycolytic metabolism to fuel cancer cell proliferation. Oncogene. 2018;37:2150-2164 pubmed publisher
  173. Solomon H, Dinowitz N, Pateras I, Cooks T, Shetzer Y, Molchadsky A, et al. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene. 2018;37:1669-1684 pubmed publisher
  174. Zhu B, Chen S, Wang H, Yin C, Han C, Peng C, et al. The protective role of DOT1L in UV-induced melanomagenesis. Nat Commun. 2018;9:259 pubmed publisher
  175. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed publisher
  176. Ka M, Kim W. ANKRD11 associated with intellectual disability and autism regulates dendrite differentiation via the BDNF/TrkB signaling pathway. Neurobiol Dis. 2018;111:138-152 pubmed publisher
  177. Tanaka N, Zhao M, Tang L, Patel A, Xi Q, Van H, et al. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Oncogene. 2018;37:1279-1292 pubmed publisher
  178. Wu J, Xiang S, Zhang M, Fang B, Huang H, Kwon O, et al. Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity. J Biol Chem. 2018;293:1976-1993 pubmed publisher
  179. Mircetic J, Dietrich A, Paszkowski Rogacz M, Krause M, Buchholz F. Development of a genetic sensor that eliminates p53 deficient cells. Nat Commun. 2017;8:1463 pubmed publisher
  180. Sorokina I, Denisenko T, Imreh G, Tyurin Kuzmin P, Kaminskyy V, Gogvadze V, et al. Involvement of autophagy in the outcome of mitotic catastrophe. Sci Rep. 2017;7:14571 pubmed publisher
  181. Zhao L, Liu J, He C, Yan R, Zhou K, Cui Q, et al. Protein kinase A determines platelet life span and survival by regulating apoptosis. J Clin Invest. 2017;127:4338-4351 pubmed publisher
  182. Thaler S, Schmidt M, Roβwag S, Thiede G, Schad A, Sleeman J. Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells. Oncotarget. 2017;8:72281-72301 pubmed publisher
  183. Huang C, Wu S, Ji H, Yan X, Xie Y, Murai S, et al. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library. Sci Adv. 2017;3:e1701383 pubmed publisher
  184. Zhao X, Huang L, Xu W, Chen X, Shen Y, Zeng W, et al. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. Oncotarget. 2017;8:70130-70141 pubmed publisher
  185. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  186. Mello S, Valente L, Raj N, Seoane J, Flowers B, McClendon J, et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 2017;32:460-473.e6 pubmed publisher
  187. Periyasamy M, Singh A, Gemma C, Kranjec C, Farzan R, Leach D, et al. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells. Nucleic Acids Res. 2017;45:11056-11069 pubmed publisher
  188. Zhang F, Virshup D, Cheong J. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis. Oncogene. 2018;37:363-376 pubmed publisher
  189. Giono L, Resnick Silverman L, Carvajal L, St Clair S, Manfredi J. Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase. Oncogene. 2017;36:6762-6773 pubmed publisher
  190. Bitler B, Wu S, Park P, Hai Y, Aird K, Wang Y, et al. ARID1A-mutated ovarian cancers depend on HDAC6 activity. Nat Cell Biol. 2017;19:962-973 pubmed publisher
  191. Liao M, Zhao X, Chang S, Lo C, Chenier I, Takano T, et al. AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression. J Pathol. 2017;243:279-293 pubmed publisher
  192. Marchesini M, Ogoti Y, Fiorini E, Aktaş Samur A, Nezi L, D Anca M, et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell. 2017;32:88-100.e6 pubmed publisher
  193. Lang M, Jenkins S, Balzano P, Owoyele A, Patel A, Bamezai A. Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4+ T-cell lines. Immun Inflamm Dis. 2017;5:448-460 pubmed publisher
  194. Patel N, Garikapati K, Pandita R, Singh D, Pandita T, Bhadra U, et al. miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin. Sci Rep. 2017;7:4263 pubmed publisher
  195. Van T, Polykratis A, Straub B, Kondylis V, Papadopoulou N, Pasparakis M. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis. J Clin Invest. 2017;127:2662-2677 pubmed publisher
  196. Szoka L, Karna E, Hlebowicz Sarat K, Karaszewski J, Palka J. Exogenous proline stimulates type I collagen and HIF-1? expression and the process is attenuated by glutamine in human skin fibroblasts. Mol Cell Biochem. 2017;435:197-206 pubmed publisher
  197. Shin C, Lee M, Han J, Jeong S, Ryu B, Chi S. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017;114:5683-5688 pubmed publisher
  198. Read M, Fong J, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson R, et al. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. Oncogene. 2017;36:5296-5308 pubmed publisher
  199. Xie Y, Ma W, Meng J, Ren X. Knockdown of ZFPL1 results in increased autophagy and autophagy‑related cell death in NCI‑N87 and BGC‑823 human gastric carcinoma cell lines. Mol Med Rep. 2017;15:2633-2642 pubmed publisher
  200. Lian W, Zhang L, Yang L, Chen W. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis. 2017;22:933-941 pubmed publisher
  201. Lee T, Pelletier J. Dependence of p53-deficient cells on the DHX9 DExH-box helicase. Oncotarget. 2017;8:30908-30921 pubmed publisher
  202. Blank M, Chen S, Poetz F, Schnolzer M, Voit R, Grummt I. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription. Nucleic Acids Res. 2017;45:2675-2686 pubmed publisher
  203. Beker M, Çağlayan B, Yalcin E, Caglayan A, Turkseven S, Gurel B, et al. Time-of-Day Dependent Neuronal Injury After Ischemic Stroke: Implication of Circadian Clock Transcriptional Factor Bmal1 and Survival Kinase AKT. Mol Neurobiol. 2018;55:2565-2576 pubmed publisher
  204. Yang X, Qi L, Lin F, Ou Z. The role of the chemokine receptor XCR1 in breast cancer cells. Breast Cancer (Dove Med Press). 2017;9:227-236 pubmed publisher
  205. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  206. Wassermann Dozorets R, Rubinstein M. C/EBPβ LIP augments cell death by inducing osteoglycin. Cell Death Dis. 2017;8:e2733 pubmed publisher
  207. Cong Q, Jia H, Li P, Qiu S, Yeh J, Wang Y, et al. p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner. Sci Rep. 2017;7:45964 pubmed publisher
  208. He L, Luo L, Zhu H, Yang H, Zhang Y, Wu H, et al. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer. Mol Oncol. 2017;11:640-654 pubmed publisher
  209. Evsyukov V, Domanskyi A, Bierhoff H, Gispert S, Mustafa R, Schlaudraff F, et al. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models. Dis Model Mech. 2017;10:633-643 pubmed publisher
  210. Bryukhovetskiy I, Lyakhova I, Mischenko P, Milkina E, Zaitsev S, Khotimchenko Y, et al. Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro. Oncol Lett. 2017;13:738-746 pubmed publisher
  211. Filipescu D, Naughtin M, Podsypanina K, Lejour V, Wilson L, Gurard Levin Z, et al. Essential role for centromeric factors following p53 loss and oncogenic transformation. Genes Dev. 2017;31:463-480 pubmed publisher
  212. Kang H, Park J, Choi K, Kim Y, Choi H, Jung C, et al. Chemical screening identifies ATM as a target for alleviating senescence. Nat Chem Biol. 2017;13:616-623 pubmed publisher
  213. Mehta N, Lyon J, Patil K, Mokarram N, Kim C, Bellamkonda R. Bacterial Carriers for Glioblastoma Therapy. Mol Ther Oncolytics. 2017;4:1-17 pubmed publisher
  214. Gagaoua M, Couvreur S, Le Bec G, Aminot G, Picard B. Associations among Protein Biomarkers and pH and Color Traits in Longissimus thoracis and Rectus abdominis Muscles in Protected Designation of Origin Maine-Anjou Cull Cows. J Agric Food Chem. 2017;65:3569-3580 pubmed publisher
  215. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  216. Coni S, Mancuso A, Di Magno L, Sdruscia G, Manni S, Serrao S, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079 pubmed publisher
  217. Shadle S, Zhong J, Campbell A, Conerly M, Jagannathan S, Wong C, et al. DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet. 2017;13:e1006658 pubmed publisher
  218. Fumagalli A, Drost J, Suijkerbuijk S, van Boxtel R, de Ligt J, Offerhaus G, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114:E2357-E2364 pubmed publisher
  219. Hui X, Zhang M, Gu P, Li K, Gao Y, Wu D, et al. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO Rep. 2017;18:645-657 pubmed publisher
  220. Obeid S, Wankell M, Charrez B, Sternberg J, Kreuter R, Esmaili S, et al. Adiponectin confers protection from acute colitis and restricts a B cell immune response. J Biol Chem. 2017;292:6569-6582 pubmed publisher
  221. Xu J, Wu Y, Lu G, Xie S, Ma Z, Chen Z, et al. Importance of ROS-mediated autophagy in determining apoptotic cell death induced by physapubescin B. Redox Biol. 2017;12:198-207 pubmed publisher
  222. Li J, Yakushi T, Parlati F, MacKinnon A, Pérez C, Ma Y, et al. Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11. Nat Chem Biol. 2017;13:486-493 pubmed publisher
  223. Barilari M, Bonfils G, Treins C, Koka V, De Villeneuve D, Fabrega S, et al. ZRF1 is a novel S6 kinase substrate that drives the senescence programme. EMBO J. 2017;36:736-750 pubmed publisher
  224. Yan H, Zhang Y, Zhang Y, Ren X, Shen Y, Cheng M, et al. CRIF1 enhances p53 activity via the chromatin remodeler SNF5 in the HCT116 colon cancer cell lines. Biochim Biophys Acta Gene Regul Mech. 2017;1860:516-522 pubmed publisher
  225. Li W, Li H, Zhang L, Hu M, Li F, Deng J, et al. Long non-coding RNA LINC00672 contributes to p53 protein-mediated gene suppression and promotes endometrial cancer chemosensitivity. J Biol Chem. 2017;292:5801-5813 pubmed publisher
  226. Oliver D, Ji H, Liu P, Gasparian A, Gardiner E, Lee S, et al. Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen. Sci Rep. 2017;7:43023 pubmed publisher
  227. Singh V, Katta S, Kumar S. WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice. BMC Cancer. 2017;17:148 pubmed publisher
  228. Wang C, Guo L, Wang S, Wang J, Li Y, Dou Y, et al. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells. Int J Mol Med. 2017;39:645-653 pubmed publisher
  229. Graham N, Minasyan A, Lomova A, Cass A, Balanis N, Friedman M, et al. Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures. Mol Syst Biol. 2017;13:914 pubmed publisher
  230. Chan L, Chen Z, Braas D, Lee J, Xiao G, Geng H, et al. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 2017;542:479-483 pubmed publisher
  231. Shin S, Song J, Hwang B, Noh D, Park S, Kim W, et al. HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation. PLoS ONE. 2017;12:e0171860 pubmed publisher
  232. Xu W, Li B, Guan X, Chung S, Wang Y, Yip Y, et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun. 2017;8:14399 pubmed publisher
  233. Yuan H, Tan B, Gao S. Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis. 2017;8:e2608 pubmed publisher
  234. Lerner L, Francisco G, Soltys D, Rocha C, Quinet A, Vessoni A, et al. Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells. Nucleic Acids Res. 2017;45:1270-1280 pubmed publisher
  235. Meisenberg C, Ashour M, El Shafie L, Liao C, Hodgson A, Pilborough A, et al. Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan. Nucleic Acids Res. 2017;45:1159-1176 pubmed publisher
  236. Liu T, Krysiak K, Shirai C, Kim S, Shao J, Ndonwi M, et al. Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells. PLoS ONE. 2017;12:e0170470 pubmed publisher
  237. Coaxum S, Tiedeken J, Garrett Mayer E, Myers J, Rosenzweig S, Neskey D. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer. Oncotarget. 2017;8:22991-23007 pubmed publisher
  238. Ritschka B, Storer M, Mas A, Heinzmann F, Ortells M, Morton J, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31:172-183 pubmed publisher
  239. Graziano A, Cardile V, Avola R, Vicario N, Parenti C, Salvatorelli L, et al. Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. Oncotarget. 2017;8:13917-13931 pubmed publisher
  240. Liu G, Xiang T, Wu Q, Wang W. Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19. Oncol Lett. 2016;12:5156-5162 pubmed publisher
  241. Xu S, Yang Z, Fan Y, Guan B, Jia J, Gao Y, et al. Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53. Oncol Lett. 2016;12:4999-5006 pubmed publisher
  242. Gan J, Wang F, Mu D, Qu Y, Luo R, Wang Q. RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy. Oncol Lett. 2016;12:4515-4523 pubmed publisher
  243. Nakazawa H, Chang K, Shinozaki S, Yasukawa T, Ishimaru K, Yasuhara S, et al. iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53. PLoS ONE. 2017;12:e0170391 pubmed publisher
  244. Ponath V, Kaina B. Death of Monocytes through Oxidative Burst of Macrophages and Neutrophils: Killing in Trans. PLoS ONE. 2017;12:e0170347 pubmed publisher
  245. Squillaro T, Antonucci I, Alessio N, Esposito A, Cipollaro M, Melone M, et al. Impact of lysosomal storage disorders on biology of mesenchymal stem cells: Evidences from in vitro silencing of glucocerebrosidase (GBA) and alpha-galactosidase A (GLA) enzymes. J Cell Physiol. 2017;232:3454-3467 pubmed publisher
  246. Ros S, Flöter J, Kaymak I, da Costa C, Houddane A, Dubuis S, et al. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells. Oncogene. 2017;36:3287-3299 pubmed publisher
  247. Worrall C, Suleymanova N, Crudden C, Trocoli Drakensjö I, Candrea E, Nedelcu D, et al. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma. Oncogene. 2017;36:3274-3286 pubmed publisher
  248. Burikhanov R, Hebbar N, Noothi S, Shukla N, Sledziona J, Araujo N, et al. Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis. Cell Rep. 2017;18:508-519 pubmed publisher
  249. Castellini L, Moon E, Razorenova O, Krieg A, von Eyben R, Giaccia A. KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage. Nucleic Acids Res. 2017;45:3674-3692 pubmed publisher
  250. Riverso M, Montagnani V, Stecca B. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth. Oncogene. 2017;36:3322-3333 pubmed publisher
  251. Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, et al. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer. 2017;24:107-117 pubmed publisher
  252. Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84-88 pubmed publisher
  253. Corbineau S, Lassalle B, Givelet M, Souissi Sarahoui I, Firlej V, Romeo P, et al. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4. Oncotarget. 2017;8:10050-10063 pubmed publisher
  254. Guan X, Lapak K, Hennessey R, Yu C, Shakya R, Zhang J, et al. Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth. Mol Cancer Res. 2017;15:237-249 pubmed publisher
  255. De Smet F, Saiz Rubio M, Hompes D, Naus E, De Baets G, Langenberg T, et al. Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. J Pathol. 2017;242:24-38 pubmed publisher
  256. Wamsley J, Issaeva N, An H, Lu X, Donehower L, Yarbrough W. LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro. Cell Cycle. 2017;16:213-223 pubmed publisher
  257. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  258. Mytych J, Wos I, Solek P, Koziorowski M. Protective role of klotho protein on epithelial cells upon co-culture with activated or senescent monocytes. Exp Cell Res. 2017;350:358-367 pubmed publisher
  259. Chao T, Zhou X, Cao B, Liao P, Liu H, Chen Y, et al. Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nat Commun. 2016;7:13755 pubmed publisher
  260. Ren Z, Aerts J, Vandenplas H, Wang J, Gorbenko O, Chen J, et al. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2. Cell Death Dis. 2016;7:e2560 pubmed publisher
  261. Zhang W, Kang M, Zhang T, Li B, Liao X, Wang R. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism. Int J Mol Sci. 2016;17: pubmed publisher
  262. Marmisolle I, Martínez J, Liu J, Mastrogiovanni M, Fergusson M, Rovira I, et al. Reciprocal regulation of acetyl-CoA carboxylase 1 and senescence in human fibroblasts involves oxidant mediated p38 MAPK activation. Arch Biochem Biophys. 2017;613:12-22 pubmed publisher
  263. Yu Z, Mouillesseaux K, Kushner E, Bautch V. Tumor-Derived Factors and Reduced p53 Promote Endothelial Cell Centrosome Over-Duplication. PLoS ONE. 2016;11:e0168334 pubmed publisher
  264. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  265. Hölzer K, Drucker E, Roessler S, Dauch D, Heinzmann F, Waldburger N, et al. Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer. Am J Pathol. 2017;187:228-235 pubmed publisher
  266. Chhabra A, Mukherji B, Batra D. Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53. Expert Opin Ther Targets. 2017;21:117-129 pubmed publisher
  267. Ronellenfitsch M, Oh J, Satomi K, Sumi K, Harter P, Steinbach J, et al. CASP9 germline mutation in a family with multiple brain tumors. Brain Pathol. 2018;28:94-102 pubmed publisher
  268. Seo B, Min K, Woo S, Choe M, Choi K, Lee Y, et al. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP. Antioxid Redox Signal. 2017;27:215-233 pubmed publisher
  269. Winder A, Maniar K, Wei J, Liu D, Scholtens D, Lurain J, et al. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study. Cancer. 2017;123:1144-1155 pubmed publisher
  270. Yu G, Dou Z, Jia Z. 5?bromo?3?(3?hydroxyprop?1?ynyl)?2H?pyran?2?one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways. Mol Med Rep. 2017;15:153-159 pubmed publisher
  271. Jang M, Kim S, Hwang D, Kim W, Lim S, Kim W, et al. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status. J Korean Med Sci. 2017;32:38-46 pubmed publisher
  272. Andresen V, Erikstein B, Mukherjee H, Sulen A, Popa M, S rnes S, et al. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis. 2016;7:e2497 pubmed publisher
  273. Walline H, Carey T, Goudsmit C, Bellile E, D Souza G, Peterson L, et al. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res. 2017;15:179-188 pubmed publisher
  274. McKenzie C, D Avino P. Investigating cytokinesis failure as a strategy in cancer therapy. Oncotarget. 2016;7:87323-87341 pubmed publisher
  275. Liu W, Huang K, Lu M, Huang H, Chen C, Cheng Y, et al. TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability. Oncogene. 2017;36:2715-2723 pubmed publisher
  276. Le Rhun E, Duhamel M, Wisztorski M, Gimeno J, Zairi F, Escande F, et al. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification. Biochim Biophys Acta Proteins Proteom. 2017;1865:875-890 pubmed publisher
  277. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  278. Schiffmacher A, Xie V, Taneyhill L. Cadherin-6B proteolysis promotes the neural crest cell epithelial-to-mesenchymal transition through transcriptional regulation. J Cell Biol. 2016;215:735-747 pubmed
  279. Singh A, Agrahari A, Singh R, Yadav S, Srivastava V, Parmar D. Imprinting of cerebral cytochrome P450s in offsprings prenatally exposed to cypermethrin augments toxicity on rechallenge. Sci Rep. 2016;6:37426 pubmed publisher
  280. Schafer C, Göder A, Beyer M, Kiweler N, Mahendrarajah N, Rauch A, et al. Class I histone deacetylases regulate p53/NF-?B crosstalk in cancer cells. Cell Signal. 2017;29:218-225 pubmed publisher
  281. Gotoh T, Kim J, Liu J, Vila Caballer M, Stauffer P, Tyson J, et al. Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2. Proc Natl Acad Sci U S A. 2016;113:13516-13521 pubmed
  282. Tian X, Dai S, Sun J, Jiang S, Sui C, Meng F, et al. Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53. Cell Physiol Biochem. 2016;39:2088-2098 pubmed
  283. Alfano L, Costa C, Caporaso A, Antonini D, Giordano A, Pentimalli F. HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation. Oncotarget. 2016;7:78127-78139 pubmed publisher
  284. Massalou D, Benizri E, Chevallier A, Duranton Tanneur V, Pedeutour F, Benchimol D, et al. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes. Am J Surg. 2017;213:377-387 pubmed publisher
  285. Gil V, Bhagat G, Howell L, Zhang J, Kim C, Stengel S, et al. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice. Dis Model Mech. 2016;9:1483-1495 pubmed
  286. Benkafadar N, Menardo J, Bourien J, Nouvian R, François F, Decaudin D, et al. Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy. EMBO Mol Med. 2017;9:7-26 pubmed publisher
  287. Cholewa B, Ndiaye M, Huang W, Liu X, Ahmad N. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo. Cancer Lett. 2017;385:179-187 pubmed publisher
  288. Parrales A, Ranjan A, Iyer S, Padhye S, Weir S, Roy A, et al. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway. Nat Cell Biol. 2016;18:1233-1243 pubmed publisher
  289. Chiche A, Moumen M, Romagnoli M, Petit V, Lasla H, Jézéquel P, et al. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene. 2017;36:2355-2365 pubmed publisher
  290. Tu S, Lin Y, Huang C, Yang P, Chang H, Chang C, et al. Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals. Oncotarget. 2016;7:77516-77531 pubmed publisher
  291. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed publisher
  292. Dong P, Xiong Y, Watari H, Hanley S, Konno Y, Ihira K, et al. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124. Sci Rep. 2016;6:35480 pubmed publisher
  293. Bulldan A, Shihan M, Goericke Pesch S, Scheiner Bobis G. Signaling events associated with gonadotropin releasing hormone-agonist-induced hormonal castration and its reversal in canines. Mol Reprod Dev. 2016;83:1092-1101 pubmed publisher
  294. Bryukhovetskiy I, Dyuizen I, Shevchenko V, Bryukhovetskiy A, Mischenko P, Milkina E, et al. Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme. Mol Med Rep. 2016;14:4511-4520 pubmed publisher
  295. Qi D, Cobrinik D. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene. 2017;36:1760-1769 pubmed publisher
  296. Lu F, Wu X, Yin F, Chia Fang Lee C, Yu M, Mihaylov I, et al. Regulation of DNA replication and chromosomal polyploidy by the MLL-WDR5-RBBP5 methyltransferases. Biol Open. 2016;5:1449-1460 pubmed publisher
  297. Hrgovic I, Doll M, Kleemann J, Wang X, Zoeller N, Pinter A, et al. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. BMC Cancer. 2016;16:763 pubmed
  298. Yang J, Platt L, Maity B, Ahlers K, Luo Z, Lin Z, et al. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Oncotarget. 2016;7:69159-69172 pubmed publisher
  299. Nonomiya Y, Noguchi K, Tanaka N, Kasagaki T, Katayama K, Sugimoto Y. Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells. Cancer Sci. 2016;107:1877-1887 pubmed publisher
  300. Barillari G, Palladino C, Bacigalupo I, Leone P, Falchi M, Ensoli B. Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels. Oncol Lett. 2016;12:2389-2394 pubmed
  301. Zhang Y, Zhang Y, Zhong C, Xiao F. Cr(VI) induces premature senescence through ROS-mediated p53 pathway in L-02 hepatocytes. Sci Rep. 2016;6:34578 pubmed publisher
  302. Zhuang J, Kamp W, Li J, Liu C, Kang J, Wang P, et al. Forkhead Box O3A (FOXO3) and the Mitochondrial Disulfide Relay Carrier (CHCHD4) Regulate p53 Protein Nuclear Activity in Response to Exercise. J Biol Chem. 2016;291:24819-24827 pubmed
  303. Narayanaswamy P, Tkachuk S, Haller H, Dumler I, Kiyan Y. CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling. Cell Death Dis. 2016;7:e2383 pubmed publisher
  304. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed publisher
  305. King B, Boccalatte F, Moran Crusio K, Wolf E, Wang J, Kayembe C, et al. The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells. Nat Immunol. 2016;17:1312-1321 pubmed publisher
  306. Schmitt A, Garcia J, Hung T, Flynn R, Shen Y, Qu K, et al. An inducible long noncoding RNA amplifies DNA damage signaling. Nat Genet. 2016;48:1370-1376 pubmed publisher
  307. Tuncel D, Roa J, Araya J, Bellolio E, Villaseca M, Tapia O, et al. Poorly cohesive cell (diffuse-infiltrative/signet ring cell) carcinomas of the gallbladder: clinicopathological analysis of 24 cases identified in 628 gallbladder carcinomas. Hum Pathol. 2017;60:24-31 pubmed publisher
  308. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  309. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  310. Hacisalihoglu P, Kucukodaci Z, Gundogdu G, Bilgic B. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Turk Neurosurg. 2017;27:682-689 pubmed publisher
  311. Schwermer M, Dreesmann S, Eggert A, Althoff K, Steenpass L, Schramm A, et al. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines. Clin Exp Ophthalmol. 2017;45:288-296 pubmed publisher
  312. Johnson R, Finger E, Olcina M, Vilalta M, Aguilera T, Miao Y, et al. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016;18:1078-1089 pubmed publisher
  313. Wu H, Li S, Hu J, Yu X, Xu H, Chen Z, et al. Demystifying the mechanistic and functional aspects of p21 gene activation with double-stranded RNAs in human cancer cells. J Exp Clin Cancer Res. 2016;35:145 pubmed publisher
  314. Nip H, Dar A, Saini S, Colden M, Varahram S, Chowdhary H, et al. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer. Oncotarget. 2016;7:68371-68384 pubmed publisher
  315. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  316. Minemura H, Takagi K, Sato A, Takahashi H, Miki Y, Shibahara Y, et al. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance. Cancer Sci. 2016;107:1898-1908 pubmed publisher
  317. Wang D, Kon N, Lasso G, Jiang L, Leng W, Zhu W, et al. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature. 2016;538:118-122 pubmed publisher
  318. Kozakai Y, Kamada R, Furuta J, Kiyota Y, Chuman Y, Sakaguchi K. PPM1D controls nucleolar formation by up-regulating phosphorylation of nucleophosmin. Sci Rep. 2016;6:33272 pubmed publisher
  319. Tavana O, Li D, Dai C, Lopez G, Banerjee D, Kon N, et al. HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med. 2016;22:1180-1186 pubmed publisher
  320. Liu T, Xiong J, Yi S, Zhang H, Zhou S, Gu L, et al. FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2. Oncogene. 2017;36:1678-1686 pubmed publisher
  321. Weber A, Drobnitzky N, Devery A, Bokobza S, Adams R, Maughan T, et al. Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer. Oncotarget. 2016;7:60807-60822 pubmed publisher
  322. Bryukhovetskiy I, Manzhulo I, Mischenko P, Milkina E, Dyuizen I, Bryukhovetskiy A, et al. Cancer stem cells and microglia in the processes of glioblastoma multiforme invasive growth. Oncol Lett. 2016;12:1721-1728 pubmed
  323. Lee J, Jung H, Han Y, Yoon Y, Yun C, Sun H, et al. Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells. Mol Med Rep. 2016;14:3777-84 pubmed publisher
  324. Twardziok M, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, et al. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS ONE. 2016;11:e0159749 pubmed publisher
  325. Muzumdar M, Dorans K, Chung K, Robbins R, Tammela T, Gocheva V, et al. Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. Nat Commun. 2016;7:12685 pubmed publisher
  326. Jones R, Robinson T, Liu J, Shrestha M, Voisin V, Ju Y, et al. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. J Clin Invest. 2016;126:3739-3757 pubmed publisher
  327. Hong X, Liu W, Song R, Shah J, Feng X, Tsang C, et al. SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. Nucleic Acids Res. 2016;44:8855-8869 pubmed
  328. Fern ndez Majada V, Welz P, Ermolaeva M, Schell M, Adam A, Dietlein F, et al. The tumour suppressor CYLD regulates the p53 DNA damage response. Nat Commun. 2016;7:12508 pubmed publisher
  329. Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
  330. Vermeij W, Dollé M, Reiling E, Jaarsma D, Payan Gomez C, Bombardieri C, et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature. 2016;537:427-431 pubmed publisher
  331. Skrdlant L, Stark J, Lin R. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C. BMC Mol Biol. 2016;17:18 pubmed publisher
  332. Shikuma N, Antoshechkin I, Medeiros J, Pilhofer M, Newman D. Stepwise metamorphosis of the tubeworm Hydroides elegans is mediated by a bacterial inducer and MAPK signaling. Proc Natl Acad Sci U S A. 2016;113:10097-102 pubmed publisher
  333. Bauer M, Joerger A, Fersht A. 2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells. Proc Natl Acad Sci U S A. 2016;113:E5271-80 pubmed publisher
  334. Park J, Yang S, Park J, Ka S, Kim J, Kong Y, et al. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat Commun. 2016;7:12513 pubmed publisher
  335. Nagano T, Nakano M, Nakashima A, Onishi K, Yamao S, Enari M, et al. Identification of cellular senescence-specific genes by comparative transcriptomics. Sci Rep. 2016;6:31758 pubmed publisher
  336. Holdt L, Stahringer A, Sass K, Pichler G, Kulak N, Wilfert W, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016;7:12429 pubmed publisher
  337. Guerra E, Cimadamore A, Simeone P, Vacca G, Lattanzio R, Botti G, et al. p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading. BMC Cancer. 2016;16:649 pubmed publisher
  338. Ratovitski E. Tumor Protein (TP)-p53 Members as Regulators of Autophagy in Tumor Cells upon Marine Drug Exposure. Mar Drugs. 2016;14: pubmed publisher
  339. Walton J, Blagih J, Ennis D, Leung E, Dowson S, Farquharson M, et al. CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma. Cancer Res. 2016;76:6118-6129 pubmed
  340. Surtees R, Dowall S, Shaw A, Armstrong S, Hewson R, Carroll M, et al. Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle. J Virol. 2016;90:9305-16 pubmed publisher
  341. Kazantseva J, Sadam H, Neuman T, Palm K. Targeted alternative splicing of TAF4: a new strategy for cell reprogramming. Sci Rep. 2016;6:30852 pubmed publisher
  342. Guimarães T, Farias L, Santos E, De Carvalho Fraga C, Orsini L, de Freitas Teles L, et al. Metformin increases PDH and suppresses HIF-1? under hypoxic conditions and induces cell death in oral squamous cell carcinoma. Oncotarget. 2016;7:55057-55068 pubmed publisher
  343. Song S, Kim K, Jo E, Kim Y, Kwon J, Bae S, et al. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate. Arterioscler Thromb Vasc Biol. 2016;36:1928-36 pubmed publisher
  344. Ah Koon L, Lesage D, Lemadre E, Souissi I, Fagard R, Varin Blank N, et al. Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells. J Cell Mol Med. 2016;20:1956-65 pubmed publisher
  345. Luo H, Cowen L, Yu G, Jiang W, Tang Y. SMG7 is a critical regulator of p53 stability and function in DNA damage stress response. Cell Discov. 2016;2:15042 pubmed publisher
  346. Kurita D, Takeuchi K, Kobayashi S, Hojo A, Uchino Y, Sakagami M, et al. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior. Virchows Arch. 2016;469:471-6 pubmed publisher
  347. Lesina M, Wörmann S, Morton J, Diakopoulos K, Korneeva O, Wimmer M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126:2919-32 pubmed publisher
  348. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  349. Liu M, Shan J, Li J, Zhang Y, Lin X. Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes. Exp Ther Med. 2016;12:1113-1118 pubmed
  350. Lao T, Jiang Z, Yun J, Qiu W, Guo F, Huang C, et al. Hhip haploinsufficiency sensitizes mice to age-related emphysema. Proc Natl Acad Sci U S A. 2016;113:E4681-7 pubmed publisher
  351. Al Maghrebi M, Renno W. Altered expression profile of glycolytic enzymes during testicular ischemia reperfusion injury is associated with the p53/TIGAR pathway: effect of fructose 1,6-diphosphate. Peerj. 2016;4:e2195 pubmed publisher
  352. Liu X, Ehmed E, Li B, Dou J, Qiao X, Jiang W, et al. Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1. Am J Cancer Res. 2016;6:1441-9 pubmed
  353. Ma T, Fan B, Zhang C, Zhao H, Han C, Gao C, et al. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway. Sci Rep. 2016;6:29926 pubmed publisher
  354. Hampp S, Kiessling T, Buechle K, Mansilla S, Thomale J, Rall M, et al. DNA damage tolerance pathway involving DNA polymerase ? and the tumor suppressor p53 regulates DNA replication fork progression. Proc Natl Acad Sci U S A. 2016;113:E4311-9 pubmed publisher
  355. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  356. Camerino G, De Bellis M, Conte E, Liantonio A, Musaraj K, Cannone M, et al. Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin. Toxicol Appl Pharmacol. 2016;306:36-46 pubmed publisher
  357. Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, et al. p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med. 2016;22:861-8 pubmed publisher
  358. Edmondson R, Adcock A, Yang L. Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins. PLoS ONE. 2016;11:e0158116 pubmed publisher
  359. Wei T, Biskup E, Gjerdrum L, Niazi O, Ødum N, Gniadecki R. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma. Oncotarget. 2016;7:48391-48400 pubmed publisher
  360. Walerych D, Lisek K, Sommaggio R, Piazza S, Ciani Y, Dalla E, et al. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nat Cell Biol. 2016;18:897-909 pubmed publisher
  361. Chen G, Liang Y, Guan X, Chen H, Liu Q, Lin B, et al. Circulating low IL-23: IL-35 cytokine ratio promotes progression associated with poor prognosisin breast cancer. Am J Transl Res. 2016;8:2255-64 pubmed
  362. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  363. Itahana Y, Zhang J, Göke J, Vardy L, Han R, Iwamoto K, et al. Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells. Sci Rep. 2016;6:28112 pubmed publisher
  364. Hong A, Tseng Y, Cowley G, Jonas O, Cheah J, Kynnap B, et al. Integrated genetic and pharmacologic interrogation of rare cancers. Nat Commun. 2016;7:11987 pubmed publisher
  365. Cesnekova J, Spáčilová J, Hansikova H, Houstek J, Zeman J, Stiburek L. LACE1 interacts with p53 and mediates its mitochondrial translocation and apoptosis. Oncotarget. 2016;7:47687-47698 pubmed publisher
  366. Lee W, Jo S, Lee M, Won C, Lee M, Choi J, et al. The Effect of MCP-1/CCR2 on the Proliferation and Senescence of Epidermal Constituent Cells in Solar Lentigo. Int J Mol Sci. 2016;17: pubmed publisher
  367. Pomo J, Taylor R, Gullapalli R. Influence of TP53 and CDH1 genes in hepatocellular cancer spheroid formation and culture: a model system to understand cancer cell growth mechanics. Cancer Cell Int. 2016;16:44 pubmed publisher
  368. Oktay Y, Ãœlgen E, Can Ã, Akyerli C, Yüksel Å, Erdemgil Y, et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016;6:27569 pubmed publisher
  369. Zhou X, Hao Q, Liao P, Luo S, Zhang M, Hu G, et al. Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator. elife. 2016;5: pubmed publisher
  370. Lin S, Gou G, Hsia C, Ho C, Huang K, Wu Y, et al. Simulated Microgravity Disrupts Cytoskeleton Organization and Increases Apoptosis of Rat Neural Crest Stem Cells Via Upregulating CXCR4 Expression and RhoA-ROCK1-p38 MAPK-p53 Signaling. Stem Cells Dev. 2016;25:1172-93 pubmed publisher
  371. Li X, Cheng K, Liu Z, Yang J, Wang B, Jiang X, et al. The MDM2-p53-pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells. Nat Commun. 2016;7:11740 pubmed publisher
  372. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed publisher
  373. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  374. Nooij L, Dreef E, Smit V, van Poelgeest M, Bosse T. Stathmin is a highly sensitive and specific biomarker for vulvar high-grade squamous intraepithelial lesions. J Clin Pathol. 2016;69:1070-1075 pubmed publisher
  375. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  376. Iltzsche F, Simon K, Stopp S, Pattschull G, Francke S, Wolter P, et al. An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma. Oncogene. 2017;36:110-121 pubmed publisher
  377. El Husseini N, Schlisser A, Hales B. Editor's Highlight: Hydroxyurea Exposure Activates the P53 Signaling Pathway in Murine Organogenesis-Stage Embryos. Toxicol Sci. 2016;152:297-308 pubmed publisher
  378. Chung M, Lee J, Kim S, Suh Y, Choi H. Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer. Medicine (Baltimore). 2016;95:e3689 pubmed publisher
  379. Wang J, Hu K, Guo J, Cheng F, Lv J, Jiang W, et al. Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK. Nat Commun. 2016;7:11363 pubmed publisher
  380. Chen R, Liu H, Cheng Q, Jiang B, Peng R, Zou Q, et al. MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide. Biol Open. 2016;5:669-77 pubmed publisher
  381. Liu B, Shi Y, Peng W, Zhang Q, Liu J, Chen N, et al. Diosmetin induces apoptosis by upregulating p53 via the TGF-? signal pathway in HepG2 hepatoma cells. Mol Med Rep. 2016;14:159-64 pubmed publisher
  382. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed publisher
  383. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  384. Scott T, Wicker C, Suganya R, Dhar B, Pittman T, Horbinski C, et al. Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin. Mol Carcinog. 2017;56:325-336 pubmed publisher
  385. Alaee M, Danesh G, Pasdar M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS ONE. 2016;11:e0154323 pubmed publisher
  386. Pereira D, Simões A, Gomes S, Castro R, Carvalho T, Rodrigues C, et al. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism. Oncotarget. 2016;7:34322-40 pubmed publisher
  387. Avila A, Illing A, Becker F, Maerz L, Morita Y, Philipp M, et al. Xpg limits the expansion of haematopoietic stem and progenitor cells after ionising radiation. Nucleic Acids Res. 2016;44:6252-61 pubmed publisher
  388. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  389. Chen Y, Pan K, Wang P, Cao Z, Wang W, Wang S, et al. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis. J Biol Chem. 2016;291:12688-705 pubmed publisher
  390. Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016;12:999-1014 pubmed publisher
  391. Beard J, Tenga A, Hills J, Hoyer J, Cherian M, Wang Y, et al. The orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network. Sci Rep. 2016;6:25108 pubmed publisher
  392. Chaudhary S, Madhukrishna B, Adhya A, Keshari S, Mishra S. Overexpression of caspase 7 is ER? dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis. 2016;5:e219 pubmed publisher
  393. Pires A, Marques C, Encarnação J, Abrantes A, Mamede A, Laranjo M, et al. Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile. Eur J Cell Biol. 2016;95:208-18 pubmed publisher
  394. Chiang T, le Sage C, Larrieu D, Demir M, Jackson S. CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing. Sci Rep. 2016;6:24356 pubmed publisher
  395. He D, Xiang J, Li B, Liu H. The dynamic behavior of Ect2 in response to DNA damage. Sci Rep. 2016;6:24504 pubmed publisher
  396. Walia M, Ho P, Taylor S, Ng A, Gupte A, Chalk A, et al. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. elife. 2016;5: pubmed publisher
  397. Xia Z, Huang X, Chen K, Wang H, Xiao J, He K, et al. Proapoptotic Role of Potassium Ions in Liver Cells. Biomed Res Int. 2016;2016:1729135 pubmed publisher
  398. Macritchie N, Volpert G, Al Washih M, Watson D, Futerman A, Kennedy S, et al. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension. Cell Signal. 2016;28:946-55 pubmed publisher
  399. Ardighieri L, Mori L, Conzadori S, Bugatti M, Falchetti M, Donzelli C, et al. Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship. Virchows Arch. 2016;469:61-9 pubmed publisher
  400. Hall A, Lu W, Godfrey J, Antonov A, Paicu C, Moxon S, et al. The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration. Cell Death Dis. 2016;7:e2184 pubmed publisher
  401. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed publisher
  402. Agaimy A, Ben Izhak O, Lorey T, Scharpf M, Rubin B. Angiosarcoma arising in association with vascular Dacron grafts and orthopedic joint prostheses: clinicopathologic, immunohistochemical, and molecular study. Ann Diagn Pathol. 2016;21:21-8 pubmed publisher
  403. Negis Y, Karabay A. Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity. Biofactors. 2016;42:358-67 pubmed publisher
  404. Huang J, Chen M, Du J, Liu H, He Y, Li G, et al. Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy. Neurochem Res. 2016;41:1774-83 pubmed publisher
  405. Jaber S, Toufektchan E, Lejour V, Bardot B, Toledo F. p53 downregulates the Fanconi anaemia DNA repair pathway. Nat Commun. 2016;7:11091 pubmed publisher
  406. Garcia C, Videla Richardson G, Dimopoulos N, Fernandez Espinosa D, Miriuka S, Sevlever G, et al. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199. PLoS ONE. 2016;11:e0152607 pubmed publisher
  407. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed publisher
  408. Perez R, Shen H, Duan L, Kim R, Kim T, Park N, et al. Modeling the Etiology of p53-mutated Cancer Cells. J Biol Chem. 2016;291:10131-47 pubmed publisher
  409. Vermeer D, Coppock J, Zeng E, Lee K, Spanos W, Onken M, et al. Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget. 2016;7:24194-207 pubmed publisher
  410. Dai Y, Wang L, Tang J, Cao P, Luo Z, Sun J, et al. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress. Oncotarget. 2016;7:25478-92 pubmed publisher
  411. Sugihara T, Nakagawa S, Sasajima Y, Ichinose T, Hiraike H, Kondo F, et al. Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer. Br J Cancer. 2016;114:1012-8 pubmed publisher
  412. Li Y, Wang X, He B, Cai H, Gao Y. Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinoma. Mol Cell Biochem. 2016;415:197-205 pubmed publisher
  413. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed publisher
  414. D Brot A, Kurtz P, Regan E, Jakubowski B, Abrams J. A platform for interrogating cancer-associated p53 alleles. Oncogene. 2017;36:286-291 pubmed publisher
  415. Kumar P, Sharad S, Petrovics G, Mohamed A, Dobi A, Sreenath T, et al. Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1. Oncotarget. 2016;7:22791-806 pubmed publisher
  416. Weeks R, Ludgate J, LeMée G, Morison I. TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells. PLoS ONE. 2016;11:e0151341 pubmed publisher
  417. Jin H, Lee K, Kim Y, Oh H, Maeng Y, Kim T, et al. Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells. Oncogene. 2016;35:5106-18 pubmed publisher
  418. Mori F, Ferraiuolo M, Santoro R, Sacconi A, Goeman F, Pallocca M, et al. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects. Oncotarget. 2016;7:20532-48 pubmed publisher
  419. Chen S, FORRESTER W, Lahav G. Schedule-dependent interaction between anticancer treatments. Science. 2016;351:1204-8 pubmed publisher
  420. Frum R, Love I, Damle P, Mukhopadhyay N, Palit Deb S, Deb S, et al. Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination. Mol Cancer Res. 2016;14:423-36 pubmed publisher
  421. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  422. Pandiri I, Chen Y, Joe Y, Kim H, Park J, Chung H, et al. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells. Breast Cancer Res Treat. 2016;156:57-64 pubmed publisher
  423. Yeo S, Itahana Y, Guo A, Han R, Iwamoto K, Nguyen H, et al. Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation. elife. 2016;5:e07101 pubmed publisher
  424. Brito A, Ribeiro M, Abrantes A, Mamede A, Laranjo M, Casalta Lopes J, et al. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin. Nutr Cancer. 2016;68:250-66 pubmed publisher
  425. Li T, Liu X, Jiang L, MANFREDI J, Zha S, Gu W. Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging. Oncotarget. 2016;7:11838-49 pubmed publisher
  426. Helbig D, Ihle M, Pütz K, Tantcheva Poor I, Mauch C, Büttner R, et al. Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget. 2016;7:21763-74 pubmed publisher
  427. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  428. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  429. Du Z, Li L, Huang X, Jin J, Huang S, Zhang Q, et al. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation. Oncotarget. 2016;7:21618-30 pubmed publisher
  430. Kemp M, Sancar A. ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. J Biol Chem. 2016;291:9330-42 pubmed publisher
  431. Ercilla A, Llopis A, Feu S, Aranda S, Ernfors P, Freire R, et al. New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress. Nucleic Acids Res. 2016;44:4745-62 pubmed publisher
  432. McNaughton M, Pitman M, Pitson S, Pyne N, Pyne S. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells. Oncotarget. 2016;7:16663-75 pubmed publisher
  433. Liu X, Wang S, Guo X, Wei F, Yin J, Zang Y, et al. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53. Oncotarget. 2016;7:18896-905 pubmed publisher
  434. Shin M, He Y, Marrogi E, Piperdi S, Ren L, Khanna C, et al. A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells. PLoS Genet. 2016;12:e1005884 pubmed publisher
  435. Swetzig W, Wang J, Das G. Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer. Oncotarget. 2016;7:16049-69 pubmed publisher
  436. Talarico C, Dattilo V, D Antona L, Barone A, Amodio N, Belviso S, et al. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. Oncotarget. 2016;7:15868-84 pubmed publisher
  437. Nim S, Jeon J, Corbi Verge C, Seo M, Ivarsson Y, Moffat J, et al. Pooled screening for antiproliferative inhibitors of protein-protein interactions. Nat Chem Biol. 2016;12:275-81 pubmed publisher
  438. Liu R, Li S, Garcia E, Glubrecht D, Poon H, Easaw J, et al. Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma. Glia. 2016;64:963-76 pubmed publisher
  439. Chernova T, Sun X, Powley I, Galavotti S, Grosso S, Murphy F, et al. Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease. Cell Death Differ. 2016;23:1152-64 pubmed publisher
  440. Han X, Tai H, Wang X, Wang Z, Zhou J, Wei X, et al. AMPK activation protects cells from oxidative stress-induced senescence via autophagic flux restoration and intracellular NAD(+) elevation. Aging Cell. 2016;15:416-27 pubmed publisher
  441. Katoh I, Fukunishi N, Fujimuro M, Kasai H, Moriishi K, Hata R, et al. Repression of Wnt/β-catenin response elements by p63 (TP63). Cell Cycle. 2016;15:699-710 pubmed publisher
  442. Ambade A, Satishchandran A, Szabo G. Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation. Sci Rep. 2016;6:21340 pubmed publisher
  443. Pecháčková S, Burdova K, Benada J, Kleiblova P, Jenikova G, Macurek L. Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3. Oncotarget. 2016;7:14458-75 pubmed publisher
  444. Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17:349-66 pubmed publisher
  445. Xie X, Lozano G, Siddik Z. Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53. Oncogene. 2016;35:4798-806 pubmed publisher
  446. Adighibe O, Leek R, Fernandez Mercado M, Hu J, Snell C, Gatter K, et al. Why some tumours trigger neovascularisation and others don't: the story thus far. Chin J Cancer. 2016;35:18 pubmed publisher
  447. Largeot A, Perez Campo F, Marinopoulou E, Lie A Ling M, Kouskoff V, Lacaud G. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence. Exp Hematol. 2016;44:231-7.e4 pubmed publisher
  448. Le Pen J, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, et al. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL. Cell Death Dis. 2016;7:e2083 pubmed publisher
  449. Delmas E, Jah N, Pirou C, Bouleau S, Le Floch N, Vayssière J, et al. FGF1 C-terminal domain and phosphorylation regulate intracrine FGF1 signaling for its neurotrophic and anti-apoptotic activities. Cell Death Dis. 2016;7:e2079 pubmed publisher
  450. Mignacca L, Saint Germain E, Benoit A, Bourdeau V, Moro A, Ferbeyre G. Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers. Cytokine. 2016;82:80-6 pubmed publisher
  451. Bober J, Olsnes S, Kostas M, Bogacz M, Zakrzewska M, Otlewski J. Identification of new FGF1 binding partners-Implications for its intracellular function. IUBMB Life. 2016;68:242-51 pubmed publisher
  452. Capell B, Drake A, Zhu J, Shah P, Dou Z, Dorsey J, et al. MLL1 is essential for the senescence-associated secretory phenotype. Genes Dev. 2016;30:321-36 pubmed publisher
  453. Duplan E, Giordano C, Checler F, Alves da Costa C. Direct α-synuclein promoter transactivation by the tumor suppressor p53. Mol Neurodegener. 2016;11:13 pubmed publisher
  454. Llanos S, García Pedrero J, Morgado Palacin L, Rodrigo J, Serrano M. Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers. Nat Commun. 2016;7:10438 pubmed publisher
  455. Esfandiari A, Hawthorne T, Nakjang S, Lunec J. Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner. Mol Cancer Ther. 2016;15:379-91 pubmed publisher
  456. Okamoto S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y, et al. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. Brain Tumor Pathol. 2016;33:129-36 pubmed publisher
  457. Nassour J, Martien S, Martin N, Deruy E, Tomellini E, Malaquin N, et al. Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat Commun. 2016;7:10399 pubmed publisher
  458. Vaughan C, Pearsall I, Singh S, Windle B, Deb S, Grossman S, et al. Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter. Oncotarget. 2016;7:12426-46 pubmed publisher
  459. Walter D, Hoffmann S, Komseli E, Rappsilber J, Gorgoulis V, Sørensen C. SCF(Cyclin F)-dependent degradation of CDC6 suppresses DNA re-replication. Nat Commun. 2016;7:10530 pubmed publisher
  460. Heyward F, Gilliam D, Coleman M, Gavin C, Wang J, Kaas G, et al. Obesity Weighs down Memory through a Mechanism Involving the Neuroepigenetic Dysregulation of Sirt1. J Neurosci. 2016;36:1324-35 pubmed publisher
  461. Heo J, Kim W, Choi K, Bae S, Jeong J, Kim K. XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence. Oncotarget. 2016;7:5118-30 pubmed publisher
  462. Martinez Zapien D, Ruiz F, Poirson J, Mitschler A, Ramirez J, Forster A, et al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 2016;529:541-5 pubmed publisher
  463. Chavoshi S, Egorova O, Lacdao I, Farhadi S, Sheng Y, Saridakis V. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7. J Biol Chem. 2016;291:6281-91 pubmed publisher
  464. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  465. Liu D, Liu X, Wu Y, Wang W, Ma X, Liu H. Cloning and Transcriptional Activity of the Mouse Omi/HtrA2 Gene Promoter. Int J Mol Sci. 2016;17: pubmed publisher
  466. Zheng F, Yue C, Li G, He B, Cheng W, Wang X, et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun. 2016;7:10180 pubmed publisher
  467. Ying M, Zhang L, Zhou Q, Shao X, Cao J, Zhang N, et al. The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα. Oncogene. 2016;35:4358-67 pubmed publisher
  468. Bai G, Smolka M, Schimenti J. Chronic DNA Replication Stress Reduces Replicative Lifespan of Cells by TRP53-Dependent, microRNA-Assisted MCM2-7 Downregulation. PLoS Genet. 2016;12:e1005787 pubmed publisher
  469. Nalwoga H, Ahmed L, Arnes J, Wabinga H, Akslen L. Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer. PLoS ONE. 2016;11:e0146823 pubmed publisher
  470. Cubillos Rojas M, Schneider T, Sánchez Tena S, Bartrons R, Ventura F, Rosa J. Tris-acetate polyacrylamide gradient gel electrophoresis for the analysis of protein oligomerization. Anal Bioanal Chem. 2016;408:1715-9 pubmed publisher
  471. Koppaka V, Chen Y, Mehta G, Orlicky D, Thompson D, Jester J, et al. ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis. PLoS ONE. 2016;11:e0146433 pubmed publisher
  472. Olsen J, Cao X, Han B, Chen L, Horvath A, Richardson T, et al. Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics. Mol Cell Proteomics. 2016;15:892-905 pubmed publisher
  473. Soragni A, Janzen D, Johnson L, Lindgren A, Thai Quynh Nguyen A, Tiourin E, et al. A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell. 2016;29:90-103 pubmed publisher
  474. Gupta Y, Pasupuleti V, Du W, Welford S. Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells. PLoS ONE. 2016;11:e0146482 pubmed publisher
  475. Wu B, Yu L, Wang Y, Wang H, Li C, Yin Y, et al. Aldehyde dehydrogenase 2 activation in aged heart improves the autophagy by reducing the carbonyl modification on SIRT1. Oncotarget. 2016;7:2175-88 pubmed publisher
  476. Han M, Lee D, Woo S, Seo B, Min K, Kim S, et al. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells. Sci Rep. 2016;6:18642 pubmed publisher
  477. Berges C, Chatterjee M, Topp M, Einsele H. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunol Res. 2016;64:687-98 pubmed publisher
  478. Kucab J, Zwart E, van Steeg H, Luijten M, Schmeiser H, Phillips D, et al. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts. DNA Repair (Amst). 2016;39:21-33 pubmed publisher
  479. Du C, Wu H, Leng R. UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation. Oncotarget. 2016;7:2823-36 pubmed publisher
  480. Pages M, Lacroix L, Tauziède Espariat A, Castel D, Daudigeos Dubus E, Ridola V, et al. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion. Acta Neuropathol Commun. 2015;3:85 pubmed publisher
  481. Gopal K, Gowtham M, Sachin S, Ravishankar Ram M, Shankar E, Kamarul T. Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice. Sci Rep. 2015;5:18300 pubmed publisher
  482. Böger C, Haag J, Egberts J, Röcken C. Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder. Pathol Res Pract. 2016;212:54-8 pubmed publisher
  483. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  484. Kondo H, Kim H, Wang L, Okada M, Paul C, Millard R, et al. Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells. Aging Cell. 2016;15:56-66 pubmed publisher
  485. Min J, Guo K, Suryadevara P, Zhu F, Holbrook G, Chen Y, et al. Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents. J Med Chem. 2016;59:559-77 pubmed publisher
  486. Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al. Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed
  487. Huang Y, Chen N, Miao D. Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1 knockout mice. Exp Ther Med. 2015;10:451-458 pubmed
  488. Gravina G, Mancini A, Sanità P, Vitale F, Marampon F, Ventura L, et al. KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models. BMC Cancer. 2015;15:941 pubmed publisher
  489. Yan Y, Ollila S, Wong I, Vallenius T, Palvimo J, Vaahtomeri K, et al. SUMOylation of AMPKα1 by PIAS4 specifically regulates mTORC1 signalling. Nat Commun. 2015;6:8979 pubmed publisher
  490. Yang B, Zhang M, Gao J, Li J, Fan L, Xiang G, et al. Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer. Oncotarget. 2015;6:37613-25 pubmed publisher
  491. Dewaele M, Tabaglio T, Willekens K, Bezzi M, Teo S, Low D, et al. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. J Clin Invest. 2016;126:68-84 pubmed publisher
  492. Messner B, Türkcan A, Ploner C, Laufer G, Bernhard D. Cadmium overkill: autophagy, apoptosis and necrosis signalling in endothelial cells exposed to cadmium. Cell Mol Life Sci. 2016;73:1699-713 pubmed publisher
  493. Lai J, Lee C, Crocker M, Najmuddin M, Lange E, Merino M, et al. Isolated Large Cell Calcifying Sertoli Cell Tumor in a Young Boy, not Associated with Peutz-Jeghers Syndrome or Carney Complex. Ann Clin Lab Res. 2015;3:2 pubmed
  494. Ivanschitz L, Takahashi Y, Jollivet F, Ayrault O, Le Bras M, de Thé H. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence. Proc Natl Acad Sci U S A. 2015;112:14278-83 pubmed publisher
  495. Cristini A, Park J, Capranico G, Legube G, Favre G, Sordet O. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions. Nucleic Acids Res. 2016;44:1161-78 pubmed publisher
  496. van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196 pubmed publisher
  497. Wang Z, Ma B, Li H, Xiao X, Zhou W, Liu F, et al. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC. Oncotarget. 2016;7:509-23 pubmed publisher
  498. Alsafadi S, Tourpin S, Bessoltane N, Salomé Desnoulez S, Vassal G, André F, et al. Nuclear localization of the caspase-3-cleaved form of p73 in anoikis. Oncotarget. 2016;7:12331-43 pubmed publisher
  499. Carpentieri A, Cozzoli E, Scimeca M, Bonanno E, Sardanelli A, Gambacurta A. Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor. Cell Death Dis. 2015;6:e1974 pubmed publisher
  500. Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget. 2015;6:43992-4004 pubmed publisher
  501. Lohberger B, Leithner A, Stuendl N, Kaltenegger H, Kullich W, Steinecker Frohnwieser B. Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation. BMC Cancer. 2015;15:891 pubmed publisher
  502. Kanu N, Zhang T, Burrell R, Chakraborty A, Cronshaw J, DaCosta C, et al. RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress. Oncogene. 2016;35:4009-19 pubmed publisher
  503. Waye S, Naeem A, Choudhry M, Parasido E, Tricoli L, Sivakumar A, et al. The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Aging (Albany NY). 2015;7:854-68 pubmed
  504. Ahn H, Kim K, Shin K, Lim K, Kim J, Lee J, et al. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells. Oncotarget. 2015;6:44523-37 pubmed publisher
  505. Xiao D, Ren P, Su H, Yue M, Xiu R, Hu Y, et al. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Oncotarget. 2015;6:40655-66 pubmed publisher
  506. Antoniali G, Marcuzzi F, Casarano E, Tell G. Cadmium treatment suppresses DNA polymerase δ catalytic subunit gene expression by acting on the p53 and Sp1 regulatory axis. DNA Repair (Amst). 2015;35:90-105 pubmed publisher
  507. Antonucci L, Fagman J, Kim J, Todoric J, Gukovsky I, Mackey M, et al. Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc Natl Acad Sci U S A. 2015;112:E6166-74 pubmed publisher
  508. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  509. Chene G, Ouellet V, Rahimi K, Barrès V, Meunier L, de Ladurantaye M, et al. Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma. Biomed Res Int. 2015;2015:808531 pubmed publisher
  510. Shen W, Chang A, Wang J, Zhou W, Gao R, Li J, et al. TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer. Oncogenesis. 2015;4:e173 pubmed publisher
  511. Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364-71 pubmed publisher
  512. Ramlee M, Yan T, Cheung A, Chuah C, Li S. High-throughput genotyping of CRISPR/Cas9-mediated mutants using fluorescent PCR-capillary gel electrophoresis. Sci Rep. 2015;5:15587 pubmed publisher
  513. Xu S, Huang J, Chen M, Zeng M, Zou F, Chen D, et al. Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation. Oncotarget. 2017;8:12705-12716 pubmed publisher
  514. Pasini L, Re A, Tebaldi T, Ricci G, Boi S, Adami V, et al. TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines. BMC Cancer. 2015;15:777 pubmed publisher
  515. Tonsing Carter E, Bailey B, Saadatzadeh M, Ding J, Wang H, Sinn A, et al. Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model. Mol Cancer Ther. 2015;14:2850-63 pubmed publisher
  516. Sellerio A, Ciusani E, Ben Moshe N, Coco S, Piccinini A, Myers C, et al. Overshoot during phenotypic switching of cancer cell populations. Sci Rep. 2015;5:15464 pubmed publisher
  517. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed publisher
  518. Habiger C, Jäger G, Walter M, Iftner T, Stubenrauch F. Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins. J Virol. 2016;90:694-704 pubmed publisher
  519. Vétillard A, Jonchère B, Moreau M, Toutain B, Henry C, Fontanel S, et al. Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis. Oncotarget. 2015;6:43342-62 pubmed publisher
  520. Acikgoz E, Guven U, Duzagac F, Uslu R, Kara M, Soner B, et al. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells. PLoS ONE. 2015;10:e0141090 pubmed publisher
  521. Guo W, Zhang Y, Ling Z, Liu X, Zhao X, Yuan Z, et al. Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner. Cell Death Dis. 2015;6:e1919 pubmed publisher
  522. Laezza C, D Alessandro A, Di Croce L, Picardi P, Ciaglia E, Pisanti S, et al. p53 regulates the mevalonate pathway in human glioblastoma multiforme. Cell Death Dis. 2015;6:e1909 pubmed publisher
  523. Xiong Y, Su H, Lv P, Ma Y, Wang S, Miao H, et al. A newly identified berberine derivative induces cancer cell senescence by stabilizing endogenous G-quadruplexes and sparking a DNA damage response at the telomere region. Oncotarget. 2015;6:35625-35 pubmed publisher
  524. Hausmann C, Temme A, Cordes N, Eke I. ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation. Oncotarget. 2015;6:34592-605 pubmed publisher
  525. Ye M, Tang Y, Tang S, Liu J, Wu K, Yao S, et al. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation. Oncotarget. 2015;6:34718-31 pubmed publisher
  526. Gruosso T, Garnier C, Abélanet S, Kieffer Y, Lemesre V, Bellanger D, et al. MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas. Nat Commun. 2015;6:8583 pubmed publisher
  527. Shang R, Zhang F, Xu B, Xi H, Zhang X, Wang W, et al. Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects. Nat Commun. 2015;6:8430 pubmed publisher
  528. Agaimy A, Specht K, Stoehr R, Lorey T, Märkl B, Niedobitek G, et al. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker. Am J Surg Pathol. 2016;40:181-91 pubmed publisher
  529. Panvichian R, Tantiwetrueangdet A, Sornmayura P, Leelaudomlipi S. Missense Mutations in Exons 18-24 of EGFR in Hepatocellular Carcinoma Tissues. Biomed Res Int. 2015;2015:171845 pubmed publisher
  530. Ortega Atienza S, Wong V, Deloughery Z, Luczak M, Zhitkovich A. ATM and KAT5 safeguard replicating chromatin against formaldehyde damage. Nucleic Acids Res. 2016;44:198-209 pubmed publisher
  531. Hu D, Gur M, Zhou Z, Gamper A, Hung M, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419 pubmed publisher
  532. Daou S, Hammond Martel I, Mashtalir N, Barbour H, Gagnon J, Iannantuono N, et al. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer. J Biol Chem. 2015;290:28643-63 pubmed publisher
  533. O Loghlen A, Brookes S, Martin N, Rapisarda V, Peters G, Gil J. CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a). Aging Cell. 2015;14:1113-21 pubmed publisher
  534. Li Z, Hao Q, Luo J, Xiong J, Zhang S, Wang T, et al. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. Oncogene. 2016;35:2902-12 pubmed publisher
  535. Kramer H, Lai C, Patel H, Periyasamy M, Lin M, Feller S, et al. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res. 2016;44:582-94 pubmed publisher
  536. Chen F, Rosiene J, Che A, Becker A, LoTurco J. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling. Development. 2015;142:3601-11 pubmed publisher
  537. Polettini J, Behnia F, Taylor B, Saade G, Taylor R, Menon R. Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?. PLoS ONE. 2015;10:e0137188 pubmed publisher
  538. Ho D, Kim H, Kim J, Sim H, Ahn H, Kim J, et al. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression. Mol Brain. 2015;8:54 pubmed publisher
  539. Lee N, Kwon J, Kim Y, Kim S, Park S, Xu W, et al. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition. Oncotarget. 2015;6:30130-48 pubmed publisher
  540. Rastetter R, Blömacher M, Drebber U, Marko M, Behrens J, Solga R, et al. Coronin 2A (CRN5) expression is associated with colorectal adenoma-adenocarcinoma sequence and oncogenic signalling. BMC Cancer. 2015;15:638 pubmed publisher
  541. Bailey M, Singh T, Mero P, Moffat J, Hieter P. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Genetics. 2015;201:885-95 pubmed publisher
  542. Seko Y, Fujimura T, Yao T, Taka H, Mineki R, Okumura K, et al. Secreted tyrosine sulfated-eIF5A mediates oxidative stress-induced apoptosis. Sci Rep. 2015;5:13737 pubmed publisher
  543. Catenacci D, Chapman C, Xu P, Koons A, Konda V, Siddiqui U, et al. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound. Gastroenterology. 2015;149:1794-1803.e4 pubmed publisher
  544. Cao L, Ding J, Dong L, Zhao J, Su J, Wang L, et al. Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability. PLoS ONE. 2015;10:e0137411 pubmed publisher
  545. Heishima K, Mori T, Sakai H, Sugito N, Murakami M, Yamada N, et al. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis. PLoS ONE. 2015;10:e0137361 pubmed publisher
  546. Wang J, Hua W, Huang S, Fan K, Takeshima L, Mao Y, et al. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb. Oncotarget. 2015;6:30165-77 pubmed publisher
  547. Zhu J, Sammons M, Donahue G, Dou Z, Vedadi M, Getlik M, et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature. 2015;525:206-11 pubmed publisher
  548. Huang J, He Y, Chen M, Du J, Li G, Li S, et al. Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma‑associated epilepsy. Mol Med Rep. 2015;12:6509-16 pubmed publisher
  549. Xia H, Najafov A, Geng J, Galan Acosta L, Han X, Guo Y, et al. Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death. J Cell Biol. 2015;210:705-16 pubmed publisher
  550. Coelho R, Calaça I, Celestrini D, Correia Carneiro A, Costa M, Zancan P, et al. Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma. Oncotarget. 2015;6:29375-87 pubmed publisher
  551. Domínguez D, Feijoo P, Bernal A, Ercilla A, Agell N, Genescà A, et al. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress. Oncotarget. 2015;6:28238-56 pubmed publisher
  552. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed publisher
  553. Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, et al. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis. Cancer Sci. 2015;106:1596-606 pubmed publisher
  554. Tan B, Mu R, Chang Y, Wang Y, Wu M, Tu H, et al. RNF4 negatively regulates NF-κB signaling by down-regulating TAB2. FEBS Lett. 2015;589:2850-8 pubmed publisher
  555. Crivellaro S, Panuzzo C, Carrà G, Volpengo A, Crasto F, Gottardi E, et al. Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion. Oncotarget. 2015;6:25217-25 pubmed publisher
  556. Mughal A, Grieg Z, Skjellegrind H, Fayzullin A, Lamkhannat M, Joel M, et al. Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells. Mol Cancer. 2015;14:160 pubmed publisher
  557. Cañeque T, Gomes F, Mai T, Maestri G, Malacria M, Rodriguez R. Synthesis of marmycin A and investigation into its cellular activity. Nat Chem. 2015;7:744-51 pubmed publisher
  558. Fan L, Peng G, Sahgal N, Fazli L, Gleave M, Zhang Y, et al. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival. Oncogene. 2016;35:2441-52 pubmed publisher
  559. Bi J, Huang A, Liu T, Zhang T, Ma H. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer. Int J Clin Exp Pathol. 2015;8:6070-82 pubmed
  560. Goh A, Xue Y, Leushacke M, Li L, Wong J, Chiam P, et al. Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice. Oncotarget. 2015;6:17968-80 pubmed
  561. Kim J, Sato M, Choi J, Kim H, Yeh B, Larsen J, et al. Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. PLoS ONE. 2015;10:e0134842 pubmed publisher
  562. Wang H, Lööf S, Borg P, Nader G, Blau H, Simon A. Turning terminally differentiated skeletal muscle cells into regenerative progenitors. Nat Commun. 2015;6:7916 pubmed publisher
  563. Khan I, Zakaria M, Kumar M, Mani P, Chattopadhyay P, Sarkar D, et al. A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]. J Transl Med. 2015;13:254 pubmed publisher
  564. Lee S, Bae S, Lee J, Lee H, Yi H, Kil W, et al. Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival. PLoS ONE. 2015;10:e0124658 pubmed publisher
  565. González Loyola A, Fernández Miranda G, Trakala M, Partida D, Samejima K, Ogawa H, et al. Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development. Mol Cell Biol. 2015;35:3566-78 pubmed publisher
  566. Wandrey F, Montellese C, Koos K, Badertscher L, Bammert L, Cook A, et al. The NF45/NF90 Heterodimer Contributes to the Biogenesis of 60S Ribosomal Subunits and Influences Nucleolar Morphology. Mol Cell Biol. 2015;35:3491-503 pubmed publisher
  567. Subbaiah V, Zhang Y, Rajagopalan D, Abdullah L, Yeo Teh N, Tomaić V, et al. E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60. Oncogene. 2016;35:2062-74 pubmed publisher
  568. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  569. Coutts A, La Thangue N. Actin nucleation by WH2 domains at the autophagosome. Nat Commun. 2015;6:7888 pubmed publisher
  570. Shatz M, Shats I, Menendez D, Resnick M. p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways. Oncotarget. 2015;6:16963-80 pubmed
  571. Xie W, Zhang L, Jiao H, Guan L, Zha J, Li X, et al. Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA. Autophagy. 2015;11:1623-35 pubmed publisher
  572. Kiyonari S, Iimori M, Matsuoka K, Watanabe S, Morikawa Ichinose T, Miura D, et al. The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis. Mol Cancer Ther. 2015;14:2332-42 pubmed publisher
  573. Succoio M, Comegna M, D Ambrosio C, Scaloni A, Cimino F, Faraonio R. Proteomic analysis reveals novel common genes modulated in both replicative and stress-induced senescence. J Proteomics. 2015;128:18-29 pubmed publisher
  574. Pencik J, Schlederer M, Gruber W, Unger C, Walker S, Chalaris A, et al. STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun. 2015;6:7736 pubmed publisher
  575. Simões M, Martins C, Ferreira F. Early intranuclear replication of African swine fever virus genome modifies the landscape of the host cell nucleus. Virus Res. 2015;210:1-7 pubmed publisher
  576. Haupt S, Buckley D, Pang J, Panimaya J, Paul P, Gamell C, et al. Targeting Mdmx to treat breast cancers with wild-type p53. Cell Death Dis. 2015;6:e1821 pubmed publisher
  577. Macher Goeppinger S, Keith M, Tagscherer K, Singer S, Winkler J, Hofmann T, et al. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas. J Pathol. 2015;237:460-71 pubmed publisher
  578. Navarro F, Lieberman J. miR-34 and p53: New Insights into a Complex Functional Relationship. PLoS ONE. 2015;10:e0132767 pubmed publisher
  579. Li M, Pehar M, Liu Y, Bhattacharyya A, Zhang S, O Riordan K, et al. The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism. Neurobiol Aging. 2015;36:2725-36 pubmed publisher
  580. Jones A, Gokhale P, Allison T, Sampson B, Athwal S, Grant S, et al. Evidence for bystander signalling between human trophoblast cells and human embryonic stem cells. Sci Rep. 2015;5:11694 pubmed publisher
  581. Zhu J, Zhao C, Zhuang T, Jonsson P, Sinha I, Williams C, et al. RING finger protein 31 promotes p53 degradation in breast cancer cells. Oncogene. 2016;35:1955-64 pubmed publisher
  582. Sharma V, Jordan J, Ciribilli Y, Resnick M, Bisio A, Inga A. Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay. PLoS ONE. 2015;10:e0130170 pubmed publisher
  583. Wu C, Huang K, Yang T, Li Y, Wen C, Hsu S, et al. The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells. PLoS ONE. 2015;10:e0132052 pubmed publisher
  584. Ohashi A, Ohori M, Iwai K, Nakayama Y, Nambu T, Morishita D, et al. Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells. Nat Commun. 2015;6:7668 pubmed publisher
  585. Liu R, Fan M, Candas D, Qin L, Zhang X, Eldridge A, et al. CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance. Mol Cancer Ther. 2015;14:2090-102 pubmed publisher
  586. Mundim F, Pasini F, Brentani M, Soares F, Nonogaki S, Waitzberg A. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol. 2015;3:506-514 pubmed
  587. Sadaie M, Dillon C, Narita M, Young A, Cairney C, Godwin L, et al. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition. Mol Biol Cell. 2015;26:2971-85 pubmed publisher
  588. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed publisher
  589. Lebrun Julien F, Suter U. Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression. ASN Neuro. 2015;7: pubmed publisher
  590. Jacquin S, Rincheval V, Mignotte B, Richard S, Humbert M, Mercier O, et al. Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. PLoS ONE. 2015;10:e0131940 pubmed publisher
  591. Marchesini M, Matocci R, Tasselli L, Cambiaghi V, Orleth A, Furia L, et al. PML is required for telomere stability in non-neoplastic human cells. Oncogene. 2016;35:1811-21 pubmed publisher
  592. Hayashi M, Cesare A, Rivera T, Karlseder J. Cell death during crisis is mediated by mitotic telomere deprotection. Nature. 2015;522:492-6 pubmed publisher
  593. Pickard A, McDade S, McFarland M, McCluggage W, Wheeler C, McCance D. HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures. PLoS Pathog. 2015;11:e1004988 pubmed publisher
  594. Sedic M, Skibinski A, Brown N, Gallardo M, Mulligan P, Martinez P, et al. Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence. Nat Commun. 2015;6:7505 pubmed publisher
  595. Wang J, Chen S, Sun C, Chien T, Chern Y. A central role of TRAX in the ATM-mediated DNA repair. Oncogene. 2016;35:1657-70 pubmed publisher
  596. Szlachcic W, Switonski P, Krzyzosiak W, Figlerowicz M, Figiel M. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway. Dis Model Mech. 2015;8:1047-57 pubmed publisher
  597. Dettmer U, Newman A, Soldner F, Luth E, Kim N, von Saucken V, et al. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314 pubmed publisher
  598. Zhao J, Zhao D, Poage G, Mazumdar A, Zhang Y, Hill J, et al. Death-associated protein kinase 1 promotes growth of p53-mutant cancers. J Clin Invest. 2015;125:2707-20 pubmed publisher
  599. Slatter T, Hung N, Bowie S, Campbell H, Rubio C, Speidel D, et al. Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant. Cell Death Dis. 2015;6:e1783 pubmed publisher
  600. Petroni M, Sardina F, Heil C, Sahún Roncero M, Colicchia V, Veschi V, et al. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ. 2016;23:197-206 pubmed publisher
  601. Amente S, Milazzo G, Sorrentino M, Ambrosio S, Di Palo G, Lania L, et al. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma. Oncotarget. 2015;6:14572-83 pubmed
  602. Xie C, Wei D, Zhao L, Marchetto S, Mei L, Borg J, et al. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol. 2015;209:721-37 pubmed publisher
  603. Yoshida Y, Shimizu I, Katsuumi G, Jiao S, Suda M, Hayashi Y, et al. p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload. J Mol Cell Cardiol. 2015;85:183-98 pubmed publisher
  604. Neo S, Itahana Y, Alagu J, Kitagawa M, Guo A, Lee S, et al. TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification. Mol Cell Biol. 2015;35:2851-63 pubmed publisher
  605. Kotipatruni R, Ren X, Thotala D, Jaboin J. NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells. Oncotarget. 2015;6:17594-604 pubmed
  606. Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt A, et al. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 2015;6:21522-32 pubmed
  607. Chen S, Wang W, Wang L, Lin Q, Zhao G, Xu G, et al. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases. Histopathology. 2016;68:378-87 pubmed publisher
  608. García Cano J, Ambroise G, Pascual Serra R, Carrión M, Serrano Oviedo L, Ortega Muelas M, et al. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance. Oncotarget. 2015;6:15551-65 pubmed
  609. Moiseeva O, Lessard F, Acevedo Aquino M, Vernier M, Tsantrizos Y, Ferbeyre G. Mutant lamin A links prophase to a p53 independent senescence program. Cell Cycle. 2015;14:2408-21 pubmed publisher
  610. Chen B, Zaveri P, Longtine M, Nelson D. N-myc downstream-regulated gene 1 (NDRG1) mediates pomegranate juice protection from apoptosis in hypoxic BeWo cells but not in primary human trophoblasts. Placenta. 2015;36:847-53 pubmed publisher
  611. Bishop R, Valle Oseguera C, Spencer J. Human Cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells. Cancer Cell Microenviron. 2015;2: pubmed
  612. Tembe V, Martino Echarri E, Marzec K, Mok M, Brodie K, Mills K, et al. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function. Cell Signal. 2015;27:1763-71 pubmed publisher
  613. Krais A, Speksnijder E, Melis J, Indra R, Moserova M, Godschalk R, et al. The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice. Arch Toxicol. 2016;90:839-51 pubmed publisher
  614. Kloet D, Polderman P, Eijkelenboom A, Smits L, van Triest M, van den Berg M, et al. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1). Biochem J. 2015;469:289-98 pubmed publisher
  615. Zhou Y, Han C, Li D, Yu Z, Li F, Li F, et al. Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth. Sci Rep. 2015;5:10433 pubmed publisher
  616. Yang K, Kohler R, Landon M, Giedt R, Weissleder R. Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci Rep. 2015;5:10129 pubmed publisher
  617. Wang J, Guo W, Zhou H, Luo N, Nie C, Zhao X, et al. Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death. Oncotarget. 2015;6:17192-205 pubmed
  618. Mortusewicz O, Evers B, Helleday T. PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites. Oncogene. 2016;35:761-70 pubmed publisher
  619. Li Y, Wang W, Xu X, Sun S, Xu X, Qu X. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3. Biomed Res Int. 2015;2015:491205 pubmed publisher
  620. Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Van Isterdael G, et al. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 2015;15:391 pubmed publisher
  621. Robl B, Pauli C, Botter S, Bode Lesniewska B, Fuchs B. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer. 2015;15:379 pubmed publisher
  622. Mahale S, Bharate S, Manda S, Joshi P, Jenkins P, Vishwakarma R, et al. Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. Cell Death Dis. 2015;6:e1743 pubmed publisher
  623. De Cesare M, Cominetti D, Doldi V, Lopergolo A, Deraco M, Gandellini P, et al. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget. 2015;6:13119-32 pubmed
  624. Waters A, Stewart J, Atigadda V, Mroczek Musulman E, Muccio D, Grubbs C, et al. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma. Mol Cancer Ther. 2015;14:1559-69 pubmed publisher
  625. Bhagirath D, Zhao X, West W, Qiu F, Band H, Band V. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes. Oncotarget. 2015;6:9018-30 pubmed
  626. Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236:43-59 pubmed publisher
  627. Zhao J, Molitor T, Langston J, Nichols R. LRRK2 dephosphorylation increases its ubiquitination. Biochem J. 2015;469:107-20 pubmed publisher
  628. Mishra A, Kumar R, Tyagi A, Kohaar I, Hedau S, Bharti A, et al. Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. Ecancermedicalscience. 2015;9:525 pubmed publisher
  629. Wright J, Atwan Z, Morris S, Leppard K. The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K. J Virol. 2015;89:7053-63 pubmed publisher
  630. Sechler M, Borowicz S, Van Scoyk M, Avasarala S, Zerayesus S, Edwards M, et al. Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1). J Biol Chem. 2015;290:15610-20 pubmed publisher
  631. Isogai T, van der Kammen R, Innocenti M. SMIFH2 has effects on Formins and p53 that perturb the cell cytoskeleton. Sci Rep. 2015;5:9802 pubmed publisher
  632. Drost J, van Jaarsveld R, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43-7 pubmed publisher
  633. Salm F, Dimitrova V, von Bueren A, Ćwiek P, Rehrauer H, Djonov V, et al. The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma. PLoS ONE. 2015;10:e0123958 pubmed publisher
  634. Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed publisher
  635. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome. Pathol Res Pract. 2015;211:505-12 pubmed publisher
  636. Abdelzaher E, Kotb A. High Coexpression of Runt-related Transcription Factor 2 (RUNX2) and p53 Independently Predicts Early Tumor Recurrence in Bladder Urothelial Carcinoma Patients. Appl Immunohistochem Mol Morphol. 2016;24:345-54 pubmed publisher
  637. Cattoglio C, Zhang E, Grubisic I, Chiba K, Fong Y, Tjian R. Functional and mechanistic studies of XPC DNA-repair complex as transcriptional coactivator in embryonic stem cells. Proc Natl Acad Sci U S A. 2015;112:E2317-26 pubmed publisher
  638. Suryavanshi M, Mehta A, Jaipuria J, Sharma A, Rawal S, Seth N. Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook. Urol Oncol. 2015;33:331.e9-15 pubmed publisher
  639. Bian C, Li Z, Xu Y, Wang J, Xu L, Shen H. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study. World J Surg Oncol. 2015;13:128 pubmed publisher
  640. Seiki T, Nagasaka K, Kranjec C, Kawana K, Maeda D, Nakamura H, et al. HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy. BMC Cancer. 2015;15:230 pubmed publisher
  641. Ahronian L, Driscoll D, Klimstra D, Lewis B. The p53R172H mutant does not enhance hepatocellular carcinoma development and progression. PLoS ONE. 2015;10:e0123816 pubmed publisher
  642. Chen P, Wu T, Cheng Y, Chen C, Lee H. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation. Oncotarget. 2015;6:14274-89 pubmed
  643. Barfeld S, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi K, et al. Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer. Oncotarget. 2015;6:12587-602 pubmed
  644. Prickaerts P, Niessen H, Dahlmans V, Spaapen F, Salvaing J, Vanhove J, et al. MK3 modulation affects BMI1-dependent and independent cell cycle check-points. PLoS ONE. 2015;10:e0118840 pubmed publisher
  645. Rodríguez Sureda V, Vilches Ã, Sánchez O, Audí L, Domínguez C. Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid Med Cell Longev. 2015;2015:509241 pubmed publisher
  646. Chen L, Rousseau R, Middleton S, Nichols G, Newell D, Lunec J, et al. Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma. Oncotarget. 2015;6:10207-21 pubmed
  647. Pilar Valdecantos M, Prieto Hontoria P, Pardo V, Módol T, Santamaría B, Weber M, et al. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. Free Radic Biol Med. 2015;84:263-278 pubmed publisher
  648. Li Y, Li B, Xu B, Han B, Xia H, Chen Q, et al. Expression of p53, p21(CIP1/WAF1) and eIF4E in the adjacent tissues of oral squamous cell carcinoma: establishing the molecular boundary and a cancer progression model. Int J Oral Sci. 2015;7:161-8 pubmed publisher
  649. Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, et al. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis. Oncotarget. 2015;6:9420-33 pubmed
  650. Cho J, Lee S, Oh A, Yoon M, Woo T, Park B. NF2 blocks Snail-mediated p53 suppression in mesothelioma. Oncotarget. 2015;6:10073-85 pubmed
  651. Zhang M, Xu E, Zhang J, Chen X. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38. Oncogene. 2015;34:5900-11 pubmed publisher
  652. Savci Heijink C, Halfwerk H, Hooijer G, Horlings H, Wesseling J, van de Vijver M. Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Res Treat. 2015;150:547-57 pubmed publisher
  653. Zhao W, Chen R, Zhao M, Li L, Fan L, Che X. High glucose promotes gastric cancer chemoresistance in vivo and in vitro. Mol Med Rep. 2015;12:843-50 pubmed publisher
  654. Xu T, Fan B, Lv C, Xiao D. Slug mediates nasopharyngeal carcinoma radioresistance via downregulation of PUMA in a p53-dependent and -independent manner. Oncol Rep. 2015;33:2631-8 pubmed publisher
  655. Leslie P, Ke H, Zhang Y. The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization. J Biol Chem. 2015;290:12941-50 pubmed publisher
  656. Markkanen E, Fischer R, Ledentcova M, Kessler B, Dianov G. Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability. Nucleic Acids Res. 2015;43:3667-79 pubmed publisher
  657. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed publisher
  658. Zhang W, Luo J, Chen F, Yang F, Song W, Zhu A, et al. BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner. Oncotarget. 2015;6:7608-18 pubmed
  659. Yoo C, Koh Y, Park Y, Ryu M, Ryoo B, Park H, et al. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib. Ann Surg Oncol. 2015;22 Suppl 3:S362-9 pubmed publisher
  660. Kirschner K, Samarajiwa S, Cairns J, Menon S, Perez Mancera P, Tomimatsu K, et al. Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53. PLoS Genet. 2015;11:e1005053 pubmed publisher
  661. Magnani K, Cataneo D, Domingues M, Hasimoto E, Evaristo T, Cataneo A. Respiratory immunohistochemical study in rats exposed to cigarette smoke and alcohol. Acta Cir Bras. 2015;30:178-85 pubmed publisher
  662. Kobayashi A, Hashizume C, Dowaki T, Wong R. Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A. Cell Cycle. 2015;14:1447-58 pubmed publisher
  663. Zhou Q, Derti A, Ruddy D, Rakiec D, Kao I, Lira M, et al. A chemical genetics approach for the functional assessment of novel cancer genes. Cancer Res. 2015;75:1949-58 pubmed publisher
  664. Mitkin N, Hook C, Schwartz A, Biswas S, Kochetkov D, Muratova A, et al. p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells. Sci Rep. 2015;5:9330 pubmed publisher
  665. Aubry S, Shin W, Crary J, Lefort R, Qureshi Y, Lefebvre C, et al. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression. PLoS ONE. 2015;10:e0120352 pubmed publisher
  666. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  667. Khoronenkova S, Dianov G. ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc Natl Acad Sci U S A. 2015;112:3997-4002 pubmed publisher
  668. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed publisher
  669. Wang B, Wu S, Tang S, Lai C, Ou C, Wu M, et al. Benzo[a]pyrene-induced cell cycle progression occurs via ERK-induced Chk1 pathway activation in human lung cancer cells. Mutat Res. 2015;773:1-8 pubmed publisher
  670. Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sultmann H, et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog. 2015;11:e1004712 pubmed publisher
  671. Ruan X, Zuo Q, Jia H, Chau J, Lin J, Ao J, et al. P53 deficiency-induced Smad1 upregulation suppresses tumorigenesis and causes chemoresistance in colorectal cancers. J Mol Cell Biol. 2015;7:105-18 pubmed publisher
  672. Griffin J, Sondalle S, del Viso F, Baserga S, Khokha M. The ribosome biogenesis factor Nol11 is required for optimal rDNA transcription and craniofacial development in Xenopus. PLoS Genet. 2015;11:e1005018 pubmed publisher
  673. Keskin N, Deniz E, Eryilmaz J, Un M, Batur T, Ersahin T, et al. PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function. Mol Cell Biol. 2015;35:1741-53 pubmed publisher
  674. Katagiri N, Kuroda T, Kishimoto H, Hayashi Y, Kumazawa T, Kimura K. The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription. Sci Rep. 2015;5:8903 pubmed publisher
  675. Luo Z, Feng X, Wang H, Xu W, Zhao Y, Ma W, et al. Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression. Aging Cell. 2015;14:391-9 pubmed publisher
  676. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed publisher
  677. Ehm P, Nalaskowski M, Wundenberg T, Jücker M. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies. Nucleus. 2015;6:154-64 pubmed publisher
  678. Yan H, Solozobova V, Zhang P, Armant O, Kuehl B, Brenner Weiss G, et al. p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53. Cell Death Dis. 2015;6:e1662 pubmed publisher
  679. McFarlane M, MacDonald A, Stevenson A, Graham S. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). J Virol. 2015;89:5276-87 pubmed publisher
  680. Tomasovic A, Kurrle N, Sürün D, Heidler J, Husnjak K, Poser I, et al. Sestrin 2 protein regulates platelet-derived growth factor receptor β (Pdgfrβ) expression by modulating proteasomal and Nrf2 transcription factor functions. J Biol Chem. 2015;290:9738-52 pubmed publisher
  681. Stolze B, Reinhart S, Bulllinger L, Fröhling S, Scholl C. Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines. Sci Rep. 2015;5:8535 pubmed publisher
  682. Balboni A, Cherukuri P, Ung M, DeCastro A, Cheng C, DiRenzo J. p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals. Mol Cancer Res. 2015;13:732-42 pubmed publisher
  683. Tamilzhalagan S, Muthuswami M, Periasamy J, Lee M, Rha S, Tan P, et al. Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer. Cell Signal. 2015;27:1075-86 pubmed publisher
  684. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, et al. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Cancer Lett. 2015;360:269-79 pubmed publisher
  685. Kitajima S, Kohno S, Kondoh A, Sasaki N, Nishimoto Y, Li F, et al. Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts. Stem Cells. 2015;33:1657-69 pubmed publisher
  686. Dow L, Fisher J, O Rourke K, Muley A, Kastenhuber E, Livshits G, et al. Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol. 2015;33:390-394 pubmed publisher
  687. Li X, Gu S, Ling Y, Shen C, Cao X, Xie R. p53 inhibition provides a pivotal protective effect against ischemia-reperfusion injury in vitro via mTOR signaling. Brain Res. 2015;1605:31-8 pubmed publisher
  688. Simons M, Nagtegaal I, Overbeek L, Flucke U, Massuger L, Bulten J. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases. Int J Gynecol Pathol. 2015;34:143-50 pubmed publisher
  689. Hsieh W, Huang Y, Wang T, Ming Y, Tsai C, Pang J. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif. 2015;48:187-97 pubmed publisher
  690. Long J, Schoonen P, Graczyk D, O Prey J, Ryan K. p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death. Oncogene. 2015;34:5152-62 pubmed publisher
  691. Guerrero A, Iglesias C, Raguz S, Floridia E, Gil J, Pombo C, et al. The cerebral cavernous malformation 3 gene is necessary for senescence induction. Aging Cell. 2015;14:274-83 pubmed publisher
  692. Loke J, Pearlman A, Upadhyay K, Tesfa L, Shao Y, Ostrer H. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway. Hum Mol Genet. 2015;24:3030-7 pubmed publisher
  693. Lewinska A, Wnuk M, Grabowska W, Zabek T, Semik E, Sikora E, et al. Curcumin induces oxidation-dependent cell cycle arrest mediated by SIRT7 inhibition of rDNA transcription in human aortic smooth muscle cells. Toxicol Lett. 2015;233:227-38 pubmed publisher
  694. Wang X, Docanto M, Sasano H, Lo C, Simpson E, Brown K. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer. Cancer Res. 2015;75:645-55 pubmed publisher
  695. Suo H, Song J, Zhou Y, Liu Z, Yi R, Zhu K, et al. Induction of apoptosis in HCT-116 colon cancer cells by polysaccharide of Larimichthys crocea swim bladder. Oncol Lett. 2015;9:972-978 pubmed
  696. Laura M, de la Cruz Herrera C, Ferreirós A, Baz Martínez M, Lang V, Vidal A, et al. KSHV latent protein LANA2 inhibits sumo2 modification of p53. Cell Cycle. 2015;14:277-82 pubmed publisher
  697. Lecona E, Narendra V, Reinberg D. USP7 cooperates with SCML2 to regulate the activity of PRC1. Mol Cell Biol. 2015;35:1157-68 pubmed publisher
  698. Wang L, Liu R, Ye P, Wong C, Chen G, Zhou P, et al. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun. 2015;6:5909 pubmed publisher
  699. Stolz A, Ertych N, Bastians H. A phenotypic screen identifies microtubule plus end assembly regulators that can function in mitotic spindle orientation. Cell Cycle. 2015;14:827-37 pubmed publisher
  700. Gao R, Liu Y, Silva Fernandes A, Fang X, Paulucci Holthauzen A, Chatterjee A, et al. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3. PLoS Genet. 2015;11:e1004834 pubmed publisher
  701. Azimzadeh O, Sievert W, Sarioglu H, Merl Pham J, Yentrapalli R, Bakshi M, et al. Integrative proteomics and targeted transcriptomics analyses in cardiac endothelial cells unravel mechanisms of long-term radiation-induced vascular dysfunction. J Proteome Res. 2015;14:1203-19 pubmed publisher
  702. Zhao X, Zhao Q, Luo Z, Yu Y, Xiao N, Sun X, et al. Spontaneous immortalization of mouse liver sinusoidal endothelial cells. Int J Mol Med. 2015;35:617-24 pubmed publisher
  703. Ochi T, Blackford A, Coates J, Jhujh S, Mehmood S, Tamura N, et al. DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science. 2015;347:185-188 pubmed publisher
  704. Xia J, Chen S, Lv Y, Lu L, Hu W, Zhou Y. ZGDHu-1 induces Gâ‚‚/M phase arrest and apoptosis in Kasumi-1 cells. Mol Med Rep. 2015;11:3398-404 pubmed publisher
  705. Van Rechem C, Black J, Boukhali M, Aryee M, Gräslund S, Haas W, et al. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis. Cancer Discov. 2015;5:255-63 pubmed publisher
  706. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  707. Akrish S, Ben Izhak O, Sabo E, Rachmiel A. Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma--a clinical, histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:318-25 pubmed publisher
  708. Pérès E, Gérault A, Valable S, Roussel S, Toutain J, Divoux D, et al. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe. Oncotarget. 2015;6:2101-19 pubmed
  709. Butin Israeli V, Adam S, Jain N, Otte G, Neems D, Wiesmüller L, et al. Role of lamin b1 in chromatin instability. Mol Cell Biol. 2015;35:884-98 pubmed publisher
  710. Green A, Caracappa D, Benhasouna A, Alshareeda A, Nolan C, Macmillan R, et al. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res Treat. 2015;149:353-62 pubmed publisher
  711. Ghorbani A, Jeddi Tehrani M, Saidpour A, Safa M, Bayat A, Zand H. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells. Arch Biochem Biophys. 2015;566:58-66 pubmed publisher
  712. Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer. J Biol Chem. 2015;290:2024-33 pubmed publisher
  713. Yang Z, Broz D, Noderer W, Ferreira J, Overton K, Spencer S, et al. p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress. Cell Death Differ. 2015;22:560-73 pubmed publisher
  714. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  715. Torma F, Koltai E, Nagy E, Ziaaldini M, Posa A, Koch L, et al. Exercise Increases Markers of Spermatogenesis in Rats Selectively Bred for Low Running Capacity. PLoS ONE. 2014;9:e114075 pubmed publisher
  716. Liu W, Lin Y, Yan X, Ding Y, Wu Y, Chen W, et al. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. FASEB J. 2015;29:1113-23 pubmed publisher
  717. Wei Z, Guo H, Liu Z, Zhang X, Liu Q, Qian Y, et al. CUL4B impedes stress-induced cellular senescence by dampening a p53-reactive oxygen species positive feedback loop. Free Radic Biol Med. 2015;79:1-13 pubmed publisher
  718. Kuo P, Huang C, Lee C, Chang H, Hsieh S, Chung Y, et al. BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability. Br J Cancer. 2015;112:391-402 pubmed publisher
  719. Kim H, Jung G. Reactive oxygen species increase HEPN1 expression via activation of the XBP1 transcription factor. FEBS Lett. 2014;588:4413-21 pubmed publisher
  720. Kim T, Kim H, Kang Y, Yoon S, Lee J, Choi W, et al. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. Biochim Biophys Acta. 2015;1850:401-10 pubmed publisher
  721. Olayanju A, Copple I, Bryan H, Edge G, Sison R, Wong M, et al. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic Biol Med. 2015;78:202-12 pubmed publisher
  722. Zhang P, Wu S, Wang Y, Fan Z, Li C, Feng M, et al. p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study. Oncol Lett. 2015;9:113-118 pubmed
  723. Giovannini C, Minguzzi M, Baglioni M, Fornari F, Giannone F, Ravaioli M, et al. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Oncotarget. 2014;5:10607-20 pubmed
  724. Park J, Lee S, Yang S, Yoo H, Park J, Seong M, et al. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage. Nat Commun. 2014;5:5483 pubmed publisher
  725. Voorneveld P, Kodach L, Jacobs R, van Noesel C, Peppelenbosch M, Korkmaz K, et al. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC. Br J Cancer. 2015;112:122-30 pubmed publisher
  726. Greve K, Lindgreen J, Terp M, Pedersen C, Schmidt S, Mollenhauer J, et al. Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability. Mol Oncol. 2015;9:437-49 pubmed publisher
  727. Magni M, Ruscica V, Buscemi G, Kim J, Nachimuthu B, Fontanella E, et al. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis. Nucleic Acids Res. 2014;42:13150-60 pubmed publisher
  728. Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T, Chikamatsu K. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci. 2015;106:1-8 pubmed publisher
  729. Kawasumi M, Bradner J, Tolliday N, Thibodeau R, Sloan H, Brummond K, et al. Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity. Cancer Res. 2014;74:7534-45 pubmed publisher
  730. Wang D, Zhang P, Gao K, Tang Y, Jin X, Zhang Y, et al. PLK1 and β-TrCP-dependent ubiquitination and degradation of Rap1GAP controls cell proliferation. PLoS ONE. 2014;9:e110296 pubmed publisher
  731. Vega Naredo I, Cunha Oliveira T, Serafim T, Sardao V, Oliveira P. Analysis of pro-apoptotic protein trafficking to and from mitochondria. Methods Mol Biol. 2015;1241:163-80 pubmed publisher
  732. Hühn D, Kousholt A, Sørensen C, Sartori A. miR-19, a component of the oncogenic miR-17∼92 cluster, targets the DNA-end resection factor CtIP. Oncogene. 2015;34:3977-84 pubmed publisher
  733. Xu H, Zhou Y, Coughlan K, Ding Y, Wang S, Wu Y, et al. AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts. Biochim Biophys Acta. 2015;1853:65-73 pubmed publisher
  734. Choi H, Choi Y, Kang H, Lim E, Park S, Lee H, et al. PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death. Hum Mol Genet. 2015;24:1127-41 pubmed publisher
  735. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  736. Li W, Song M. Expression of multidrug resistance proteins in invasive ductal carcinoma of the breast. Oncol Lett. 2014;8:2103-2109 pubmed
  737. Peltonen K, Colis L, Liu H, Jäämaa S, Zhang Z, Af Hällström T, et al. Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress. Mol Cancer Ther. 2014;13:2537-46 pubmed publisher
  738. Idogawa M, Ohashi T, Sugisaka J, Sasaki Y, Suzuki H, Tokino T. Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells. Oncotarget. 2014;5:7540-8 pubmed
  739. Waisberg J, de Souza Viana L, Affonso Junior R, Silva S, Denadai M, Margeotto F, et al. Overexpression of the ITGAV gene is associated with progression and spread of colorectal cancer. Anticancer Res. 2014;34:5599-607 pubmed
  740. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  741. Iannetti A, Ledoux A, Tudhope S, Sellier H, Zhao B, Mowla S, et al. Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence. PLoS Genet. 2014;10:e1004642 pubmed publisher
  742. Cao J, Lu Y, Qi J, An G, Mao Z, Jia H, et al. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells. Cell Death Dis. 2014;5:e1426 pubmed publisher
  743. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  744. Fan Y, Meley D, Pizer B, Sée V. Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells. PLoS ONE. 2014;9:e108514 pubmed publisher
  745. Chen D, Ming L, Zou F, Peng Y, Van Houten B, Yu J, et al. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity. Oncotarget. 2014;5:8107-22 pubmed
  746. Huang E, Wang F, Chen Y, Chen Y, Wang C, Lin I, et al. Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation. Oncotarget. 2014;5:9756-69 pubmed
  747. Harashima N, Minami T, Uemura H, Harada M. Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system. Mol Cancer. 2014;13:217 pubmed publisher
  748. Hu Z, Zeng Q, Zhang B, Liu H, Wang W. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells. Biochimie. 2014;107 Pt B:257-62 pubmed publisher
  749. Shi Z, Shi F, Wang Y, Sheftel A, Nie G, Zhao Y, et al. Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation. Cell Mol Life Sci. 2015;72:983-97 pubmed publisher
  750. Jebelli J, Hooper C, Pocock J. Microglial p53 activation is detrimental to neuronal synapses during activation-induced inflammation: Implications for neurodegeneration. Neurosci Lett. 2014;583:92-7 pubmed publisher
  751. Sevcenco S, Haitel A, Ponhold L, Susani M, Fajkovic H, Shariat S, et al. Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity. PLoS ONE. 2014;9:e106866 pubmed publisher
  752. Patwardhan G, Hosain S, Liu D, Khiste S, Zhao Y, Bielawski J, et al. Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells. Biochim Biophys Acta. 2014;1841:1571-80 pubmed publisher
  753. Santos J, Gil J. TRIM28/KAP1 regulates senescence. Immunol Lett. 2014;162:281-9 pubmed publisher
  754. Castro G, Cayado Gutiérrez N, Zoppino F, Fanelli M, Cuello Carrión F, Sottile M, et al. Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells. Cell Stress Chaperones. 2015;20:253-65 pubmed publisher
  755. Alpay K, Farshchian M, Tuomela J, Sandholm J, Aittokallio K, Siljamäki E, et al. Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone. PLoS ONE. 2014;9:e105526 pubmed publisher
  756. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  757. Noguchi A, Kikuchi K, Zheng H, Takahashi H, Miyagi Y, Aoki I, et al. SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer. Cancer Med. 2014;3:1553-61 pubmed publisher
  758. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  759. Nicholson A, Guo X, Sullivan C, Cha C. Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival. J Am Coll Surg. 2014;219:977-87 pubmed publisher
  760. Jacob A, Singh R, Comiskey D, Rouhier M, Mohammad F, Bebee T, et al. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways. PLoS ONE. 2014;9:e104444 pubmed publisher
  761. Li L, Wu P, Lee J, Li P, Hsieh W, Ho C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS ONE. 2014;9:e104203 pubmed publisher
  762. Vassilopoulos A, Tominaga Y, Kim H, Lahusen T, Li B, Yu H, et al. WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis. Oncogene. 2015;34:3023-35 pubmed publisher
  763. Zhang X, Ma W, Cui J, Yao H, Zhou H, Ge Y, et al. Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia. Oncogene. 2015;34:3000-10 pubmed publisher
  764. Zhang P, Wei Y, Wang L, Debeb B, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864-75 pubmed publisher
  765. Suico M, Fukuda R, Miyakita R, Koyama K, Taura M, Shuto T, et al. The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism. J Biol Chem. 2014;289:26143-54 pubmed publisher
  766. Clewell R, Sun B, Adeleye Y, Carmichael P, Efremenko A, McMullen P, et al. Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage. Toxicol Sci. 2014;142:56-73 pubmed publisher
  767. Watanabe T, Nakamura S, Ono T, Ui S, Yagi S, Kagawa H, et al. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma. Biochem Biophys Res Commun. 2014;451:93-100 pubmed publisher
  768. Ji X, Lu H, Zhou Q, Luo K. LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis. elife. 2014;3:e02907 pubmed publisher
  769. Chuang H, Liao J, Chang H, Wang J, Lin S, Hsieh P. Ciliated muconodular papillary tumor of the lung: a newly defined peripheral pulmonary tumor with conspicuous mucin pool mimicking colloid adenocarcinoma: a case report and review of literature. Pathol Int. 2014;64:352-7 pubmed publisher
  770. Morita A, Ariyasu S, Wang B, Asanuma T, Onoda T, Sawa A, et al. AS-2, a novel inhibitor of p53-dependent apoptosis, prevents apoptotic mitochondrial dysfunction in a transcription-independent manner and protects mice from a lethal dose of ionizing radiation. Biochem Biophys Res Commun. 2014;450:1498-504 pubmed publisher
  771. Patel A, Burton D, Halvorsen K, Balkan W, Reiner T, Perez Stable C, et al. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways. Oncogene. 2015;34:2586-96 pubmed publisher
  772. Mingels M, Masadah R, Geels Y, Otte Holler I, de Kievit I, van der Laak J, et al. High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer. Am J Clin Pathol. 2014;142:213-21 pubmed publisher
  773. Tsou Y, Huang H, Wang T, Tai C, Chen C, Chen C. Evaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation. Biomed Res Int. 2014;2014:634945 pubmed publisher
  774. Weilbacher A, Gutekunst M, Oren M, Aulitzky W, van der Kuip H. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38. Cell Death Dis. 2014;5:e1318 pubmed publisher
  775. Brohl A, Solomon D, Chang W, Wang J, Song Y, Sindiri S, et al. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet. 2014;10:e1004475 pubmed publisher
  776. Syed B, Green A, Nolan C, Morgan D, Ellis I, Cheung K. Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. PLoS ONE. 2014;9:e100573 pubmed publisher
  777. Lindström A, Hellberg D. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome. Eur J Histochem. 2014;58:2227 pubmed publisher
  778. Oi N, Yuan J, Malakhova M, Luo K, Ryu J, Zhang L, et al. Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene. 2015;34:2660-71 pubmed publisher
  779. Yang H, Hwangbo K, Zheng M, Cho J, Son J, Kim H, et al. Inhibitory effects of (-)-loliolide on cellular senescence in human dermal fibroblasts. Arch Pharm Res. 2015;38:876-84 pubmed publisher
  780. Costales M, Lopez F, García Inclán C, Fernandez S, Marcos C, Llorente J, et al. Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model. Head Neck. 2015;37:1769-75 pubmed publisher
  781. Yamauchi T, Nishiyama M, Moroishi T, Yumimoto K, Nakayama K. MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. Mol Cell Biol. 2014;34:3321-40 pubmed publisher
  782. Piazzolla D, Palla A, Pantoja C, Canamero M, de Castro I, Ortega S, et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun. 2014;5:4226 pubmed publisher
  783. Kim C, Pasparakis M. Epidermal p65/NF-?B signalling is essential for skin carcinogenesis. EMBO Mol Med. 2014;6:970-83 pubmed publisher
  784. Micklem D, Blø M, Bergström P, Hodneland E, Tiron C, Høiby T, et al. Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targets. BMC Biotechnol. 2014;14:57 pubmed publisher
  785. Basak K, Doguc D, Aylak F, Karadayi N, Gultekin F. Effects of maternally exposed food coloring additives on laryngeal histology in rats. J Environ Pathol Toxicol Oncol. 2014;33:123-30 pubmed
  786. Schreurs L, Smit J, Pavlov K, Pultrum B, Pruim J, Groen H, et al. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer. Ann Surg Oncol. 2014;21:3751-7 pubmed publisher
  787. Luo X, Suzuki M, Ghandhi S, Amundson S, Boothman D. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence. PLoS ONE. 2014;9:e99983 pubmed publisher
  788. Lee J, Guo Z, Myler L, Zheng S, Paull T. Direct activation of ATM by resveratrol under oxidizing conditions. PLoS ONE. 2014;9:e97969 pubmed publisher
  789. Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, et al. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol. 2014;234:302-15 pubmed publisher
  790. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Kasai K, Inoue T, et al. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review. Pathol Res Pract. 2014;210:1142-5 pubmed publisher
  791. Mahadevan D, Morales C, Cooke L, Manziello A, Mount D, Persky D, et al. Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2. PLoS ONE. 2014;9:e95184 pubmed publisher
  792. Kumar P P, Emechebe U, Smith R, Franklin S, Moore B, Yandell M, et al. Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. elife. 2014;3: pubmed publisher
  793. Ying Y, Kim J, Westphal S, Long K, Padanilam B. Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. J Am Soc Nephrol. 2014;25:2707-16 pubmed publisher
  794. Zeng L, Holly J, Perks C. Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells. Front Endocrinol (Lausanne). 2014;5:61 pubmed publisher
  795. Carvalho S, Vítor A, Sridhara S, Martins F, Raposo A, Desterro J, et al. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint. elife. 2014;3:e02482 pubmed publisher
  796. Shoji K, Teishima J, Hayashi T, Ohara S, McKeehan W, Matsubara A. Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells. Oncol Rep. 2014;32:65-70 pubmed publisher
  797. Lu H, Fang E, Sykora P, Kulikowicz T, Zhang Y, Becker K, et al. Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice. Cell Death Dis. 2014;5:e1226 pubmed publisher
  798. Senkiv Y, Riabtseva A, Heffeter P, Boiko N, Kowol C, Jungwith U, et al. Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/ phospholipidic nanocarriers of doxorubicin. J Biomed Nanotechnol. 2014;10:1369-81 pubmed
  799. Kim M, Kim M, Kim H, Kim Y, Song Y. Expression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinoma. Biomed Res Int. 2014;2014:495754 pubmed publisher
  800. Moriarity B, Rahrmann E, Beckmann D, Conboy C, Watson A, Carlson D, et al. Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS ONE. 2014;9:e96114 pubmed publisher
  801. Brown D, LASSEGUE B, Lee M, Zafari R, Long J, Saavedra H, et al. Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts. PLoS ONE. 2014;9:e96657 pubmed publisher
  802. Klaus C, Kaemmerer E, Reinartz A, Schneider U, Plum P, Jeon M, et al. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas. Cell Tissue Res. 2014;357:267-78 pubmed publisher
  803. Abuali G, Chaisaklert W, Stelloo E, Pazarentzos E, Hwang M, Qize D, et al. The anticancer gene ORCTL3 targets stearoyl-CoA desaturase-1 for tumour-specific apoptosis. Oncogene. 2015;34:1718-28 pubmed publisher
  804. Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, et al. Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7:1459-1463 pubmed
  805. Li B, Iglesias Pedraz J, Chen L, Yin F, Cadenas E, Reddy S, et al. Downregulation of the Werner syndrome protein induces a metabolic shift that compromises redox homeostasis and limits proliferation of cancer cells. Aging Cell. 2014;13:367-78 pubmed
  806. Wilking M, SINGH C, Nihal M, Zhong W, Ahmad N. SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation. Arch Biochem Biophys. 2014;563:94-100 pubmed publisher
  807. Ram R, Mendiratta S, Bodemann B, Torres M, Eskiocak U, White M. RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. Mol Cell Biol. 2014;34:2350-8 pubmed publisher
  808. Bhansali M, Shemshedini L. COP9 subunits 4 and 5 target soluble guanylyl cyclase ?1 and p53 in prostate cancer cells. Mol Endocrinol. 2014;28:834-45 pubmed publisher
  809. Munne P, Gu Y, Tumiati M, Gao P, Koopal S, Uusivirta S, et al. TP53 supports basal-like differentiation of mammary epithelial cells by preventing translocation of deltaNp63 into nucleoli. Sci Rep. 2014;4:4663 pubmed publisher
  810. Rizzardi A, Rosener N, Koopmeiners J, Isaksson Vogel R, Metzger G, Forster C, et al. Evaluation of protein biomarkers of prostate cancer aggressiveness. BMC Cancer. 2014;14:244 pubmed publisher
  811. Gad H, Koolmeister T, Jemth A, Eshtad S, Jacques S, Ström C, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature. 2014;508:215-21 pubmed publisher
  812. Matsumoto T, Tabata K, Suzuki T. The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. Biol Pharm Bull. 2014;37:633-41 pubmed
  813. Girardot M, Pecquet C, Chachoua I, Van Hees J, Guibert S, Ferrant A, et al. Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation. Oncogene. 2015;34:1323-32 pubmed publisher
  814. Wong P, Yeoh C, Ahmad A, Chelala C, Gillett C, Speirs V, et al. Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer. Oncogene. 2014;33:4579-88 pubmed publisher
  815. Levay K, Slepak V. Regulation of Cop9 signalosome activity by the EF-hand Ca2+-binding protein tescalcin. J Cell Sci. 2014;127:2448-59 pubmed publisher
  816. Ma M, Baumgartner M. Intracellular Theileria annulata promote invasive cell motility through kinase regulation of the host actin cytoskeleton. PLoS Pathog. 2014;10:e1004003 pubmed publisher
  817. Kuga Y, Ohnishi H, Kodama Y, Takakura S, Hayashi M, Yagi R, et al. Cerebral and spinal cord tanycytic ependymomas in a young adult with a mutation in the NF2 gene. Neuropathology. 2014;34:406-13 pubmed publisher
  818. Sabò A, Doni M, Amati B. SUMOylation of Myc-family proteins. PLoS ONE. 2014;9:e91072 pubmed publisher
  819. Cheng J, Fan Y, Xu X, Dou J, Tang Y, Zhong X, et al. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways. Cell Death Dis. 2014;5:e1079 pubmed publisher
  820. Okada N, Lin C, Ribeiro M, Biton A, Lai G, He X, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 2014;28:438-50 pubmed publisher
  821. El Ashmawy N, El Bahrawy H, Shamloula M, El Feky O. Biochemical/metabolic changes associated with hepatocellular carcinoma development in mice. Tumour Biol. 2014;35:5459-66 pubmed publisher
  822. Milićević Z, Bajic V, Zivkovic L, Kasapović J, Andjelković U, Spremo Potparevic B. Identification of p53 and its isoforms in human breast carcinoma cells. ScientificWorldJournal. 2014;2014:618698 pubmed publisher
  823. Batsaikhan B, Kurita N, Iwata T, Sato H, Yoshikawa K, Takasu C, et al. The role of activation-induced cytidine deaminase expression in gastric adenocarcinoma. Anticancer Res. 2014;34:995-1000 pubmed
  824. Williams R, Barnhill L, Kuo H, Lin W, Batova A, Yu A, et al. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. PLoS ONE. 2014;9:e88219 pubmed publisher
  825. Berkenkamp B, Susnik N, Baisantry A, Kuznetsova I, Jacobi C, Sörensen Zender I, et al. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE. 2014;9:e88071 pubmed publisher
  826. Miyazawa N, Yoshikawa H, Magae S, Ishikawa H, Izumikawa K, Terukina G, et al. Human cell growth regulator Ly-1 antibody reactive homologue accelerates processing of preribosomal RNA. Genes Cells. 2014;19:273-86 pubmed publisher
  827. Fiori M, Barbini C, Haas T, Marroncelli N, Patrizii M, Biffoni M, et al. Antitumor effect of miR-197 targeting in p53 wild-type lung cancer. Cell Death Differ. 2014;21:774-82 pubmed publisher
  828. Borkham Kamphorst E, Schaffrath C, Van De Leur E, Haas U, Tihaa L, Meurer S, et al. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-? signaling. Biochim Biophys Acta. 2014;1843:902-14 pubmed publisher
  829. Facciuto F, Bugnon Valdano M, Marziali F, Massimi P, Banks L, Cavatorta A, et al. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein. Mol Oncol. 2014;8:533-43 pubmed publisher
  830. Furuya N, Ikeda S, Sato S, Soma S, Ezaki J, Oliva Trejo J, et al. PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation. Autophagy. 2014;10:631-41 pubmed publisher
  831. Kulzer J, Stitzel M, Morken M, Huyghe J, Fuchsberger C, Kuusisto J, et al. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. Am J Hum Genet. 2014;94:186-97 pubmed publisher
  832. Hernández Bule M, Trillo M, Ubeda A. Molecular mechanisms underlying antiproliferative and differentiating responses of hepatocarcinoma cells to subthermal electric stimulation. PLoS ONE. 2014;9:e84636 pubmed publisher
  833. Heyne K, Förster J, Schüle R, Roemer K. Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2. Nucleic Acids Res. 2014;42:3565-79 pubmed publisher
  834. Schweikl H, Petzel C, Bolay C, Hiller K, Buchalla W, Krifka S. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway. Biomaterials. 2014;35:2890-904 pubmed publisher
  835. Lindsey Boltz L, Kemp M, Reardon J, DEROCCO V, Iyer R, Modrich P, et al. Coupling of human DNA excision repair and the DNA damage checkpoint in a defined in vitro system. J Biol Chem. 2014;289:5074-82 pubmed publisher
  836. Qi M, Zhang J, Zeng W, Chen X. DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner. Biochim Biophys Acta. 2014;1839:62-9 pubmed publisher
  837. Du Y, Teng X, Wang N, Zhang X, Chen J, Ding P, et al. NF-?B and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack. J Biol Chem. 2014;289:2711-24 pubmed publisher
  838. Pishas K, Neuhaus S, Clayer M, Schreiber A, Lawrence D, Perugini M, et al. Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling. Cancer Res. 2014;74:921-31 pubmed publisher
  839. Kim S, Kim M, Kim M, Kim S, Choi J, Yu E, et al. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential. Hum Pathol. 2014;45:166-74 pubmed publisher
  840. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  841. Tanaka T, Iino M. Knockdown of Sec8 promotes cell-cycle arrest at G1/S phase by inducing p21 via control of FOXO proteins. FEBS J. 2014;281:1068-84 pubmed publisher
  842. Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed publisher
  843. Guo M, Cao Y, Wang T, Song X, Liu Z, Zhou E, et al. Baicalin inhibits Staphylococcus aureus-induced apoptosis by regulating TLR2 and TLR2-related apoptotic factors in the mouse mammary glands. Eur J Pharmacol. 2014;723:481-8 pubmed publisher
  844. Zhang R, Misra V. Effects of cyclic AMP response element binding protein-Zhangfei (CREBZF) on the unfolded protein response and cell growth are exerted through the tumor suppressor p53. Cell Cycle. 2014;13:279-92 pubmed publisher
  845. Kusama K, Yoshie M, Tamura K, Nakayama T, Nishi H, Isaka K, et al. The role of exchange protein directly activated by cyclic AMP 2-mediated calreticulin expression in the decidualization of human endometrial stromal cells. Endocrinology. 2014;155:240-8 pubmed publisher
  846. Meijer A, Kruyt F, van der Zee A, Hollema H, Le P, Ten Hoor K, et al. Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL. Br J Cancer. 2013;109:2685-95 pubmed publisher
  847. Gubanova E, Issaeva N, Gokturk C, Djureinovic T, Helleday T. SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways. Cell Cycle. 2013;12:3770-80 pubmed publisher
  848. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed publisher
  849. Fernandez S, Genis L, Torres Aleman I. A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop. Oncogene. 2014;33:4114-22 pubmed publisher
  850. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher
  851. Hou A, Voorhoeve P, Lan W, Tin M, Tong L. Comparison of gene expression profiles in primary and immortalized human pterygium fibroblast cells. Exp Cell Res. 2013;319:2781-9 pubmed publisher
  852. Chen Y, Kamili A, Hardy J, Groblewski G, Khanna K, Byrne J. Tumor protein D52 represents a negative regulator of ATM protein levels. Cell Cycle. 2013;12:3083-97 pubmed publisher
  853. Jeong Y, Jeong H, Lee S, Bong J, Park S, Oh H. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients. Oncol Rep. 2013;30:2270-8 pubmed publisher
  854. Maschio L, Madallozo B, Capellasso B, Jardim B, Moschetta M, Jampietro J, et al. Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1? and CD34 in invasive ductal carcinoma of the breast. Acta Histochem. 2014;116:148-57 pubmed publisher
  855. Xu Y, Swartz K, Siu K, Bhattacharyya M, Minella A. Fbw7-dependent cyclin E regulation ensures terminal maturation of bone marrow erythroid cells by restraining oxidative metabolism. Oncogene. 2014;33:3161-71 pubmed publisher
  856. Sy S, Jiang J, O W, Deng Y, Huen M. The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaks. Nucleic Acids Res. 2013;41:8572-80 pubmed publisher
  857. Xiong Y, Yu Y, Montani J, Yang Z, Ming X. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc. 2013;2:e000096 pubmed publisher
  858. Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  859. Noda Y, Fujita N, Kobayashi G, Ito K, Horaguchi J, Hashimoto S, et al. Prospective randomized controlled study comparing cell block method and conventional smear method for bile cytology. Dig Endosc. 2013;25:444-52 pubmed publisher
  860. Bradford C, Kumar B, Bellile E, Lee J, Taylor J, D SILVA N, et al. Biomarkers in advanced larynx cancer. Laryngoscope. 2014;124:179-87 pubmed publisher
  861. Zakharchenko O, Cojoc M, Dubrovska A, Souchelnytskyi S. A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance. PLoS ONE. 2013;8:e65163 pubmed publisher
  862. García Regalado A, Vargas M, Garcia Carranca A, Arechaga Ocampo E, Gonzalez De la Rosa C. Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells. Mol Cancer. 2013;12:44 pubmed publisher
  863. Hao J, Yang C, Liu F, Yang Y, Li S, Li W, et al. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol Med. 2012;9:197-201 pubmed publisher
  864. Brochier C, Dennis G, Rivieccio M, McLaughlin K, Coppola G, Ratan R, et al. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci. 2013;33:8621-32 pubmed publisher
  865. Ranaweera R, Yang X. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity. J Biol Chem. 2013;288:18939-46 pubmed publisher
  866. Contreras A, Mebratu Y, Delgado M, Montaño G, Hu C, Ryter S, et al. Deacetylation of p53 induces autophagy by suppressing Bmf expression. J Cell Biol. 2013;201:427-37 pubmed publisher
  867. Erdem H, Oktay M, Yildirim U, Uzunlar A, Kayikci M. Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: a microarray study. Pol J Pathol. 2013;64:28-32 pubmed
  868. Moreno A, Soleto I, García Sanz P, Moreno Bueno G, Palmero I. ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth. Oncogene. 2014;33:1945-53 pubmed publisher
  869. Kojima K, Kornblau S, Ruvolo V, Dilip A, Duvvuri S, Davis R, et al. Prognostic impact and targeting of CRM1 in acute myeloid leukemia. Blood. 2013;121:4166-74 pubmed publisher
  870. Kofod Olsen E, Møller J, Schleimann M, Bundgaard B, Bak R, Øster B, et al. Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B. PLoS ONE. 2013;8:e59223 pubmed publisher
  871. Yang B, Ma C, Chen Z, Yi W, McNutt M, Wang Y, et al. Correlation of immunoglobulin G expression and histological subtype and stage in breast cancer. PLoS ONE. 2013;8:e58706 pubmed publisher
  872. Andrews P, He Z, Tzenov Y, Popadiuk C, Kao K. Evidence of a novel role for Pygopus in rRNA transcription. Biochem J. 2013;453:61-70 pubmed publisher
  873. Kasimanickam V, Kasimanickam R, Rogers H. Immunolocalization of retinoic acid receptor-alpha, -beta, and -gamma, in bovine and canine sperm. Theriogenology. 2013;79:1010-8 pubmed publisher
  874. Martin N, Popov N, Aguilo F, O Loghlen A, Raguz S, Snijders A, et al. Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK?a regulation. EMBO J. 2013;32:982-95 pubmed publisher
  875. Yakkioui Y, Temel Y, Creytens D, Jahanshahi A, Fleischeuer R, Santegoeds R, et al. A comparison of cell-cycle markers in skull base and sacral chordomas. World Neurosurg. 2014;82:e311-8 pubmed publisher
  876. Li L, Yang G, Ren C, Tanimoto R, Hirayama T, Wang J, et al. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2. Mol Oncol. 2013;7:484-96 pubmed publisher
  877. Olszewska E, Rutkowska J, Minovi A, Sieskiewicz A, Rogowski M, Dazert S. The role of p21 and p53 proteins in congenital cholesteatoma. Otol Neurotol. 2013;34:266-74 pubmed publisher
  878. Nakamura K, Aizawa K, Nakabayashi K, Kato N, Yamauchi J, Hata K, et al. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis. PLoS ONE. 2013;8:e54036 pubmed publisher
  879. Penicud K, Behrens A. DMAP1 is an essential regulator of ATM activity and function. Oncogene. 2014;33:525-31 pubmed publisher
  880. Khoronenkova S, Dianov G. USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair. Nucleic Acids Res. 2013;41:1750-6 pubmed publisher
  881. Wu L, Shao L, Li M, Zheng J, Wang J, Feng W, et al. BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks. Radiat Res. 2013;179:160-70 pubmed publisher
  882. Zhang T, Penicud K, Bruhn C, Loizou J, Kanu N, Wang Z, et al. Competition between NBS1 and ATMIN controls ATM signaling pathway choice. Cell Rep. 2012;2:1498-504 pubmed publisher
  883. Jullien L, Mestre M, Roux P, Gire V. Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Res. 2013;41:900-11 pubmed publisher
  884. Viana L, Affonso R, Silva S, Denadai M, Matos D, Salinas de Souza C, et al. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination. Oncology. 2013;84:81-91 pubmed publisher
  885. Lau R, Niu M, Pratt M. cIAP2 represses IKK?/?-mediated activation of MDM2 to prevent p53 degradation. Cell Cycle. 2012;11:4009-19 pubmed publisher
  886. McCoy A, Besch Williford C, Franklin C, Weinstein E, Cui X. Creation and preliminary characterization of a Tp53 knockout rat. Dis Model Mech. 2013;6:269-78 pubmed publisher
  887. Rotondo F, Bernardo M, Scheithauer B, Latif S, Bogaev C, Sav A, et al. Atypical pituitary adenoma with neurocytic transformation. Appl Immunohistochem Mol Morphol. 2014;22:72-6 pubmed publisher
  888. Napoli E, Ross Inta C, Wong S, Hung C, Fujisawa Y, Sakaguchi D, et al. Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS ONE. 2012;7:e42504 pubmed publisher
  889. Frazzi R, Valli R, Tamagnini I, Casali B, Latruffe N, Merli F. Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. Int J Cancer. 2013;132:1013-21 pubmed publisher
  890. Hardee M, Marciscano A, Medina Ramirez C, Zagzag D, Narayana A, Lonning S, et al. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-?. Cancer Res. 2012;72:4119-29 pubmed publisher
  891. Gallardo A, Lerma E, Escuin D, Tibau A, Munoz J, Ojeda B, et al. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br J Cancer. 2012;106:1367-73 pubmed publisher
  892. Ottenhof N, Morsink F, Ten Kate F, Van Noorden C, Offerhaus G. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only. Cell Oncol (Dordr). 2012;35:119-26 pubmed publisher
  893. Yue W, Sai K, Wu Q, Xia Y, Yu S, Chen Z. Long-term molecular changes in WHO grade II astrocytomas following radiotherapy. Chin J Cancer. 2012;31:159-65 pubmed publisher
  894. Simon K, Ma H, Dombkowski A, Cabelof D. Aging alters folate homeostasis and DNA damage response in colon. Mech Ageing Dev. 2012;133:75-82 pubmed publisher
  895. Rebel H, Bodmann C, van de Glind G, de Gruijl F. UV-induced ablation of the epidermal basal layer including p53-mutant clones resets UV carcinogenesis showing squamous cell carcinomas to originate from interfollicular epidermis. Carcinogenesis. 2012;33:714-20 pubmed publisher
  896. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  897. Singh K, Shukla P, Quan A, Desjardins J, Lovren F, Pan Y, et al. BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure. J Biol Chem. 2012;287:6604-14 pubmed publisher
  898. Mesplede T, Gagnon D, Bergeron Labrecque F, Azar I, Sénéchal H, Coutlee F, et al. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J Virol. 2012;86:94-107 pubmed publisher
  899. Wu Y, Posner M, Schumaker L, Nikitakis N, Goloubeva O, Tan M, et al. Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial. Cancer. 2012;118:1811-7 pubmed publisher
  900. Kwon M, Suh Y. Pituicytoma with unusual histological features. Pathol Int. 2011;61:598-602 pubmed publisher
  901. Helal T, Fadel M, El Thobbani A, El Sarhi A. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors. Oral Oncol. 2012;48:120-4 pubmed publisher
  902. Liu C, Chen C, Huang A, Li J. Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. J Ethnopharmacol. 2011;137:503-11 pubmed publisher
  903. Benatti P, Dolfini D, Vigano A, Ravo M, Weisz A, Imbriano C. Specific inhibition of NF-Y subunits triggers different cell proliferation defects. Nucleic Acids Res. 2011;39:5356-68 pubmed publisher
  904. Huang Y, Chuang A, Hao H, Talbot C, Sen T, Trink B, et al. Phospho-?Np63? is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ. 2011;18:1220-30 pubmed publisher
  905. Frazzi R, Casali B, Iori M, Nicoli D, Mammi C, Merli F. Increase in clusterin forms part of the stress response in Hodgkin's lymphoma. Int J Oncol. 2011;38:677-84 pubmed publisher
  906. Lee J, Lee K, Park J, Bae S, Lee K, Lee J, et al. Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms. World J Gastroenterol. 2010;16:5353-8 pubmed
  907. Su X, Li G, Liu W, Xie B, Jiang Y. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol. 2011;39:900-8 pubmed publisher
  908. Atha D, Manne U, Grizzle W, Wagner P, Srivastava S, Reipa V. Standards for immunohistochemical imaging: a protein reference device for biomarker quantitation. J Histochem Cytochem. 2010;58:1005-14 pubmed publisher
  909. Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed publisher
  910. He J, Qiao J, Zhu H. p14ARF promoter region methylation as a marker for gliomas diagnosis. Med Oncol. 2011;28:1218-24 pubmed publisher
  911. Park H, Jang K, Heo J, Choi Y, Han J, Kim S. A potential case of intraductal tubulopapillary neoplasms of the bile duct. Pathol Int. 2010;60:630-5 pubmed publisher
  912. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer. 2011;128:1793-803 pubmed publisher
  913. Lee E, Kim T, Kim D, Choi C, Lee J, Lee J, et al. p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review. Gynecol Oncol. 2010;116:533-8 pubmed publisher
  914. Kim S, Lee J, Park S, Park J, Lim H, Kang W, et al. The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer. Med Oncol. 2010;27:1277-85 pubmed publisher
  915. Li X, Wu L, Corsa C, Kunkel S, Dou Y. Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. Mol Cell. 2009;36:290-301 pubmed publisher
  916. Suzuki S, Takeshita K, Asamoto M, Takahashi S, Kandori H, Tsujimura K, et al. High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humans. Toxicology. 2009;255:160-70 pubmed publisher
  917. Agrawal A, Sharma M, Rai S, Singh B, Tiwari M, Chandra R. The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine. Phytother Res. 2008;22:1175-82 pubmed publisher
  918. Gunia S, May M, Scholmann K, Störkel S, Hoschke B, Koch S, et al. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Arch. 2008;453:165-70 pubmed publisher
  919. Itahana K, Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell. 2008;13:542-53 pubmed publisher
  920. Wolff S, Erster S, Palacios G, Moll U. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res. 2008;18:733-44 pubmed publisher
  921. Sakasai R, Tibbetts R. RNF8-dependent and RNF8-independent regulation of 53BP1 in response to DNA damage. J Biol Chem. 2008;283:13549-55 pubmed publisher
  922. Cho E, Choi Y, Han J, Kim K, Oh Y. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol Int. 2008;58:17-25 pubmed
  923. Strauss G, Westhoff M, Fischer Posovszky P, Fulda S, Schanbacher M, Eckhoff S, et al. 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG. Cell Death Differ. 2008;15:332-43 pubmed
  924. Barzilai A, Lyakhovitsky A, Trau H, Fogel M, Huszar M. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion. J Am Acad Dermatol. 2007;57:669-76 pubmed
  925. Zarfoss M, Klauss G, Newkirk K, Kiupel M, Jones Y, Colitz C, et al. Uveal spindle cell tumor of blue-eyed dogs: an immunohistochemical study. Vet Pathol. 2007;44:276-84 pubmed
  926. Preyer M, Shu C, Wang J. Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals. Cell Death Differ. 2007;14:1139-48 pubmed
  927. Meng L, Kohn K, Pommier Y. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288). Oncogene. 2007;26:4806-16 pubmed
  928. Christmann M, Tomicic M, Origer J, Aasland D, Kaina B. c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF. Nucleic Acids Res. 2006;34:6530-9 pubmed
  929. Liu Z, Wan G, Heaphy C, Bisoffi M, Griffith J, Hu C. A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model. Mol Cell Biochem. 2007;297:179-87 pubmed
  930. Martin L, Liu Z, Chen K, Price A, Pan Y, Swaby J, et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol. 2007;500:20-46 pubmed
  931. Seidman J, Kumar D, Cosin J, Winter W, Cargill C, Boice C. Carcinomas of the female genital tract occurring after pelvic irradiation: a report of 15 cases. Int J Gynecol Pathol. 2006;25:293-7 pubmed
  932. Cho E, Choi Y, Chae S, Sohn J, Ahn G. Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms. Int J Gynecol Cancer. 2006;16:1000-6 pubmed
  933. Kanezaki R, Toki T, Xu G, Narayanan R, Ito E. Cloning and characterization of the novel chimeric gene p53/FXR2 in the acute megakaryoblastic leukemia cell line CMK11-5. Tohoku J Exp Med. 2006;209:169-80 pubmed
  934. Kim K, Park E, Seo Y, Cho H, Kim C, Kim K, et al. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. J Dermatol. 2006;33:319-25 pubmed
  935. Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev. 2006;15:258-65 pubmed
  936. Pizzimenti S, Briatore F, Laurora S, Toaldo C, Maggio M, De Grandi M, et al. 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radic Biol Med. 2006;40:1578-91 pubmed
  937. Cao Y, Zhang M, Wang J, Zhang W, Li G, Zhao J. Recurrent intracranial hemangiopericytoma with multiple metastases. Chin Med J (Engl). 2006;119:169-73 pubmed
  938. Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, Resnick M. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas. Gynecol Oncol. 2006;100:152-9 pubmed
  939. Gumus E, Erdamar S, Demirel G, Horasanli K, Kendirci M, Miroglu C. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients. Int J Urol. 2004;11:1070-7 pubmed
  940. Laurora S, Tamagno E, Briatore F, Bardini P, Pizzimenti S, Toaldo C, et al. 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radic Biol Med. 2005;38:215-25 pubmed
  941. Rosas Acosta G, Russell W, Deyrieux A, Russell D, Wilson V. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics. 2005;4:56-72 pubmed
  942. Bar Sela G, Ben Arush M, Sabo E, Kuten A, Minkov I, Ben Izhak O. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults. Pediatr Blood Cancer. 2005;45:291-7 pubmed
  943. Elso C, Lu X, Culiat C, Rutledge J, Cacheiro N, Generoso W, et al. Heightened susceptibility to chronic gastritis, hyperplasia and metaplasia in Kcnq1 mutant mice. Hum Mol Genet. 2004;13:2813-21 pubmed
  944. Mathur S, Kaur P, Sharma M, Katyal A, Singh B, Tiwari M, et al. The treatment of skin carcinoma, induced by UV B radiation, using 1-oxo-5beta, 6beta-epoxy-witha-2-enolide, isolated from the roots of Withania somnifera, in a rat model. Phytomedicine. 2004;11:452-60 pubmed
  945. Park H, Min S, Cho H, Kim K, Shin H, Park Y. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. J Cutan Pathol. 2004;31:544-9 pubmed
  946. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  947. Kim N, Wang K, Bang J, Choe G, Park Y, Kim S, et al. Glioblastomatous transformation of ganglioglioma: case report with reference to molecular genetic and flow cytometric analysis. Pathol Int. 2003;53:874-82 pubmed
  948. Mathur M, Das S, Samuels H. PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration. Oncogene. 2003;22:5031-44 pubmed
  949. Li C, Hirokawa M, Qian Z, Fujii Y, Ino H, Wakatsuki S, et al. Morules with optically clear nuclei in ovarian borderline endometrioid tumor. APMIS. 2002;110:783-8 pubmed
  950. Lee S, Park C, Sung C, Choi J, Oh Y, Cho J, et al. Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people. J Korean Med Sci. 2002;17:801-5 pubmed
  951. Rheinwald J, Hahn W, Ramsey M, Wu J, Guo Z, Tsao H, et al. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol. 2002;22:5157-72 pubmed
  952. Barshack I, Goldberg I, Chowers Y, Weiss B, Horowitz A, Kopolovic J. Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue. J Clin Pathol. 2001;54:684-8 pubmed
  953. Kang Y, Kim K, Yu Y, Lim S, Kim Y, Park K. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer. J Korean Med Sci. 2001;16:417-23 pubmed
  954. Shenk J, Fisher C, Chen S, Zhou X, Tillman K, Shemshedini L. p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. J Biol Chem. 2001;276:38472-9 pubmed
  955. Evdokiou A, Atkins G, Bouralexis S, Hay S, Raggatt L, Cowled P, et al. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone. Int J Oncol. 2001;19:625-32 pubmed
  956. Park Y, Park H, Chi S, Ushigome S, Unni K. Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma. Int J Oncol. 2001;19:353-7 pubmed
  957. Chowers I, Pe er J, Zamir E, Livni N, Ilsar M, Frucht Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology. 2001;108:985-8 pubmed
  958. Kale A, Soylemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol. 2001;184:567-74 pubmed
  959. Zeng M, Narayanan L, Xu X, Prolla T, Liskay R, Glazer P. Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways. Cancer Res. 2000;60:4889-93 pubmed
  960. Dickson M, Hahn W, Ino Y, Ronfard V, Wu J, Weinberg R, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000;20:1436-47 pubmed
  961. Tashima S, Shimada S, Yamaguchi K, Tsuruta J, Ogawa M. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas. Am J Gastroenterol. 2000;95:255-63 pubmed
  962. Shiga H, Heath E, Rasmussen A, Trock B, Johnston P, Forastiere A, et al. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res. 1999;5:4097-104 pubmed
  963. Bradford C, Wolf G, Carey T, Zhu S, Beals T, Truelson J, et al. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma. Otolaryngol Head Neck Surg. 1999;121:534-8 pubmed
  964. Hodak E, Hammel I, Feinmesser M, Zelinger A, Maron L, Sulkes J, et al. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma. Am J Dermatopathol. 1999;21:138-45 pubmed
  965. Nikol S, Huehns T, Weir L, Wight T, Hofling B. Restenosis in human vein bypass grafts. Atherosclerosis. 1998;139:31-9 pubmed
  966. Mateo M, Sanchez Beato M, Martinez J, Orfao A, Orradre J, Piris M. p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol. 1995;48:151-9 pubmed
  967. Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis L, et al. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer. 1995;75:2420-6 pubmed